{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "1ae0c9cc",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "19d13192",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Sample ID</th>\n",
       "      <th>Patient Name</th>\n",
       "      <th>Gender</th>\n",
       "      <th>DOB</th>\n",
       "      <th>Test Name</th>\n",
       "      <th>Unit</th>\n",
       "      <th>Category</th>\n",
       "      <th>Result</th>\n",
       "      <th>DOS</th>\n",
       "      <th>Standard Test Name</th>\n",
       "      <th>Lab</th>\n",
       "      <th>Age</th>\n",
       "      <th>Outcome</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>118</td>\n",
       "      <td>Xalil Ahmad Mhamad</td>\n",
       "      <td>Male</td>\n",
       "      <td>16/04/1959</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>95</td>\n",
       "      <td>16/04/2023</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>Biolab</td>\n",
       "      <td>64.0</td>\n",
       "      <td>normal</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>126</td>\n",
       "      <td>Dyar Omar</td>\n",
       "      <td>Male</td>\n",
       "      <td>16/04/1986</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>86</td>\n",
       "      <td>16/04/2023</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>Biolab</td>\n",
       "      <td>37.0</td>\n",
       "      <td>normal</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>132</td>\n",
       "      <td>Fatah Mhamad Qadr</td>\n",
       "      <td>Male</td>\n",
       "      <td>16/04/1970</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>84</td>\n",
       "      <td>16/04/2023</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>Biolab</td>\n",
       "      <td>53.0</td>\n",
       "      <td>normal</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>177</td>\n",
       "      <td>Sesna Qubad Anwar</td>\n",
       "      <td>Female</td>\n",
       "      <td>17/04/1973</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>84</td>\n",
       "      <td>17/04/2023</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>Biolab</td>\n",
       "      <td>50.0</td>\n",
       "      <td>normal</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>179</td>\n",
       "      <td>Bayan Abdulla Abdurahman</td>\n",
       "      <td>Female</td>\n",
       "      <td>17/04/1981</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>96</td>\n",
       "      <td>17/04/2023</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>Biolab</td>\n",
       "      <td>42.0</td>\n",
       "      <td>normal</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Sample ID              Patient Name  Gender         DOB    Test Name  \\\n",
       "0        118        Xalil Ahmad Mhamad    Male  16/04/1959  Blood Sugar   \n",
       "1        126                 Dyar Omar    Male  16/04/1986  Blood Sugar   \n",
       "2        132         Fatah Mhamad Qadr    Male  16/04/1970  Blood Sugar   \n",
       "3        177         Sesna Qubad Anwar  Female  17/04/1973  Blood Sugar   \n",
       "4        179  Bayan Abdulla Abdurahman  Female  17/04/1981  Blood Sugar   \n",
       "\n",
       "    Unit       Category Result         DOS Standard Test Name     Lab   Age  \\\n",
       "0  mg/dl  Diabetes Test     95  16/04/2023        Blood Sugar  Biolab  64.0   \n",
       "1  mg/dl  Diabetes Test     86  16/04/2023        Blood Sugar  Biolab  37.0   \n",
       "2  mg/dl  Diabetes Test     84  16/04/2023        Blood Sugar  Biolab  53.0   \n",
       "3  mg/dl  Diabetes Test     84  17/04/2023        Blood Sugar  Biolab  50.0   \n",
       "4  mg/dl  Diabetes Test     96  17/04/2023        Blood Sugar  Biolab  42.0   \n",
       "\n",
       "  Outcome  \n",
       "0  normal  \n",
       "1  normal  \n",
       "2  normal  \n",
       "3  normal  \n",
       "4  normal  "
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_csv('../df_cleaned.csv', encoding='latin-1')\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "26938aa7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "=== MAIN DATASET STRUCTURE ===\n",
      "Shape: (139737, 13)\n",
      "Columns: ['Sample ID', 'Patient Name', 'Gender', 'DOB', 'Test Name', 'Unit', 'Category', 'Result', 'DOS', 'Standard Test Name', 'Lab', 'Age', 'Outcome']\n",
      "Sample data:\n",
      "   Sample ID              Patient Name  Gender         DOB    Test Name  \\\n",
      "0        118        Xalil Ahmad Mhamad    Male  16/04/1959  Blood Sugar   \n",
      "1        126                 Dyar Omar    Male  16/04/1986  Blood Sugar   \n",
      "2        132         Fatah Mhamad Qadr    Male  16/04/1970  Blood Sugar   \n",
      "3        177         Sesna Qubad Anwar  Female  17/04/1973  Blood Sugar   \n",
      "4        179  Bayan Abdulla Abdurahman  Female  17/04/1981  Blood Sugar   \n",
      "\n",
      "    Unit       Category Result         DOS Standard Test Name     Lab   Age  \\\n",
      "0  mg/dl  Diabetes Test     95  16/04/2023        Blood Sugar  Biolab  64.0   \n",
      "1  mg/dl  Diabetes Test     86  16/04/2023        Blood Sugar  Biolab  37.0   \n",
      "2  mg/dl  Diabetes Test     84  16/04/2023        Blood Sugar  Biolab  53.0   \n",
      "3  mg/dl  Diabetes Test     84  17/04/2023        Blood Sugar  Biolab  50.0   \n",
      "4  mg/dl  Diabetes Test     96  17/04/2023        Blood Sugar  Biolab  42.0   \n",
      "\n",
      "  Outcome  \n",
      "0  normal  \n",
      "1  normal  \n",
      "2  normal  \n",
      "3  normal  \n",
      "4  normal  \n",
      "\n",
      "=== AGE DISTRIBUTION ===\n",
      "count    139737.000000\n",
      "mean         39.326127\n",
      "std          19.854340\n",
      "min           0.000000\n",
      "25%          26.000000\n",
      "50%          39.000000\n",
      "75%          52.000000\n",
      "max         106.000000\n",
      "Name: Age, dtype: float64\n",
      "\n",
      "=== LAB DISTRIBUTION ===\n",
      "Lab\n",
      "Biolab     74433\n",
      "Hawkari    63003\n",
      "Darugha     2301\n",
      "Name: count, dtype: int64\n",
      "Lab percentages:\n",
      "Lab\n",
      "Biolab     53.266493\n",
      "Hawkari    45.086842\n",
      "Darugha     1.646665\n",
      "Name: proportion, dtype: float64\n",
      "\n",
      "=== GENDER DISTRIBUTION ===\n",
      "Gender\n",
      "Female    88918\n",
      "Male      50819\n",
      "Name: count, dtype: int64\n",
      "Gender percentages:\n",
      "Gender\n",
      "Female    63.632395\n",
      "Male      36.367605\n",
      "Name: proportion, dtype: float64\n",
      "\n",
      "=== OUTCOME DISTRIBUTION ===\n",
      "Outcome\n",
      "normal      103085\n",
      "abnormal     36652\n",
      "Name: count, dtype: int64\n",
      "Outcome percentages:\n",
      "Outcome\n",
      "normal      73.770726\n",
      "abnormal    26.229274\n",
      "Name: proportion, dtype: float64\n",
      "\n",
      "=== DATA QUALITY CHECK ===\n",
      "Patient Name: 0 null values (0.00%)\n",
      "Standard Test Name: 0 null values (0.00%)\n",
      "Outcome: 0 null values (0.00%)\n",
      "Result: 0 null values (0.00%)\n",
      "Gender: 0 null values (0.00%)\n",
      "Lab: 0 null values (0.00%)\n",
      "\n",
      "=== AVAILABLE TESTS ===\n",
      "Total unique tests: 42\n",
      "Top 10 most common tests:\n",
      "Standard Test Name\n",
      "TSH                            12452\n",
      "Serum Creatinine                9268\n",
      "Blood Glucose                   8977\n",
      "Vitamin D3                      6841\n",
      "Complete Blood Count            6163\n",
      "C-Reactive Protein Titer        6019\n",
      "HbA1c                           5088\n",
      "Hepatitis B Surface Antigen     5025\n",
      "Total Serum Bilirubin           5020\n",
      "Hepatitis C Antibody            5007\n",
      "Name: count, dtype: int64\n"
     ]
    }
   ],
   "source": [
    "# Prepare the dataframe for classification and create dataframes for each test combination\n",
    "\n",
    "# First, let's examine the structure of our main dataset\n",
    "print(\"=== MAIN DATASET STRUCTURE ===\")\n",
    "print(f\"Shape: {df.shape}\")\n",
    "print(f\"Columns: {df.columns.tolist()}\")\n",
    "print(f\"Sample data:\")\n",
    "print(df.head())\n",
    "\n",
    "# Check the age distribution\n",
    "print(f\"\\n=== AGE DISTRIBUTION ===\")\n",
    "print(df['Age'].describe())\n",
    "\n",
    "# Check the Lab distribution\n",
    "print(f\"\\n=== LAB DISTRIBUTION ===\")\n",
    "print(df['Lab'].value_counts())\n",
    "print(f\"Lab percentages:\")\n",
    "print(df['Lab'].value_counts(normalize=True) * 100)\n",
    "\n",
    "# Check the Gender distribution\n",
    "print(f\"\\n=== GENDER DISTRIBUTION ===\")\n",
    "print(df['Gender'].value_counts())\n",
    "print(f\"Gender percentages:\")\n",
    "print(df['Gender'].value_counts(normalize=True) * 100)\n",
    "\n",
    "# Check the outcome distribution\n",
    "print(f\"\\n=== OUTCOME DISTRIBUTION ===\")\n",
    "print(df['Outcome'].value_counts())\n",
    "print(f\"Outcome percentages:\")\n",
    "print(df['Outcome'].value_counts(normalize=True) * 100)\n",
    "\n",
    "# Check for null values in key columns\n",
    "print(f\"\\n=== DATA QUALITY CHECK ===\")\n",
    "key_columns = ['Patient Name', 'Standard Test Name', 'Outcome', 'Result', 'Gender', 'Lab']\n",
    "for col in key_columns:\n",
    "    if col in df.columns:\n",
    "        null_count = df[col].isnull().sum()\n",
    "        print(f\"{col}: {null_count} null values ({null_count/len(df)*100:.2f}%)\")\n",
    "\n",
    "# Get unique test names to understand what we're working with\n",
    "print(f\"\\n=== AVAILABLE TESTS ===\")\n",
    "print(f\"Total unique tests: {df['Standard Test Name'].nunique()}\")\n",
    "test_counts = df['Standard Test Name'].value_counts()\n",
    "print(f\"Top 10 most common tests:\")\n",
    "print(test_counts.head(10))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "a3591666",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total unique tests after filtering: 42\n",
      "Pivot table shape: (31906, 42)\n",
      "Patients: 31906, Tests: 42\n",
      "Total subsets of size 5: 850668\n",
      "\n",
      "Subsets of 5 tests with more than 500 patients:\n",
      "Found 31 qualifying subsets\n",
      "\n",
      "================================================================================\n",
      "Rank 31: ('TSH', 'Serum Creatinine', 'Blood Glucose', 'Total Cholesterol', 'LDL Cholesterol') - 767 patients\n",
      "Rank 30: ('TSH', 'Serum Creatinine', 'Total Serum Bilirubin', 'Serum Ferritin', 'Blood Glucose') - 740 patients\n",
      "Rank 29: ('Serum Creatinine', 'Aspartate Aminotransferase (AST)', 'Alanine Aminotransferase (ALT)', 'Alkaline Phosphatase', 'Total Serum Bilirubin') - 705 patients\n",
      "Rank 28: ('Serum Creatinine', 'Blood Glucose', 'Total Cholesterol', 'Triglycerides', 'LDL Cholesterol') - 641 patients\n",
      "Rank 27: ('Aspartate Aminotransferase (AST)', 'Alanine Aminotransferase (ALT)', 'Alkaline Phosphatase', 'Total Serum Bilirubin', 'Blood Glucose') - 626 patients\n",
      "Rank 26: ('Serum Creatinine', 'Aspartate Aminotransferase (AST)', 'Alanine Aminotransferase (ALT)', 'Alkaline Phosphatase', 'Blood Glucose') - 602 patients\n",
      "Rank 25: ('TSH', 'Serum Creatinine', 'Total Serum Bilirubin', 'Blood Glucose', 'LDL Cholesterol') - 602 patients\n",
      "Rank 24: ('Serum Creatinine', 'Aspartate Aminotransferase (AST)', 'Alanine Aminotransferase (ALT)', 'Total Serum Bilirubin', 'Blood Glucose') - 601 patients\n",
      "Rank 23: ('Serum Cholesterol', 'Serum Triglycerides', 'Serum HDL Cholesterol', 'Serum LDL Cholesterol', 'Complete Blood Count') - 601 patients\n",
      "Rank 22: ('TSH', 'Serum Creatinine', 'Total Cholesterol', 'Triglycerides', 'LDL Cholesterol') - 576 patients\n",
      "Rank 21: ('TSH', 'Serum Cholesterol', 'Serum Triglycerides', 'Serum HDL Cholesterol', 'Serum LDL Cholesterol') - 574 patients\n",
      "Rank 20: ('TSH', 'Blood Glucose', 'Total Cholesterol', 'Triglycerides', 'LDL Cholesterol') - 572 patients\n",
      "Rank 19: ('TSH', 'Serum Creatinine', 'Blood Glucose', 'Triglycerides', 'LDL Cholesterol') - 571 patients\n",
      "Rank 18: ('TSH', 'Serum Creatinine', 'Total Serum Bilirubin', 'Blood Glucose', 'C-Reactive Protein Titer') - 568 patients\n",
      "Rank 17: ('Serum Creatinine', 'Total Serum Bilirubin', 'Blood Glucose', 'Total Cholesterol', 'LDL Cholesterol') - 562 patients\n",
      "Rank 16: ('Serum Creatinine', 'Aspartate Aminotransferase (AST)', 'Alkaline Phosphatase', 'Total Serum Bilirubin', 'Blood Glucose') - 561 patients\n",
      "Rank 15: ('Serum Creatinine', 'Alanine Aminotransferase (ALT)', 'Alkaline Phosphatase', 'Total Serum Bilirubin', 'Blood Glucose') - 561 patients\n",
      "Rank 14: ('Serum Cholesterol', 'Serum Triglycerides', 'Serum LDL Cholesterol', 'Blood Urea Nitrogen', 'Serum Creatinine') - 561 patients\n",
      "Rank 13: ('Serum Cholesterol', 'Serum Triglycerides', 'Serum HDL Cholesterol', 'Serum LDL Cholesterol', 'Serum Creatinine') - 552 patients\n",
      "Rank 12: ('TSH', 'Serum Creatinine', 'Total Serum Bilirubin', 'Total Cholesterol', 'LDL Cholesterol') - 547 patients\n",
      "Rank 11: ('TSH', 'Serum Creatinine', 'Blood Glucose', 'Total Cholesterol', 'Triglycerides') - 535 patients\n",
      "Rank 10: ('TSH', 'Total Serum Bilirubin', 'Blood Glucose', 'Total Cholesterol', 'LDL Cholesterol') - 534 patients\n",
      "Rank 9: ('Serum Cholesterol', 'Serum Triglycerides', 'Serum HDL Cholesterol', 'Serum LDL Cholesterol', 'Vitamin D3') - 528 patients\n",
      "Rank 8: ('Serum Cholesterol', 'Serum Triglycerides', 'Blood Urea Nitrogen', 'Serum Creatinine', 'Complete Blood Count') - 525 patients\n",
      "Rank 7: ('TSH', 'Serum Creatinine', 'Total Serum Bilirubin', 'Blood Glucose', 'Total Cholesterol') - 521 patients\n",
      "Rank 6: ('TSH', 'Serum Creatinine', 'Aspartate Aminotransferase (AST)', 'Alanine Aminotransferase (ALT)', 'Blood Glucose') - 509 patients\n",
      "Rank 5: ('Blood Urea Nitrogen', 'Serum Creatinine', 'Hepatitis B Surface Antigen', 'Hepatitis C Antibody', 'HIV Antibody') - 506 patients\n",
      "Rank 4: ('Serum Cholesterol', 'Serum Triglycerides', 'Serum HDL Cholesterol', 'Serum LDL Cholesterol', 'Blood Urea Nitrogen') - 504 patients\n",
      "Rank 3: ('Serum Triglycerides', 'Serum HDL Cholesterol', 'Serum LDL Cholesterol', 'Blood Urea Nitrogen', 'Serum Creatinine') - 502 patients\n",
      "Rank 2: ('Serum Cholesterol', 'Serum HDL Cholesterol', 'Serum LDL Cholesterol', 'Blood Urea Nitrogen', 'Serum Creatinine') - 501 patients\n",
      "Rank 1: ('Serum Cholesterol', 'Serum Triglycerides', 'Serum HDL Cholesterol', 'Blood Urea Nitrogen', 'Serum Creatinine') - 501 patients\n",
      "\n",
      "=== TOP SUBSETS DATAFRAME ===\n",
      "                                                                                                                                     subset  count                                                                                                                             tests\n",
      "                                                       ('TSH', 'Serum Creatinine', 'Blood Glucose', 'Total Cholesterol', 'LDL Cholesterol')    767                                                        [TSH, Serum Creatinine, Blood Glucose, Total Cholesterol, LDL Cholesterol]\n",
      "                                                    ('TSH', 'Serum Creatinine', 'Total Serum Bilirubin', 'Serum Ferritin', 'Blood Glucose')    740                                                     [TSH, Serum Creatinine, Total Serum Bilirubin, Serum Ferritin, Blood Glucose]\n",
      "('Serum Creatinine', 'Aspartate Aminotransferase (AST)', 'Alanine Aminotransferase (ALT)', 'Alkaline Phosphatase', 'Total Serum Bilirubin')    705 [Serum Creatinine, Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), Alkaline Phosphatase, Total Serum Bilirubin]\n",
      "                                             ('Serum Creatinine', 'Blood Glucose', 'Total Cholesterol', 'Triglycerides', 'LDL Cholesterol')    641                                              [Serum Creatinine, Blood Glucose, Total Cholesterol, Triglycerides, LDL Cholesterol]\n",
      "   ('Aspartate Aminotransferase (AST)', 'Alanine Aminotransferase (ALT)', 'Alkaline Phosphatase', 'Total Serum Bilirubin', 'Blood Glucose')    626    [Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), Alkaline Phosphatase, Total Serum Bilirubin, Blood Glucose]\n",
      "        ('Serum Creatinine', 'Aspartate Aminotransferase (AST)', 'Alanine Aminotransferase (ALT)', 'Alkaline Phosphatase', 'Blood Glucose')    602         [Serum Creatinine, Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), Alkaline Phosphatase, Blood Glucose]\n",
      "                                                   ('TSH', 'Serum Creatinine', 'Total Serum Bilirubin', 'Blood Glucose', 'LDL Cholesterol')    602                                                    [TSH, Serum Creatinine, Total Serum Bilirubin, Blood Glucose, LDL Cholesterol]\n",
      "       ('Serum Creatinine', 'Aspartate Aminotransferase (AST)', 'Alanine Aminotransferase (ALT)', 'Total Serum Bilirubin', 'Blood Glucose')    601        [Serum Creatinine, Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), Total Serum Bilirubin, Blood Glucose]\n",
      "                     ('Serum Cholesterol', 'Serum Triglycerides', 'Serum HDL Cholesterol', 'Serum LDL Cholesterol', 'Complete Blood Count')    601                      [Serum Cholesterol, Serum Triglycerides, Serum HDL Cholesterol, Serum LDL Cholesterol, Complete Blood Count]\n",
      "                                                       ('TSH', 'Serum Creatinine', 'Total Cholesterol', 'Triglycerides', 'LDL Cholesterol')    576                                                        [TSH, Serum Creatinine, Total Cholesterol, Triglycerides, LDL Cholesterol]\n",
      "                                      ('TSH', 'Serum Cholesterol', 'Serum Triglycerides', 'Serum HDL Cholesterol', 'Serum LDL Cholesterol')    574                                       [TSH, Serum Cholesterol, Serum Triglycerides, Serum HDL Cholesterol, Serum LDL Cholesterol]\n",
      "                                                          ('TSH', 'Blood Glucose', 'Total Cholesterol', 'Triglycerides', 'LDL Cholesterol')    572                                                           [TSH, Blood Glucose, Total Cholesterol, Triglycerides, LDL Cholesterol]\n",
      "                                                           ('TSH', 'Serum Creatinine', 'Blood Glucose', 'Triglycerides', 'LDL Cholesterol')    571                                                            [TSH, Serum Creatinine, Blood Glucose, Triglycerides, LDL Cholesterol]\n",
      "                                          ('TSH', 'Serum Creatinine', 'Total Serum Bilirubin', 'Blood Glucose', 'C-Reactive Protein Titer')    568                                           [TSH, Serum Creatinine, Total Serum Bilirubin, Blood Glucose, C-Reactive Protein Titer]\n",
      "                                     ('Serum Creatinine', 'Total Serum Bilirubin', 'Blood Glucose', 'Total Cholesterol', 'LDL Cholesterol')    562                                      [Serum Creatinine, Total Serum Bilirubin, Blood Glucose, Total Cholesterol, LDL Cholesterol]\n",
      "                 ('Serum Creatinine', 'Aspartate Aminotransferase (AST)', 'Alkaline Phosphatase', 'Total Serum Bilirubin', 'Blood Glucose')    561                  [Serum Creatinine, Aspartate Aminotransferase (AST), Alkaline Phosphatase, Total Serum Bilirubin, Blood Glucose]\n",
      "                   ('Serum Creatinine', 'Alanine Aminotransferase (ALT)', 'Alkaline Phosphatase', 'Total Serum Bilirubin', 'Blood Glucose')    561                    [Serum Creatinine, Alanine Aminotransferase (ALT), Alkaline Phosphatase, Total Serum Bilirubin, Blood Glucose]\n",
      "                           ('Serum Cholesterol', 'Serum Triglycerides', 'Serum LDL Cholesterol', 'Blood Urea Nitrogen', 'Serum Creatinine')    561                            [Serum Cholesterol, Serum Triglycerides, Serum LDL Cholesterol, Blood Urea Nitrogen, Serum Creatinine]\n",
      "                         ('Serum Cholesterol', 'Serum Triglycerides', 'Serum HDL Cholesterol', 'Serum LDL Cholesterol', 'Serum Creatinine')    552                          [Serum Cholesterol, Serum Triglycerides, Serum HDL Cholesterol, Serum LDL Cholesterol, Serum Creatinine]\n",
      "                                               ('TSH', 'Serum Creatinine', 'Total Serum Bilirubin', 'Total Cholesterol', 'LDL Cholesterol')    547                                                [TSH, Serum Creatinine, Total Serum Bilirubin, Total Cholesterol, LDL Cholesterol]\n",
      "                                                         ('TSH', 'Serum Creatinine', 'Blood Glucose', 'Total Cholesterol', 'Triglycerides')    535                                                          [TSH, Serum Creatinine, Blood Glucose, Total Cholesterol, Triglycerides]\n",
      "                                                  ('TSH', 'Total Serum Bilirubin', 'Blood Glucose', 'Total Cholesterol', 'LDL Cholesterol')    534                                                   [TSH, Total Serum Bilirubin, Blood Glucose, Total Cholesterol, LDL Cholesterol]\n",
      "                               ('Serum Cholesterol', 'Serum Triglycerides', 'Serum HDL Cholesterol', 'Serum LDL Cholesterol', 'Vitamin D3')    528                                [Serum Cholesterol, Serum Triglycerides, Serum HDL Cholesterol, Serum LDL Cholesterol, Vitamin D3]\n",
      "                            ('Serum Cholesterol', 'Serum Triglycerides', 'Blood Urea Nitrogen', 'Serum Creatinine', 'Complete Blood Count')    525                             [Serum Cholesterol, Serum Triglycerides, Blood Urea Nitrogen, Serum Creatinine, Complete Blood Count]\n",
      "                                                 ('TSH', 'Serum Creatinine', 'Total Serum Bilirubin', 'Blood Glucose', 'Total Cholesterol')    521                                                  [TSH, Serum Creatinine, Total Serum Bilirubin, Blood Glucose, Total Cholesterol]\n",
      "                         ('TSH', 'Serum Creatinine', 'Aspartate Aminotransferase (AST)', 'Alanine Aminotransferase (ALT)', 'Blood Glucose')    509                          [TSH, Serum Creatinine, Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), Blood Glucose]\n",
      "                         ('Blood Urea Nitrogen', 'Serum Creatinine', 'Hepatitis B Surface Antigen', 'Hepatitis C Antibody', 'HIV Antibody')    506                          [Blood Urea Nitrogen, Serum Creatinine, Hepatitis B Surface Antigen, Hepatitis C Antibody, HIV Antibody]\n",
      "                      ('Serum Cholesterol', 'Serum Triglycerides', 'Serum HDL Cholesterol', 'Serum LDL Cholesterol', 'Blood Urea Nitrogen')    504                       [Serum Cholesterol, Serum Triglycerides, Serum HDL Cholesterol, Serum LDL Cholesterol, Blood Urea Nitrogen]\n",
      "                       ('Serum Triglycerides', 'Serum HDL Cholesterol', 'Serum LDL Cholesterol', 'Blood Urea Nitrogen', 'Serum Creatinine')    502                        [Serum Triglycerides, Serum HDL Cholesterol, Serum LDL Cholesterol, Blood Urea Nitrogen, Serum Creatinine]\n",
      "                         ('Serum Cholesterol', 'Serum HDL Cholesterol', 'Serum LDL Cholesterol', 'Blood Urea Nitrogen', 'Serum Creatinine')    501                          [Serum Cholesterol, Serum HDL Cholesterol, Serum LDL Cholesterol, Blood Urea Nitrogen, Serum Creatinine]\n",
      "                           ('Serum Cholesterol', 'Serum Triglycerides', 'Serum HDL Cholesterol', 'Blood Urea Nitrogen', 'Serum Creatinine')    501                            [Serum Cholesterol, Serum Triglycerides, Serum HDL Cholesterol, Blood Urea Nitrogen, Serum Creatinine]\n"
     ]
    }
   ],
   "source": [
    "from itertools import combinations\n",
    "\n",
    "# bring back all the patients that are tested for v tests.\n",
    "# with more than 300 patients\n",
    "\n",
    "unique_tests = df['Standard Test Name'].unique()\n",
    "print(f\"Total unique tests after filtering: {len(unique_tests)}\")\n",
    "\n",
    "limit = 500\n",
    "v = 5\n",
    "\n",
    "# Create a pivot table with patients as rows and tests as columns\n",
    "# Count how many times each patient had each test (binary: 1 if tested, 0 if not)\n",
    "df_pivot = df.groupby(['Patient Name', 'Standard Test Name']).size().unstack(fill_value=0)\n",
    "# Convert to binary (1 if patient had the test, 0 if not)\n",
    "df_pivot = (df_pivot > 0).astype(int)\n",
    "\n",
    "print(f\"Pivot table shape: {df_pivot.shape}\")\n",
    "print(f\"Patients: {len(df_pivot)}, Tests: {len(df_pivot.columns)}\")\n",
    "\n",
    "# for each subset of v items together in unique_tests,\n",
    "# we find the subset that has more than limit patients\n",
    "subsets = list(combinations(unique_tests, v))\n",
    "print(f\"Total subsets of size {v}: {len(subsets)}\")\n",
    "\n",
    "# Initialize results list\n",
    "results = []\n",
    "\n",
    "for subset in subsets:\n",
    "    # Handle subsets of any size, not just pairs\n",
    "    if len(subset) >= 2:\n",
    "        # Check if all tests in subset exist in our pivot table\n",
    "        available_tests = [test for test in subset if test in df_pivot.columns]\n",
    "        \n",
    "        if len(available_tests) == len(subset):\n",
    "            # Create a boolean mask for patients who have all tests in the subset\n",
    "            mask = df_pivot[available_tests[0]] > 0\n",
    "            for test in available_tests[1:]:\n",
    "                mask = mask & (df_pivot[test] > 0)\n",
    "            \n",
    "            count = mask.sum()\n",
    "            if count > limit:\n",
    "                # Store results in a list for creating DataFrame\n",
    "                results.append({\n",
    "                    'subset': str(subset),\n",
    "                    'count': count,\n",
    "                    'tests': list(subset)\n",
    "                })\n",
    "\n",
    "\n",
    "# Create DataFrame from results\n",
    "results_df = pd.DataFrame(results)\n",
    "\n",
    "# Sort by count in descending order\n",
    "results_df = results_df.sort_values('count', ascending=False)\n",
    "\n",
    "print(f\"\\nSubsets of {v} tests with more than {limit} patients:\")\n",
    "print(f\"Found {len(results_df)} qualifying subsets\")\n",
    "print(\"\\n\" + \"=\"*80)\n",
    "for i, row in results_df.iterrows():\n",
    "    print(f\"Rank {len(results_df) - list(results_df.index).index(i)}: {row['subset']} - {row['count']} patients\")\n",
    "\n",
    "# Display as DataFrame\n",
    "print(f\"\\n=== TOP SUBSETS DATAFRAME ===\")\n",
    "print(results_df.to_string(index=False))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "485c7b72",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "31"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(results_df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "2565f6da",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "=== OUTCOME DISTRIBUTION ANALYSIS FOR 5-TEST COMBINATIONS ===\n",
      "Analyzing 31 test combinations with >500 patients each\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: TSH + Serum Creatinine + Blood Glucose + Total Cholesterol + LDL Cholesterol\n",
      "ğŸ“Š Total Patients: 767\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ TSH:\n",
      "   Total Records: 894\n",
      "   âœ… Normal: 676 (75.6%)\n",
      "   âŒ Abnormal: 218 (24.4%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 583 (65.2%)\n",
      "      Male: 311 (34.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 891 (99.7%)\n",
      "      Biolab: 3 (0.3%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 929\n",
      "   âœ… Normal: 663 (71.4%)\n",
      "   âŒ Abnormal: 266 (28.6%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 586 (63.1%)\n",
      "      Male: 343 (36.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 927 (99.8%)\n",
      "      Biolab: 2 (0.2%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 928\n",
      "   âœ… Normal: 928 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 591 (63.7%)\n",
      "      Male: 337 (36.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 926 (99.8%)\n",
      "      Biolab: 2 (0.2%)\n",
      "\n",
      "ğŸ“‹ Total Cholesterol:\n",
      "   Total Records: 824\n",
      "   âœ… Normal: 641 (77.8%)\n",
      "   âŒ Abnormal: 183 (22.2%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 514 (62.4%)\n",
      "      Male: 310 (37.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 824 (100.0%)\n",
      "\n",
      "ğŸ“‹ LDL Cholesterol:\n",
      "   Total Records: 854\n",
      "   âœ… Normal: 854 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 536 (62.8%)\n",
      "      Male: 318 (37.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 854 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (767 patients):\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: normal + LDL Cholesterol: normal\n",
      "      350 patients (45.6%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Blood Glucose: normal + Total Cholesterol: normal + LDL Cholesterol: normal\n",
      "      137 patients (17.9%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: normal + LDL Cholesterol: normal\n",
      "      89 patients (11.6%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: abnormal + LDL Cholesterol: normal\n",
      "      80 patients (10.4%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Blood Glucose: normal + Total Cholesterol: abnormal + LDL Cholesterol: normal\n",
      "      46 patients (6.0%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: abnormal + LDL Cholesterol: normal\n",
      "      29 patients (3.8%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Blood Glucose: normal + Total Cholesterol: normal + LDL Cholesterol: normal\n",
      "      29 patients (3.8%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Blood Glucose: normal + Total Cholesterol: abnormal + LDL Cholesterol: normal\n",
      "      7 patients (0.9%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 350 (45.6%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: TSH + Serum Creatinine + Total Serum Bilirubin + Serum Ferritin + Blood Glucose\n",
      "ğŸ“Š Total Patients: 740\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ TSH:\n",
      "   Total Records: 939\n",
      "   âœ… Normal: 663 (70.6%)\n",
      "   âŒ Abnormal: 276 (29.4%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 775 (82.5%)\n",
      "      Male: 164 (17.5%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 910 (96.9%)\n",
      "      Biolab: 29 (3.1%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 928\n",
      "   âœ… Normal: 533 (57.4%)\n",
      "   âŒ Abnormal: 395 (42.6%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 751 (80.9%)\n",
      "      Male: 177 (19.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 893 (96.2%)\n",
      "      Biolab: 35 (3.8%)\n",
      "\n",
      "ğŸ“‹ Total Serum Bilirubin:\n",
      "   Total Records: 820\n",
      "   âœ… Normal: 820 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 659 (80.4%)\n",
      "      Male: 161 (19.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 811 (98.9%)\n",
      "      Biolab: 9 (1.1%)\n",
      "\n",
      "ğŸ“‹ Serum Ferritin:\n",
      "   Total Records: 848\n",
      "   âœ… Normal: 660 (77.8%)\n",
      "   âŒ Abnormal: 188 (22.2%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 690 (81.4%)\n",
      "      Male: 158 (18.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 839 (98.9%)\n",
      "      Biolab: 9 (1.1%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 893\n",
      "   âœ… Normal: 893 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 727 (81.4%)\n",
      "      Male: 166 (18.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 880 (98.5%)\n",
      "      Biolab: 13 (1.5%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (767 patients):\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: normal + LDL Cholesterol: normal\n",
      "      350 patients (45.6%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Blood Glucose: normal + Total Cholesterol: normal + LDL Cholesterol: normal\n",
      "      137 patients (17.9%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: normal + LDL Cholesterol: normal\n",
      "      89 patients (11.6%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: abnormal + LDL Cholesterol: normal\n",
      "      80 patients (10.4%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Blood Glucose: normal + Total Cholesterol: abnormal + LDL Cholesterol: normal\n",
      "      46 patients (6.0%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: abnormal + LDL Cholesterol: normal\n",
      "      29 patients (3.8%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Blood Glucose: normal + Total Cholesterol: normal + LDL Cholesterol: normal\n",
      "      29 patients (3.8%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Blood Glucose: normal + Total Cholesterol: abnormal + LDL Cholesterol: normal\n",
      "      7 patients (0.9%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 350 (45.6%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: TSH + Serum Creatinine + Total Serum Bilirubin + Serum Ferritin + Blood Glucose\n",
      "ğŸ“Š Total Patients: 740\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ TSH:\n",
      "   Total Records: 939\n",
      "   âœ… Normal: 663 (70.6%)\n",
      "   âŒ Abnormal: 276 (29.4%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 775 (82.5%)\n",
      "      Male: 164 (17.5%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 910 (96.9%)\n",
      "      Biolab: 29 (3.1%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 928\n",
      "   âœ… Normal: 533 (57.4%)\n",
      "   âŒ Abnormal: 395 (42.6%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 751 (80.9%)\n",
      "      Male: 177 (19.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 893 (96.2%)\n",
      "      Biolab: 35 (3.8%)\n",
      "\n",
      "ğŸ“‹ Total Serum Bilirubin:\n",
      "   Total Records: 820\n",
      "   âœ… Normal: 820 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 659 (80.4%)\n",
      "      Male: 161 (19.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 811 (98.9%)\n",
      "      Biolab: 9 (1.1%)\n",
      "\n",
      "ğŸ“‹ Serum Ferritin:\n",
      "   Total Records: 848\n",
      "   âœ… Normal: 660 (77.8%)\n",
      "   âŒ Abnormal: 188 (22.2%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 690 (81.4%)\n",
      "      Male: 158 (18.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 839 (98.9%)\n",
      "      Biolab: 9 (1.1%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 893\n",
      "   âœ… Normal: 893 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 727 (81.4%)\n",
      "      Male: 166 (18.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 880 (98.5%)\n",
      "      Biolab: 13 (1.5%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (740 patients):\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Total: normal + Serum Ferritin: normal + Blood Glucose: normal\n",
      "      252 patients (34.1%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Total: normal + Serum Ferritin: normal + Blood Glucose: normal\n",
      "      202 patients (27.3%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Total: normal + Serum Ferritin: normal + Blood Glucose: normal\n",
      "      80 patients (10.8%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Total: normal + Serum Ferritin: abnormal + Blood Glucose: normal\n",
      "      66 patients (8.9%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Total: normal + Serum Ferritin: normal + Blood Glucose: normal\n",
      "      55 patients (7.4%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Total: normal + Serum Ferritin: abnormal + Blood Glucose: normal\n",
      "      55 patients (7.4%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Total: normal + Serum Ferritin: abnormal + Blood Glucose: normal\n",
      "      21 patients (2.8%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Total: normal + Serum Ferritin: abnormal + Blood Glucose: normal\n",
      "      9 patients (1.2%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 252 (34.1%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Creatinine + Aspartate Aminotransferase (AST) + Alanine Aminotransferase (ALT) + Alkaline Phosphatase + Total Serum Bilirubin\n",
      "ğŸ“Š Total Patients: 705\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 956\n",
      "   âœ… Normal: 635 (66.4%)\n",
      "   âŒ Abnormal: 321 (33.6%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 563 (58.9%)\n",
      "      Male: 393 (41.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 833 (87.1%)\n",
      "      Biolab: 123 (12.9%)\n",
      "\n",
      "ğŸ“‹ Aspartate Aminotransferase (AST):\n",
      "   Total Records: 820\n",
      "   âœ… Normal: 713 (87.0%)\n",
      "   âŒ Abnormal: 107 (13.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 479 (58.4%)\n",
      "      Male: 341 (41.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 708 (86.3%)\n",
      "      Biolab: 112 (13.7%)\n",
      "\n",
      "ğŸ“‹ Alanine Aminotransferase (ALT):\n",
      "   Total Records: 821\n",
      "   âœ… Normal: 730 (88.9%)\n",
      "   âŒ Abnormal: 91 (11.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 479 (58.3%)\n",
      "      Male: 342 (41.7%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 709 (86.4%)\n",
      "      Biolab: 112 (13.6%)\n",
      "\n",
      "ğŸ“‹ Alkaline Phosphatase:\n",
      "   Total Records: 815\n",
      "   âœ… Normal: 706 (86.6%)\n",
      "   âŒ Abnormal: 109 (13.4%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 476 (58.4%)\n",
      "      Male: 339 (41.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 706 (86.6%)\n",
      "      Biolab: 109 (13.4%)\n",
      "\n",
      "ğŸ“‹ Total Serum Bilirubin:\n",
      "   Total Records: 912\n",
      "   âœ… Normal: 912 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 530 (58.1%)\n",
      "      Male: 382 (41.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 813 (89.1%)\n",
      "      Biolab: 99 (10.9%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (740 patients):\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Total: normal + Serum Ferritin: normal + Blood Glucose: normal\n",
      "      252 patients (34.1%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Total: normal + Serum Ferritin: normal + Blood Glucose: normal\n",
      "      202 patients (27.3%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Total: normal + Serum Ferritin: normal + Blood Glucose: normal\n",
      "      80 patients (10.8%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Total: normal + Serum Ferritin: abnormal + Blood Glucose: normal\n",
      "      66 patients (8.9%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Total: normal + Serum Ferritin: normal + Blood Glucose: normal\n",
      "      55 patients (7.4%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Total: normal + Serum Ferritin: abnormal + Blood Glucose: normal\n",
      "      55 patients (7.4%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Total: normal + Serum Ferritin: abnormal + Blood Glucose: normal\n",
      "      21 patients (2.8%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Total: normal + Serum Ferritin: abnormal + Blood Glucose: normal\n",
      "      9 patients (1.2%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 252 (34.1%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Creatinine + Aspartate Aminotransferase (AST) + Alanine Aminotransferase (ALT) + Alkaline Phosphatase + Total Serum Bilirubin\n",
      "ğŸ“Š Total Patients: 705\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 956\n",
      "   âœ… Normal: 635 (66.4%)\n",
      "   âŒ Abnormal: 321 (33.6%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 563 (58.9%)\n",
      "      Male: 393 (41.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 833 (87.1%)\n",
      "      Biolab: 123 (12.9%)\n",
      "\n",
      "ğŸ“‹ Aspartate Aminotransferase (AST):\n",
      "   Total Records: 820\n",
      "   âœ… Normal: 713 (87.0%)\n",
      "   âŒ Abnormal: 107 (13.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 479 (58.4%)\n",
      "      Male: 341 (41.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 708 (86.3%)\n",
      "      Biolab: 112 (13.7%)\n",
      "\n",
      "ğŸ“‹ Alanine Aminotransferase (ALT):\n",
      "   Total Records: 821\n",
      "   âœ… Normal: 730 (88.9%)\n",
      "   âŒ Abnormal: 91 (11.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 479 (58.3%)\n",
      "      Male: 342 (41.7%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 709 (86.4%)\n",
      "      Biolab: 112 (13.6%)\n",
      "\n",
      "ğŸ“‹ Alkaline Phosphatase:\n",
      "   Total Records: 815\n",
      "   âœ… Normal: 706 (86.6%)\n",
      "   âŒ Abnormal: 109 (13.4%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 476 (58.4%)\n",
      "      Male: 339 (41.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 706 (86.6%)\n",
      "      Biolab: 109 (13.4%)\n",
      "\n",
      "ğŸ“‹ Total Serum Bilirubin:\n",
      "   Total Records: 912\n",
      "   âœ… Normal: 912 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 530 (58.1%)\n",
      "      Male: 382 (41.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 813 (89.1%)\n",
      "      Biolab: 99 (10.9%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (705 patients):\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: normal + Alanine: normal + Alkaline Phosphatase: normal + Total: normal\n",
      "      383 patients (54.3%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: normal + Alanine: normal + Alkaline Phosphatase: normal + Total: normal\n",
      "      172 patients (24.4%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: normal + Alanine: normal + Alkaline Phosphatase: abnormal + Total: normal\n",
      "      30 patients (4.3%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: normal + Alanine: normal + Alkaline Phosphatase: abnormal + Total: normal\n",
      "      21 patients (3.0%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: normal + Alanine: abnormal + Alkaline Phosphatase: normal + Total: normal\n",
      "      21 patients (3.0%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: abnormal + Alanine: abnormal + Alkaline Phosphatase: normal + Total: normal\n",
      "      15 patients (2.1%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: abnormal + Alanine: normal + Alkaline Phosphatase: normal + Total: normal\n",
      "      15 patients (2.1%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: abnormal + Alanine: abnormal + Alkaline Phosphatase: normal + Total: normal\n",
      "      9 patients (1.3%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: abnormal + Alanine: normal + Alkaline Phosphatase: normal + Total: normal\n",
      "      8 patients (1.1%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: abnormal + Alanine: abnormal + Alkaline Phosphatase: abnormal + Total: normal\n",
      "      8 patients (1.1%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 383 (54.3%)\n",
      "   Four or More Tests Abnormal: 8 (1.1%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Creatinine + Blood Glucose + Total Cholesterol + Triglycerides + LDL Cholesterol\n",
      "ğŸ“Š Total Patients: 641\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 781\n",
      "   âœ… Normal: 578 (74.0%)\n",
      "   âŒ Abnormal: 203 (26.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 475 (60.8%)\n",
      "      Male: 306 (39.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 779 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 787\n",
      "   âœ… Normal: 787 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 486 (61.8%)\n",
      "      Male: 301 (38.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 786 (99.9%)\n",
      "      Biolab: 1 (0.1%)\n",
      "\n",
      "ğŸ“‹ Total Cholesterol:\n",
      "   Total Records: 713\n",
      "   âœ… Normal: 553 (77.6%)\n",
      "   âŒ Abnormal: 160 (22.4%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 436 (61.2%)\n",
      "      Male: 277 (38.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 713 (100.0%)\n",
      "\n",
      "ğŸ“‹ Triglycerides:\n",
      "   Total Records: 697\n",
      "   âœ… Normal: 293 (42.0%)\n",
      "   âŒ Abnormal: 404 (58.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 430 (61.7%)\n",
      "      Male: 267 (38.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 697 (100.0%)\n",
      "\n",
      "ğŸ“‹ LDL Cholesterol:\n",
      "   Total Records: 736\n",
      "   âœ… Normal: 736 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 456 (62.0%)\n",
      "      Male: 280 (38.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 736 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (705 patients):\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: normal + Alanine: normal + Alkaline Phosphatase: normal + Total: normal\n",
      "      383 patients (54.3%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: normal + Alanine: normal + Alkaline Phosphatase: normal + Total: normal\n",
      "      172 patients (24.4%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: normal + Alanine: normal + Alkaline Phosphatase: abnormal + Total: normal\n",
      "      30 patients (4.3%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: normal + Alanine: normal + Alkaline Phosphatase: abnormal + Total: normal\n",
      "      21 patients (3.0%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: normal + Alanine: abnormal + Alkaline Phosphatase: normal + Total: normal\n",
      "      21 patients (3.0%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: abnormal + Alanine: abnormal + Alkaline Phosphatase: normal + Total: normal\n",
      "      15 patients (2.1%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: abnormal + Alanine: normal + Alkaline Phosphatase: normal + Total: normal\n",
      "      15 patients (2.1%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: abnormal + Alanine: abnormal + Alkaline Phosphatase: normal + Total: normal\n",
      "      9 patients (1.3%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: abnormal + Alanine: normal + Alkaline Phosphatase: normal + Total: normal\n",
      "      8 patients (1.1%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: abnormal + Alanine: abnormal + Alkaline Phosphatase: abnormal + Total: normal\n",
      "      8 patients (1.1%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 383 (54.3%)\n",
      "   Four or More Tests Abnormal: 8 (1.1%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Creatinine + Blood Glucose + Total Cholesterol + Triglycerides + LDL Cholesterol\n",
      "ğŸ“Š Total Patients: 641\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 781\n",
      "   âœ… Normal: 578 (74.0%)\n",
      "   âŒ Abnormal: 203 (26.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 475 (60.8%)\n",
      "      Male: 306 (39.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 779 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 787\n",
      "   âœ… Normal: 787 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 486 (61.8%)\n",
      "      Male: 301 (38.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 786 (99.9%)\n",
      "      Biolab: 1 (0.1%)\n",
      "\n",
      "ğŸ“‹ Total Cholesterol:\n",
      "   Total Records: 713\n",
      "   âœ… Normal: 553 (77.6%)\n",
      "   âŒ Abnormal: 160 (22.4%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 436 (61.2%)\n",
      "      Male: 277 (38.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 713 (100.0%)\n",
      "\n",
      "ğŸ“‹ Triglycerides:\n",
      "   Total Records: 697\n",
      "   âœ… Normal: 293 (42.0%)\n",
      "   âŒ Abnormal: 404 (58.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 430 (61.7%)\n",
      "      Male: 267 (38.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 697 (100.0%)\n",
      "\n",
      "ğŸ“‹ LDL Cholesterol:\n",
      "   Total Records: 736\n",
      "   âœ… Normal: 736 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 456 (62.0%)\n",
      "      Male: 280 (38.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 736 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (641 patients):\n",
      "   ğŸ“Š Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      210 patients (32.8%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      157 patients (24.5%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: abnormal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      71 patients (11.1%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      70 patients (10.9%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      67 patients (10.5%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: abnormal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      31 patients (4.8%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Blood Glucose: normal + Total Cholesterol: abnormal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      23 patients (3.6%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Blood Glucose: normal + Total Cholesterol: abnormal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      12 patients (1.9%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 157 (24.5%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Aspartate Aminotransferase (AST) + Alanine Aminotransferase (ALT) + Alkaline Phosphatase + Total Serum Bilirubin + Blood Glucose\n",
      "ğŸ“Š Total Patients: 626\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Aspartate Aminotransferase (AST):\n",
      "   Total Records: 724\n",
      "   âœ… Normal: 630 (87.0%)\n",
      "   âŒ Abnormal: 94 (13.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 434 (59.9%)\n",
      "      Male: 290 (40.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 670 (92.5%)\n",
      "      Biolab: 54 (7.5%)\n",
      "\n",
      "ğŸ“‹ Alanine Aminotransferase (ALT):\n",
      "   Total Records: 726\n",
      "   âœ… Normal: 650 (89.5%)\n",
      "   âŒ Abnormal: 76 (10.5%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 435 (59.9%)\n",
      "      Male: 291 (40.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 672 (92.6%)\n",
      "      Biolab: 54 (7.4%)\n",
      "\n",
      "ğŸ“‹ Alkaline Phosphatase:\n",
      "   Total Records: 719\n",
      "   âœ… Normal: 627 (87.2%)\n",
      "   âŒ Abnormal: 92 (12.8%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 432 (60.1%)\n",
      "      Male: 287 (39.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 667 (92.8%)\n",
      "      Biolab: 52 (7.2%)\n",
      "\n",
      "ğŸ“‹ Total Serum Bilirubin:\n",
      "   Total Records: 817\n",
      "   âœ… Normal: 817 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 484 (59.2%)\n",
      "      Male: 333 (40.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 774 (94.7%)\n",
      "      Biolab: 43 (5.3%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 806\n",
      "   âœ… Normal: 806 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 491 (60.9%)\n",
      "      Male: 315 (39.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 772 (95.8%)\n",
      "      Biolab: 34 (4.2%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (641 patients):\n",
      "   ğŸ“Š Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      210 patients (32.8%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      157 patients (24.5%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: abnormal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      71 patients (11.1%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      70 patients (10.9%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      67 patients (10.5%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: abnormal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      31 patients (4.8%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Blood Glucose: normal + Total Cholesterol: abnormal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      23 patients (3.6%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Blood Glucose: normal + Total Cholesterol: abnormal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      12 patients (1.9%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 157 (24.5%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Aspartate Aminotransferase (AST) + Alanine Aminotransferase (ALT) + Alkaline Phosphatase + Total Serum Bilirubin + Blood Glucose\n",
      "ğŸ“Š Total Patients: 626\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Aspartate Aminotransferase (AST):\n",
      "   Total Records: 724\n",
      "   âœ… Normal: 630 (87.0%)\n",
      "   âŒ Abnormal: 94 (13.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 434 (59.9%)\n",
      "      Male: 290 (40.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 670 (92.5%)\n",
      "      Biolab: 54 (7.5%)\n",
      "\n",
      "ğŸ“‹ Alanine Aminotransferase (ALT):\n",
      "   Total Records: 726\n",
      "   âœ… Normal: 650 (89.5%)\n",
      "   âŒ Abnormal: 76 (10.5%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 435 (59.9%)\n",
      "      Male: 291 (40.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 672 (92.6%)\n",
      "      Biolab: 54 (7.4%)\n",
      "\n",
      "ğŸ“‹ Alkaline Phosphatase:\n",
      "   Total Records: 719\n",
      "   âœ… Normal: 627 (87.2%)\n",
      "   âŒ Abnormal: 92 (12.8%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 432 (60.1%)\n",
      "      Male: 287 (39.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 667 (92.8%)\n",
      "      Biolab: 52 (7.2%)\n",
      "\n",
      "ğŸ“‹ Total Serum Bilirubin:\n",
      "   Total Records: 817\n",
      "   âœ… Normal: 817 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 484 (59.2%)\n",
      "      Male: 333 (40.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 774 (94.7%)\n",
      "      Biolab: 43 (5.3%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 806\n",
      "   âœ… Normal: 806 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 491 (60.9%)\n",
      "      Male: 315 (39.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 772 (95.8%)\n",
      "      Biolab: 34 (4.2%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (626 patients):\n",
      "   ğŸ“Š Aspartate: normal + Alanine: normal + Alkaline Phosphatase: normal + Total: normal + Blood Glucose: normal\n",
      "      489 patients (78.1%)\n",
      "   ğŸ“Š Aspartate: normal + Alanine: normal + Alkaline Phosphatase: abnormal + Total: normal + Blood Glucose: normal\n",
      "      48 patients (7.7%)\n",
      "   ğŸ“Š Aspartate: abnormal + Alanine: normal + Alkaline Phosphatase: normal + Total: normal + Blood Glucose: normal\n",
      "      23 patients (3.7%)\n",
      "   ğŸ“Š Aspartate: abnormal + Alanine: abnormal + Alkaline Phosphatase: normal + Total: normal + Blood Glucose: normal\n",
      "      23 patients (3.7%)\n",
      "   ğŸ“Š Aspartate: normal + Alanine: abnormal + Alkaline Phosphatase: normal + Total: normal + Blood Glucose: normal\n",
      "      22 patients (3.5%)\n",
      "   ğŸ“Š Aspartate: abnormal + Alanine: normal + Alkaline Phosphatase: abnormal + Total: normal + Blood Glucose: normal\n",
      "      12 patients (1.9%)\n",
      "   ğŸ“Š Aspartate: abnormal + Alanine: abnormal + Alkaline Phosphatase: abnormal + Total: normal + Blood Glucose: normal\n",
      "      8 patients (1.3%)\n",
      "   ğŸ“Š Aspartate: normal + Alanine: abnormal + Alkaline Phosphatase: abnormal + Total: normal + Blood Glucose: normal\n",
      "      1 patients (0.2%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 489 (78.1%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Creatinine + Aspartate Aminotransferase (AST) + Alanine Aminotransferase (ALT) + Alkaline Phosphatase + Blood Glucose\n",
      "ğŸ“Š Total Patients: 602\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 838\n",
      "   âœ… Normal: 562 (67.1%)\n",
      "   âŒ Abnormal: 276 (32.9%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 501 (59.8%)\n",
      "      Male: 337 (40.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 748 (89.3%)\n",
      "      Biolab: 90 (10.7%)\n",
      "\n",
      "ğŸ“‹ Aspartate Aminotransferase (AST):\n",
      "   Total Records: 703\n",
      "   âœ… Normal: 610 (86.8%)\n",
      "   âŒ Abnormal: 93 (13.2%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 422 (60.0%)\n",
      "      Male: 281 (40.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 618 (87.9%)\n",
      "      Biolab: 85 (12.1%)\n",
      "\n",
      "ğŸ“‹ Alanine Aminotransferase (ALT):\n",
      "   Total Records: 705\n",
      "   âœ… Normal: 634 (89.9%)\n",
      "   âŒ Abnormal: 71 (10.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 423 (60.0%)\n",
      "      Male: 282 (40.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 620 (87.9%)\n",
      "      Biolab: 85 (12.1%)\n",
      "\n",
      "ğŸ“‹ Alkaline Phosphatase:\n",
      "   Total Records: 694\n",
      "   âœ… Normal: 608 (87.6%)\n",
      "   âŒ Abnormal: 86 (12.4%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 415 (59.8%)\n",
      "      Male: 279 (40.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 617 (88.9%)\n",
      "      Biolab: 77 (11.1%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 790\n",
      "   âœ… Normal: 790 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 475 (60.1%)\n",
      "      Male: 315 (39.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 723 (91.5%)\n",
      "      Biolab: 67 (8.5%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (626 patients):\n",
      "   ğŸ“Š Aspartate: normal + Alanine: normal + Alkaline Phosphatase: normal + Total: normal + Blood Glucose: normal\n",
      "      489 patients (78.1%)\n",
      "   ğŸ“Š Aspartate: normal + Alanine: normal + Alkaline Phosphatase: abnormal + Total: normal + Blood Glucose: normal\n",
      "      48 patients (7.7%)\n",
      "   ğŸ“Š Aspartate: abnormal + Alanine: normal + Alkaline Phosphatase: normal + Total: normal + Blood Glucose: normal\n",
      "      23 patients (3.7%)\n",
      "   ğŸ“Š Aspartate: abnormal + Alanine: abnormal + Alkaline Phosphatase: normal + Total: normal + Blood Glucose: normal\n",
      "      23 patients (3.7%)\n",
      "   ğŸ“Š Aspartate: normal + Alanine: abnormal + Alkaline Phosphatase: normal + Total: normal + Blood Glucose: normal\n",
      "      22 patients (3.5%)\n",
      "   ğŸ“Š Aspartate: abnormal + Alanine: normal + Alkaline Phosphatase: abnormal + Total: normal + Blood Glucose: normal\n",
      "      12 patients (1.9%)\n",
      "   ğŸ“Š Aspartate: abnormal + Alanine: abnormal + Alkaline Phosphatase: abnormal + Total: normal + Blood Glucose: normal\n",
      "      8 patients (1.3%)\n",
      "   ğŸ“Š Aspartate: normal + Alanine: abnormal + Alkaline Phosphatase: abnormal + Total: normal + Blood Glucose: normal\n",
      "      1 patients (0.2%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 489 (78.1%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Creatinine + Aspartate Aminotransferase (AST) + Alanine Aminotransferase (ALT) + Alkaline Phosphatase + Blood Glucose\n",
      "ğŸ“Š Total Patients: 602\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 838\n",
      "   âœ… Normal: 562 (67.1%)\n",
      "   âŒ Abnormal: 276 (32.9%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 501 (59.8%)\n",
      "      Male: 337 (40.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 748 (89.3%)\n",
      "      Biolab: 90 (10.7%)\n",
      "\n",
      "ğŸ“‹ Aspartate Aminotransferase (AST):\n",
      "   Total Records: 703\n",
      "   âœ… Normal: 610 (86.8%)\n",
      "   âŒ Abnormal: 93 (13.2%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 422 (60.0%)\n",
      "      Male: 281 (40.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 618 (87.9%)\n",
      "      Biolab: 85 (12.1%)\n",
      "\n",
      "ğŸ“‹ Alanine Aminotransferase (ALT):\n",
      "   Total Records: 705\n",
      "   âœ… Normal: 634 (89.9%)\n",
      "   âŒ Abnormal: 71 (10.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 423 (60.0%)\n",
      "      Male: 282 (40.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 620 (87.9%)\n",
      "      Biolab: 85 (12.1%)\n",
      "\n",
      "ğŸ“‹ Alkaline Phosphatase:\n",
      "   Total Records: 694\n",
      "   âœ… Normal: 608 (87.6%)\n",
      "   âŒ Abnormal: 86 (12.4%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 415 (59.8%)\n",
      "      Male: 279 (40.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 617 (88.9%)\n",
      "      Biolab: 77 (11.1%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 790\n",
      "   âœ… Normal: 790 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 475 (60.1%)\n",
      "      Male: 315 (39.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 723 (91.5%)\n",
      "      Biolab: 67 (8.5%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (602 patients):\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: normal + Alanine: normal + Alkaline Phosphatase: normal + Blood Glucose: normal\n",
      "      331 patients (55.0%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: normal + Alanine: normal + Alkaline Phosphatase: normal + Blood Glucose: normal\n",
      "      141 patients (23.4%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: normal + Alanine: normal + Alkaline Phosphatase: abnormal + Blood Glucose: normal\n",
      "      26 patients (4.3%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: normal + Alanine: normal + Alkaline Phosphatase: abnormal + Blood Glucose: normal\n",
      "      18 patients (3.0%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: normal + Alanine: abnormal + Alkaline Phosphatase: normal + Blood Glucose: normal\n",
      "      17 patients (2.8%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: abnormal + Alanine: normal + Alkaline Phosphatase: normal + Blood Glucose: normal\n",
      "      15 patients (2.5%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: abnormal + Alanine: abnormal + Alkaline Phosphatase: normal + Blood Glucose: normal\n",
      "      12 patients (2.0%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: abnormal + Alanine: normal + Alkaline Phosphatase: normal + Blood Glucose: normal\n",
      "      9 patients (1.5%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: abnormal + Alanine: normal + Alkaline Phosphatase: abnormal + Blood Glucose: normal\n",
      "      8 patients (1.3%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: abnormal + Alanine: abnormal + Alkaline Phosphatase: normal + Blood Glucose: normal\n",
      "      8 patients (1.3%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 331 (55.0%)\n",
      "   Four or More Tests Abnormal: 4 (0.7%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: TSH + Serum Creatinine + Total Serum Bilirubin + Blood Glucose + LDL Cholesterol\n",
      "ğŸ“Š Total Patients: 602\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ TSH:\n",
      "   Total Records: 699\n",
      "   âœ… Normal: 534 (76.4%)\n",
      "   âŒ Abnormal: 165 (23.6%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 454 (64.9%)\n",
      "      Male: 245 (35.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 696 (99.6%)\n",
      "      Biolab: 3 (0.4%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 761\n",
      "   âœ… Normal: 532 (69.9%)\n",
      "   âŒ Abnormal: 229 (30.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 487 (64.0%)\n",
      "      Male: 274 (36.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 757 (99.5%)\n",
      "      Biolab: 4 (0.5%)\n",
      "\n",
      "ğŸ“‹ Total Serum Bilirubin:\n",
      "   Total Records: 658\n",
      "   âœ… Normal: 658 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 402 (61.1%)\n",
      "      Male: 256 (38.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 658 (100.0%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 746\n",
      "   âœ… Normal: 746 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 476 (63.8%)\n",
      "      Male: 270 (36.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 746 (100.0%)\n",
      "\n",
      "ğŸ“‹ LDL Cholesterol:\n",
      "   Total Records: 676\n",
      "   âœ… Normal: 676 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 420 (62.1%)\n",
      "      Male: 256 (37.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 676 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (602 patients):\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: normal + Alanine: normal + Alkaline Phosphatase: normal + Blood Glucose: normal\n",
      "      331 patients (55.0%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: normal + Alanine: normal + Alkaline Phosphatase: normal + Blood Glucose: normal\n",
      "      141 patients (23.4%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: normal + Alanine: normal + Alkaline Phosphatase: abnormal + Blood Glucose: normal\n",
      "      26 patients (4.3%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: normal + Alanine: normal + Alkaline Phosphatase: abnormal + Blood Glucose: normal\n",
      "      18 patients (3.0%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: normal + Alanine: abnormal + Alkaline Phosphatase: normal + Blood Glucose: normal\n",
      "      17 patients (2.8%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: abnormal + Alanine: normal + Alkaline Phosphatase: normal + Blood Glucose: normal\n",
      "      15 patients (2.5%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: abnormal + Alanine: abnormal + Alkaline Phosphatase: normal + Blood Glucose: normal\n",
      "      12 patients (2.0%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: abnormal + Alanine: normal + Alkaline Phosphatase: normal + Blood Glucose: normal\n",
      "      9 patients (1.5%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: abnormal + Alanine: normal + Alkaline Phosphatase: abnormal + Blood Glucose: normal\n",
      "      8 patients (1.3%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: abnormal + Alanine: abnormal + Alkaline Phosphatase: normal + Blood Glucose: normal\n",
      "      8 patients (1.3%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 331 (55.0%)\n",
      "   Four or More Tests Abnormal: 4 (0.7%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: TSH + Serum Creatinine + Total Serum Bilirubin + Blood Glucose + LDL Cholesterol\n",
      "ğŸ“Š Total Patients: 602\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ TSH:\n",
      "   Total Records: 699\n",
      "   âœ… Normal: 534 (76.4%)\n",
      "   âŒ Abnormal: 165 (23.6%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 454 (64.9%)\n",
      "      Male: 245 (35.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 696 (99.6%)\n",
      "      Biolab: 3 (0.4%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 761\n",
      "   âœ… Normal: 532 (69.9%)\n",
      "   âŒ Abnormal: 229 (30.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 487 (64.0%)\n",
      "      Male: 274 (36.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 757 (99.5%)\n",
      "      Biolab: 4 (0.5%)\n",
      "\n",
      "ğŸ“‹ Total Serum Bilirubin:\n",
      "   Total Records: 658\n",
      "   âœ… Normal: 658 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 402 (61.1%)\n",
      "      Male: 256 (38.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 658 (100.0%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 746\n",
      "   âœ… Normal: 746 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 476 (63.8%)\n",
      "      Male: 270 (36.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 746 (100.0%)\n",
      "\n",
      "ğŸ“‹ LDL Cholesterol:\n",
      "   Total Records: 676\n",
      "   âœ… Normal: 676 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 420 (62.1%)\n",
      "      Male: 256 (37.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 676 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (602 patients):\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Total: normal + Blood Glucose: normal + LDL Cholesterol: normal\n",
      "      337 patients (56.0%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Total: normal + Blood Glucose: normal + LDL Cholesterol: normal\n",
      "      145 patients (24.1%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Total: normal + Blood Glucose: normal + LDL Cholesterol: normal\n",
      "      92 patients (15.3%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Total: normal + Blood Glucose: normal + LDL Cholesterol: normal\n",
      "      28 patients (4.7%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 337 (56.0%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Creatinine + Aspartate Aminotransferase (AST) + Alanine Aminotransferase (ALT) + Total Serum Bilirubin + Blood Glucose\n",
      "ğŸ“Š Total Patients: 601\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 861\n",
      "   âœ… Normal: 575 (66.8%)\n",
      "   âŒ Abnormal: 286 (33.2%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 527 (61.2%)\n",
      "      Male: 334 (38.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 782 (90.8%)\n",
      "      Biolab: 79 (9.2%)\n",
      "\n",
      "ğŸ“‹ Aspartate Aminotransferase (AST):\n",
      "   Total Records: 717\n",
      "   âœ… Normal: 625 (87.2%)\n",
      "   âŒ Abnormal: 92 (12.8%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 434 (60.5%)\n",
      "      Male: 283 (39.5%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 643 (89.7%)\n",
      "      Biolab: 74 (10.3%)\n",
      "\n",
      "ğŸ“‹ Alanine Aminotransferase (ALT):\n",
      "   Total Records: 722\n",
      "   âœ… Normal: 655 (90.7%)\n",
      "   âŒ Abnormal: 67 (9.3%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 438 (60.7%)\n",
      "      Male: 284 (39.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 648 (89.8%)\n",
      "      Biolab: 74 (10.2%)\n",
      "\n",
      "ğŸ“‹ Total Serum Bilirubin:\n",
      "   Total Records: 819\n",
      "   âœ… Normal: 819 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 490 (59.8%)\n",
      "      Male: 329 (40.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 753 (91.9%)\n",
      "      Biolab: 66 (8.1%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 787\n",
      "   âœ… Normal: 787 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 479 (60.9%)\n",
      "      Male: 308 (39.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 749 (95.2%)\n",
      "      Biolab: 38 (4.8%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (602 patients):\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Total: normal + Blood Glucose: normal + LDL Cholesterol: normal\n",
      "      337 patients (56.0%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Total: normal + Blood Glucose: normal + LDL Cholesterol: normal\n",
      "      145 patients (24.1%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Total: normal + Blood Glucose: normal + LDL Cholesterol: normal\n",
      "      92 patients (15.3%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Total: normal + Blood Glucose: normal + LDL Cholesterol: normal\n",
      "      28 patients (4.7%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 337 (56.0%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Creatinine + Aspartate Aminotransferase (AST) + Alanine Aminotransferase (ALT) + Total Serum Bilirubin + Blood Glucose\n",
      "ğŸ“Š Total Patients: 601\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 861\n",
      "   âœ… Normal: 575 (66.8%)\n",
      "   âŒ Abnormal: 286 (33.2%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 527 (61.2%)\n",
      "      Male: 334 (38.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 782 (90.8%)\n",
      "      Biolab: 79 (9.2%)\n",
      "\n",
      "ğŸ“‹ Aspartate Aminotransferase (AST):\n",
      "   Total Records: 717\n",
      "   âœ… Normal: 625 (87.2%)\n",
      "   âŒ Abnormal: 92 (12.8%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 434 (60.5%)\n",
      "      Male: 283 (39.5%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 643 (89.7%)\n",
      "      Biolab: 74 (10.3%)\n",
      "\n",
      "ğŸ“‹ Alanine Aminotransferase (ALT):\n",
      "   Total Records: 722\n",
      "   âœ… Normal: 655 (90.7%)\n",
      "   âŒ Abnormal: 67 (9.3%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 438 (60.7%)\n",
      "      Male: 284 (39.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 648 (89.8%)\n",
      "      Biolab: 74 (10.2%)\n",
      "\n",
      "ğŸ“‹ Total Serum Bilirubin:\n",
      "   Total Records: 819\n",
      "   âœ… Normal: 819 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 490 (59.8%)\n",
      "      Male: 329 (40.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 753 (91.9%)\n",
      "      Biolab: 66 (8.1%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 787\n",
      "   âœ… Normal: 787 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 479 (60.9%)\n",
      "      Male: 308 (39.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 749 (95.2%)\n",
      "      Biolab: 38 (4.8%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (601 patients):\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: normal + Alanine: normal + Total: normal + Blood Glucose: normal\n",
      "      349 patients (58.1%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: normal + Alanine: normal + Total: normal + Blood Glucose: normal\n",
      "      166 patients (27.6%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: abnormal + Alanine: normal + Total: normal + Blood Glucose: normal\n",
      "      21 patients (3.5%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: abnormal + Alanine: normal + Total: normal + Blood Glucose: normal\n",
      "      19 patients (3.2%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: normal + Alanine: abnormal + Total: normal + Blood Glucose: normal\n",
      "      17 patients (2.8%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: abnormal + Alanine: abnormal + Total: normal + Blood Glucose: normal\n",
      "      16 patients (2.7%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: abnormal + Alanine: abnormal + Total: normal + Blood Glucose: normal\n",
      "      10 patients (1.7%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: normal + Alanine: abnormal + Total: normal + Blood Glucose: normal\n",
      "      3 patients (0.5%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 349 (58.1%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol + Complete Blood Count\n",
      "ğŸ“Š Total Patients: 601\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Cholesterol:\n",
      "   Total Records: 990\n",
      "   âœ… Normal: 989 (99.9%)\n",
      "   âŒ Abnormal: 1 (0.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 640 (64.6%)\n",
      "      Female: 350 (35.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 990 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum Triglycerides:\n",
      "   Total Records: 997\n",
      "   âœ… Normal: 412 (41.3%)\n",
      "   âŒ Abnormal: 585 (58.7%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 649 (65.1%)\n",
      "      Female: 348 (34.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 997 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum HDL Cholesterol:\n",
      "   Total Records: 830\n",
      "   âœ… Normal: 506 (61.0%)\n",
      "   âŒ Abnormal: 324 (39.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 530 (63.9%)\n",
      "      Female: 300 (36.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 830 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum LDL Cholesterol:\n",
      "   Total Records: 910\n",
      "   âœ… Normal: 282 (31.0%)\n",
      "   âŒ Abnormal: 628 (69.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 591 (64.9%)\n",
      "      Female: 319 (35.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 910 (100.0%)\n",
      "\n",
      "ğŸ“‹ Complete Blood Count:\n",
      "   Total Records: 784\n",
      "   âœ… Normal: 784 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 462 (58.9%)\n",
      "      Female: 322 (41.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 784 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (601 patients):\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: normal + Alanine: normal + Total: normal + Blood Glucose: normal\n",
      "      349 patients (58.1%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: normal + Alanine: normal + Total: normal + Blood Glucose: normal\n",
      "      166 patients (27.6%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: abnormal + Alanine: normal + Total: normal + Blood Glucose: normal\n",
      "      21 patients (3.5%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: abnormal + Alanine: normal + Total: normal + Blood Glucose: normal\n",
      "      19 patients (3.2%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: normal + Alanine: abnormal + Total: normal + Blood Glucose: normal\n",
      "      17 patients (2.8%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: abnormal + Alanine: abnormal + Total: normal + Blood Glucose: normal\n",
      "      16 patients (2.7%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: abnormal + Alanine: abnormal + Total: normal + Blood Glucose: normal\n",
      "      10 patients (1.7%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: normal + Alanine: abnormal + Total: normal + Blood Glucose: normal\n",
      "      3 patients (0.5%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 349 (58.1%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol + Complete Blood Count\n",
      "ğŸ“Š Total Patients: 601\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Cholesterol:\n",
      "   Total Records: 990\n",
      "   âœ… Normal: 989 (99.9%)\n",
      "   âŒ Abnormal: 1 (0.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 640 (64.6%)\n",
      "      Female: 350 (35.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 990 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum Triglycerides:\n",
      "   Total Records: 997\n",
      "   âœ… Normal: 412 (41.3%)\n",
      "   âŒ Abnormal: 585 (58.7%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 649 (65.1%)\n",
      "      Female: 348 (34.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 997 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum HDL Cholesterol:\n",
      "   Total Records: 830\n",
      "   âœ… Normal: 506 (61.0%)\n",
      "   âŒ Abnormal: 324 (39.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 530 (63.9%)\n",
      "      Female: 300 (36.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 830 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum LDL Cholesterol:\n",
      "   Total Records: 910\n",
      "   âœ… Normal: 282 (31.0%)\n",
      "   âŒ Abnormal: 628 (69.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 591 (64.9%)\n",
      "      Female: 319 (35.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 910 (100.0%)\n",
      "\n",
      "ğŸ“‹ Complete Blood Count:\n",
      "   Total Records: 784\n",
      "   âœ… Normal: 784 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 462 (58.9%)\n",
      "      Female: 322 (41.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 784 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (601 patients):\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: abnormal + Complete: normal\n",
      "      143 patients (23.8%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Serum: abnormal + Complete: normal\n",
      "      131 patients (21.8%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Serum: abnormal + Complete: normal\n",
      "      110 patients (18.3%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: normal + Complete: normal\n",
      "      85 patients (14.1%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Serum: normal + Complete: normal\n",
      "      39 patients (6.5%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: abnormal + Serum: abnormal + Complete: normal\n",
      "      32 patients (5.3%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: abnormal + Serum: normal + Complete: normal\n",
      "      31 patients (5.2%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Serum: normal + Complete: normal\n",
      "      29 patients (4.8%)\n",
      "   ğŸ“Š Serum Cholesterol: abnormal + Serum Triglycerides: abnormal + Serum: abnormal + Serum: normal + Complete: normal\n",
      "      1 patients (0.2%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 85 (14.1%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: TSH + Serum Creatinine + Total Cholesterol + Triglycerides + LDL Cholesterol\n",
      "ğŸ“Š Total Patients: 576\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ TSH:\n",
      "   Total Records: 683\n",
      "   âœ… Normal: 509 (74.5%)\n",
      "   âŒ Abnormal: 174 (25.5%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 456 (66.8%)\n",
      "      Male: 227 (33.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 681 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 677\n",
      "   âœ… Normal: 481 (71.0%)\n",
      "   âŒ Abnormal: 196 (29.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 435 (64.3%)\n",
      "      Male: 242 (35.7%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 675 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Total Cholesterol:\n",
      "   Total Records: 631\n",
      "   âœ… Normal: 487 (77.2%)\n",
      "   âŒ Abnormal: 144 (22.8%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 405 (64.2%)\n",
      "      Male: 226 (35.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 631 (100.0%)\n",
      "\n",
      "ğŸ“‹ Triglycerides:\n",
      "   Total Records: 619\n",
      "   âœ… Normal: 265 (42.8%)\n",
      "   âŒ Abnormal: 354 (57.2%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 402 (64.9%)\n",
      "      Male: 217 (35.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 619 (100.0%)\n",
      "\n",
      "ğŸ“‹ LDL Cholesterol:\n",
      "   Total Records: 649\n",
      "   âœ… Normal: 649 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 421 (64.9%)\n",
      "      Male: 228 (35.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 649 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (601 patients):\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: abnormal + Complete: normal\n",
      "      143 patients (23.8%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Serum: abnormal + Complete: normal\n",
      "      131 patients (21.8%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Serum: abnormal + Complete: normal\n",
      "      110 patients (18.3%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: normal + Complete: normal\n",
      "      85 patients (14.1%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Serum: normal + Complete: normal\n",
      "      39 patients (6.5%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: abnormal + Serum: abnormal + Complete: normal\n",
      "      32 patients (5.3%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: abnormal + Serum: normal + Complete: normal\n",
      "      31 patients (5.2%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Serum: normal + Complete: normal\n",
      "      29 patients (4.8%)\n",
      "   ğŸ“Š Serum Cholesterol: abnormal + Serum Triglycerides: abnormal + Serum: abnormal + Serum: normal + Complete: normal\n",
      "      1 patients (0.2%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 85 (14.1%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: TSH + Serum Creatinine + Total Cholesterol + Triglycerides + LDL Cholesterol\n",
      "ğŸ“Š Total Patients: 576\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ TSH:\n",
      "   Total Records: 683\n",
      "   âœ… Normal: 509 (74.5%)\n",
      "   âŒ Abnormal: 174 (25.5%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 456 (66.8%)\n",
      "      Male: 227 (33.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 681 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 677\n",
      "   âœ… Normal: 481 (71.0%)\n",
      "   âŒ Abnormal: 196 (29.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 435 (64.3%)\n",
      "      Male: 242 (35.7%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 675 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Total Cholesterol:\n",
      "   Total Records: 631\n",
      "   âœ… Normal: 487 (77.2%)\n",
      "   âŒ Abnormal: 144 (22.8%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 405 (64.2%)\n",
      "      Male: 226 (35.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 631 (100.0%)\n",
      "\n",
      "ğŸ“‹ Triglycerides:\n",
      "   Total Records: 619\n",
      "   âœ… Normal: 265 (42.8%)\n",
      "   âŒ Abnormal: 354 (57.2%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 402 (64.9%)\n",
      "      Male: 217 (35.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 619 (100.0%)\n",
      "\n",
      "ğŸ“‹ LDL Cholesterol:\n",
      "   Total Records: 649\n",
      "   âœ… Normal: 649 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 421 (64.9%)\n",
      "      Male: 228 (35.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 649 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (576 patients):\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Total Cholesterol: normal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      132 patients (22.9%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Total Cholesterol: normal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      122 patients (21.2%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Total Cholesterol: normal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      59 patients (10.2%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Total Cholesterol: normal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      50 patients (8.7%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Total Cholesterol: normal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      41 patients (7.1%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Total Cholesterol: abnormal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      37 patients (6.4%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Total Cholesterol: abnormal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      25 patients (4.3%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Total Cholesterol: normal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      24 patients (4.2%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Total Cholesterol: abnormal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      21 patients (3.6%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Total Cholesterol: abnormal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      20 patients (3.5%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 122 (21.2%)\n",
      "   Four or More Tests Abnormal: 6 (1.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: TSH + Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol\n",
      "ğŸ“Š Total Patients: 574\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ TSH:\n",
      "   Total Records: 894\n",
      "   âœ… Normal: 584 (65.3%)\n",
      "   âŒ Abnormal: 310 (34.7%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 502 (56.2%)\n",
      "      Male: 392 (43.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 887 (99.2%)\n",
      "      Hawkari: 7 (0.8%)\n",
      "\n",
      "ğŸ“‹ Serum Cholesterol:\n",
      "   Total Records: 896\n",
      "   âœ… Normal: 896 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 482 (53.8%)\n",
      "      Female: 414 (46.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 896 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum Triglycerides:\n",
      "   Total Records: 903\n",
      "   âœ… Normal: 398 (44.1%)\n",
      "   âŒ Abnormal: 505 (55.9%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 490 (54.3%)\n",
      "      Female: 413 (45.7%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 903 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum HDL Cholesterol:\n",
      "   Total Records: 750\n",
      "   âœ… Normal: 484 (64.5%)\n",
      "   âŒ Abnormal: 266 (35.5%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 397 (52.9%)\n",
      "      Female: 353 (47.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 750 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum LDL Cholesterol:\n",
      "   Total Records: 816\n",
      "   âœ… Normal: 269 (33.0%)\n",
      "   âŒ Abnormal: 547 (67.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 445 (54.5%)\n",
      "      Female: 371 (45.5%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 816 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (576 patients):\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Total Cholesterol: normal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      132 patients (22.9%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Total Cholesterol: normal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      122 patients (21.2%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Total Cholesterol: normal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      59 patients (10.2%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Total Cholesterol: normal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      50 patients (8.7%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Total Cholesterol: normal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      41 patients (7.1%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Total Cholesterol: abnormal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      37 patients (6.4%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Total Cholesterol: abnormal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      25 patients (4.3%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Total Cholesterol: normal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      24 patients (4.2%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Total Cholesterol: abnormal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      21 patients (3.6%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Total Cholesterol: abnormal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      20 patients (3.5%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 122 (21.2%)\n",
      "   Four or More Tests Abnormal: 6 (1.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: TSH + Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol\n",
      "ğŸ“Š Total Patients: 574\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ TSH:\n",
      "   Total Records: 894\n",
      "   âœ… Normal: 584 (65.3%)\n",
      "   âŒ Abnormal: 310 (34.7%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 502 (56.2%)\n",
      "      Male: 392 (43.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 887 (99.2%)\n",
      "      Hawkari: 7 (0.8%)\n",
      "\n",
      "ğŸ“‹ Serum Cholesterol:\n",
      "   Total Records: 896\n",
      "   âœ… Normal: 896 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 482 (53.8%)\n",
      "      Female: 414 (46.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 896 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum Triglycerides:\n",
      "   Total Records: 903\n",
      "   âœ… Normal: 398 (44.1%)\n",
      "   âŒ Abnormal: 505 (55.9%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 490 (54.3%)\n",
      "      Female: 413 (45.7%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 903 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum HDL Cholesterol:\n",
      "   Total Records: 750\n",
      "   âœ… Normal: 484 (64.5%)\n",
      "   âŒ Abnormal: 266 (35.5%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 397 (52.9%)\n",
      "      Female: 353 (47.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 750 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum LDL Cholesterol:\n",
      "   Total Records: 816\n",
      "   âœ… Normal: 269 (33.0%)\n",
      "   âŒ Abnormal: 547 (67.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 445 (54.5%)\n",
      "      Female: 371 (45.5%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 816 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (574 patients):\n",
      "   ğŸ“Š TSH: normal + Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: abnormal\n",
      "      99 patients (17.2%)\n",
      "   ğŸ“Š TSH: normal + Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Serum: abnormal\n",
      "      94 patients (16.4%)\n",
      "   ğŸ“Š TSH: normal + Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Serum: abnormal\n",
      "      76 patients (13.2%)\n",
      "   ğŸ“Š TSH: normal + Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: normal\n",
      "      65 patients (11.3%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: abnormal\n",
      "      33 patients (5.7%)\n",
      "   ğŸ“Š TSH: normal + Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Serum: normal\n",
      "      31 patients (5.4%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Serum: abnormal\n",
      "      30 patients (5.2%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: normal\n",
      "      29 patients (5.1%)\n",
      "   ğŸ“Š TSH: normal + Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: abnormal + Serum: normal\n",
      "      23 patients (4.0%)\n",
      "   ğŸ“Š TSH: normal + Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Serum: normal\n",
      "      23 patients (4.0%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 65 (11.3%)\n",
      "   Four or More Tests Abnormal: 20 (3.5%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: TSH + Blood Glucose + Total Cholesterol + Triglycerides + LDL Cholesterol\n",
      "ğŸ“Š Total Patients: 572\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ TSH:\n",
      "   Total Records: 681\n",
      "   âœ… Normal: 513 (75.3%)\n",
      "   âŒ Abnormal: 168 (24.7%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 462 (67.8%)\n",
      "      Male: 219 (32.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 679 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 683\n",
      "   âœ… Normal: 683 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 456 (66.8%)\n",
      "      Male: 227 (33.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 682 (99.9%)\n",
      "      Biolab: 1 (0.1%)\n",
      "\n",
      "ğŸ“‹ Total Cholesterol:\n",
      "   Total Records: 631\n",
      "   âœ… Normal: 489 (77.5%)\n",
      "   âŒ Abnormal: 142 (22.5%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 412 (65.3%)\n",
      "      Male: 219 (34.7%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 631 (100.0%)\n",
      "\n",
      "ğŸ“‹ Triglycerides:\n",
      "   Total Records: 618\n",
      "   âœ… Normal: 274 (44.3%)\n",
      "   âŒ Abnormal: 344 (55.7%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 408 (66.0%)\n",
      "      Male: 210 (34.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 618 (100.0%)\n",
      "\n",
      "ğŸ“‹ LDL Cholesterol:\n",
      "   Total Records: 648\n",
      "   âœ… Normal: 648 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 427 (65.9%)\n",
      "      Male: 221 (34.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 648 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (574 patients):\n",
      "   ğŸ“Š TSH: normal + Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: abnormal\n",
      "      99 patients (17.2%)\n",
      "   ğŸ“Š TSH: normal + Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Serum: abnormal\n",
      "      94 patients (16.4%)\n",
      "   ğŸ“Š TSH: normal + Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Serum: abnormal\n",
      "      76 patients (13.2%)\n",
      "   ğŸ“Š TSH: normal + Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: normal\n",
      "      65 patients (11.3%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: abnormal\n",
      "      33 patients (5.7%)\n",
      "   ğŸ“Š TSH: normal + Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Serum: normal\n",
      "      31 patients (5.4%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Serum: abnormal\n",
      "      30 patients (5.2%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: normal\n",
      "      29 patients (5.1%)\n",
      "   ğŸ“Š TSH: normal + Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: abnormal + Serum: normal\n",
      "      23 patients (4.0%)\n",
      "   ğŸ“Š TSH: normal + Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Serum: normal\n",
      "      23 patients (4.0%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 65 (11.3%)\n",
      "   Four or More Tests Abnormal: 20 (3.5%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: TSH + Blood Glucose + Total Cholesterol + Triglycerides + LDL Cholesterol\n",
      "ğŸ“Š Total Patients: 572\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ TSH:\n",
      "   Total Records: 681\n",
      "   âœ… Normal: 513 (75.3%)\n",
      "   âŒ Abnormal: 168 (24.7%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 462 (67.8%)\n",
      "      Male: 219 (32.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 679 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 683\n",
      "   âœ… Normal: 683 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 456 (66.8%)\n",
      "      Male: 227 (33.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 682 (99.9%)\n",
      "      Biolab: 1 (0.1%)\n",
      "\n",
      "ğŸ“‹ Total Cholesterol:\n",
      "   Total Records: 631\n",
      "   âœ… Normal: 489 (77.5%)\n",
      "   âŒ Abnormal: 142 (22.5%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 412 (65.3%)\n",
      "      Male: 219 (34.7%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 631 (100.0%)\n",
      "\n",
      "ğŸ“‹ Triglycerides:\n",
      "   Total Records: 618\n",
      "   âœ… Normal: 274 (44.3%)\n",
      "   âŒ Abnormal: 344 (55.7%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 408 (66.0%)\n",
      "      Male: 210 (34.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 618 (100.0%)\n",
      "\n",
      "ğŸ“‹ LDL Cholesterol:\n",
      "   Total Records: 648\n",
      "   âœ… Normal: 648 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 427 (65.9%)\n",
      "      Male: 221 (34.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 648 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (572 patients):\n",
      "   ğŸ“Š TSH: normal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      187 patients (32.7%)\n",
      "   ğŸ“Š TSH: normal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      179 patients (31.3%)\n",
      "   ğŸ“Š TSH: normal + Blood Glucose: normal + Total Cholesterol: abnormal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      57 patients (10.0%)\n",
      "   ğŸ“Š TSH: abnormal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      53 patients (9.3%)\n",
      "   ğŸ“Š TSH: normal + Blood Glucose: normal + Total Cholesterol: abnormal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      34 patients (5.9%)\n",
      "   ğŸ“Š TSH: abnormal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      32 patients (5.6%)\n",
      "   ğŸ“Š TSH: abnormal + Blood Glucose: normal + Total Cholesterol: abnormal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      23 patients (4.0%)\n",
      "   ğŸ“Š TSH: abnormal + Blood Glucose: normal + Total Cholesterol: abnormal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      7 patients (1.2%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 179 (31.3%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: TSH + Serum Creatinine + Blood Glucose + Triglycerides + LDL Cholesterol\n",
      "ğŸ“Š Total Patients: 571\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ TSH:\n",
      "   Total Records: 677\n",
      "   âœ… Normal: 508 (75.0%)\n",
      "   âŒ Abnormal: 169 (25.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 452 (66.8%)\n",
      "      Male: 225 (33.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 675 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 686\n",
      "   âœ… Normal: 489 (71.3%)\n",
      "   âŒ Abnormal: 197 (28.7%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 442 (64.4%)\n",
      "      Male: 244 (35.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 684 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 685\n",
      "   âœ… Normal: 685 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 450 (65.7%)\n",
      "      Male: 235 (34.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 684 (99.9%)\n",
      "      Biolab: 1 (0.1%)\n",
      "\n",
      "ğŸ“‹ Triglycerides:\n",
      "   Total Records: 610\n",
      "   âœ… Normal: 267 (43.8%)\n",
      "   âŒ Abnormal: 343 (56.2%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 394 (64.6%)\n",
      "      Male: 216 (35.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 610 (100.0%)\n",
      "\n",
      "ğŸ“‹ LDL Cholesterol:\n",
      "   Total Records: 644\n",
      "   âœ… Normal: 644 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 416 (64.6%)\n",
      "      Male: 228 (35.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 644 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (572 patients):\n",
      "   ğŸ“Š TSH: normal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      187 patients (32.7%)\n",
      "   ğŸ“Š TSH: normal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      179 patients (31.3%)\n",
      "   ğŸ“Š TSH: normal + Blood Glucose: normal + Total Cholesterol: abnormal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      57 patients (10.0%)\n",
      "   ğŸ“Š TSH: abnormal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      53 patients (9.3%)\n",
      "   ğŸ“Š TSH: normal + Blood Glucose: normal + Total Cholesterol: abnormal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      34 patients (5.9%)\n",
      "   ğŸ“Š TSH: abnormal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      32 patients (5.6%)\n",
      "   ğŸ“Š TSH: abnormal + Blood Glucose: normal + Total Cholesterol: abnormal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      23 patients (4.0%)\n",
      "   ğŸ“Š TSH: abnormal + Blood Glucose: normal + Total Cholesterol: abnormal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      7 patients (1.2%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 179 (31.3%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: TSH + Serum Creatinine + Blood Glucose + Triglycerides + LDL Cholesterol\n",
      "ğŸ“Š Total Patients: 571\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ TSH:\n",
      "   Total Records: 677\n",
      "   âœ… Normal: 508 (75.0%)\n",
      "   âŒ Abnormal: 169 (25.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 452 (66.8%)\n",
      "      Male: 225 (33.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 675 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 686\n",
      "   âœ… Normal: 489 (71.3%)\n",
      "   âŒ Abnormal: 197 (28.7%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 442 (64.4%)\n",
      "      Male: 244 (35.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 684 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 685\n",
      "   âœ… Normal: 685 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 450 (65.7%)\n",
      "      Male: 235 (34.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 684 (99.9%)\n",
      "      Biolab: 1 (0.1%)\n",
      "\n",
      "ğŸ“‹ Triglycerides:\n",
      "   Total Records: 610\n",
      "   âœ… Normal: 267 (43.8%)\n",
      "   âŒ Abnormal: 343 (56.2%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 394 (64.6%)\n",
      "      Male: 216 (35.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 610 (100.0%)\n",
      "\n",
      "ğŸ“‹ LDL Cholesterol:\n",
      "   Total Records: 644\n",
      "   âœ… Normal: 644 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 416 (64.6%)\n",
      "      Male: 228 (35.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 644 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (571 patients):\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Blood Glucose: normal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      168 patients (29.4%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Blood Glucose: normal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      147 patients (25.7%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Blood Glucose: normal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      80 patients (14.0%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Blood Glucose: normal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      59 patients (10.3%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Blood Glucose: normal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      59 patients (10.3%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Blood Glucose: normal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      29 patients (5.1%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Blood Glucose: normal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      15 patients (2.6%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Blood Glucose: normal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      14 patients (2.5%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 147 (25.7%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: TSH + Serum Creatinine + Total Serum Bilirubin + Blood Glucose + C-Reactive Protein Titer\n",
      "ğŸ“Š Total Patients: 568\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ TSH:\n",
      "   Total Records: 700\n",
      "   âœ… Normal: 504 (72.0%)\n",
      "   âŒ Abnormal: 196 (28.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 508 (72.6%)\n",
      "      Male: 192 (27.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 680 (97.1%)\n",
      "      Biolab: 20 (2.9%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 816\n",
      "   âœ… Normal: 496 (60.8%)\n",
      "   âŒ Abnormal: 320 (39.2%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 589 (72.2%)\n",
      "      Male: 227 (27.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 785 (96.2%)\n",
      "      Biolab: 31 (3.8%)\n",
      "\n",
      "ğŸ“‹ Total Serum Bilirubin:\n",
      "   Total Records: 667\n",
      "   âœ… Normal: 667 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 473 (70.9%)\n",
      "      Male: 194 (29.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 661 (99.1%)\n",
      "      Biolab: 6 (0.9%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 768\n",
      "   âœ… Normal: 768 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 553 (72.0%)\n",
      "      Male: 215 (28.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 758 (98.7%)\n",
      "      Biolab: 10 (1.3%)\n",
      "\n",
      "ğŸ“‹ C-Reactive Protein Titer:\n",
      "   Total Records: 740\n",
      "   âœ… Normal: 740 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 535 (72.3%)\n",
      "      Male: 205 (27.7%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 720 (97.3%)\n",
      "      Biolab: 20 (2.7%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (571 patients):\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Blood Glucose: normal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      168 patients (29.4%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Blood Glucose: normal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      147 patients (25.7%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Blood Glucose: normal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      80 patients (14.0%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Blood Glucose: normal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      59 patients (10.3%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Blood Glucose: normal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      59 patients (10.3%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Blood Glucose: normal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      29 patients (5.1%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Blood Glucose: normal + Triglycerides: abnormal + LDL Cholesterol: normal\n",
      "      15 patients (2.6%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Blood Glucose: normal + Triglycerides: normal + LDL Cholesterol: normal\n",
      "      14 patients (2.5%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 147 (25.7%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: TSH + Serum Creatinine + Total Serum Bilirubin + Blood Glucose + C-Reactive Protein Titer\n",
      "ğŸ“Š Total Patients: 568\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ TSH:\n",
      "   Total Records: 700\n",
      "   âœ… Normal: 504 (72.0%)\n",
      "   âŒ Abnormal: 196 (28.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 508 (72.6%)\n",
      "      Male: 192 (27.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 680 (97.1%)\n",
      "      Biolab: 20 (2.9%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 816\n",
      "   âœ… Normal: 496 (60.8%)\n",
      "   âŒ Abnormal: 320 (39.2%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 589 (72.2%)\n",
      "      Male: 227 (27.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 785 (96.2%)\n",
      "      Biolab: 31 (3.8%)\n",
      "\n",
      "ğŸ“‹ Total Serum Bilirubin:\n",
      "   Total Records: 667\n",
      "   âœ… Normal: 667 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 473 (70.9%)\n",
      "      Male: 194 (29.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 661 (99.1%)\n",
      "      Biolab: 6 (0.9%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 768\n",
      "   âœ… Normal: 768 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 553 (72.0%)\n",
      "      Male: 215 (28.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 758 (98.7%)\n",
      "      Biolab: 10 (1.3%)\n",
      "\n",
      "ğŸ“‹ C-Reactive Protein Titer:\n",
      "   Total Records: 740\n",
      "   âœ… Normal: 740 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 535 (72.3%)\n",
      "      Male: 205 (27.7%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 720 (97.3%)\n",
      "      Biolab: 20 (2.7%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (568 patients):\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Total: normal + Blood Glucose: normal + C-Reactive: normal\n",
      "      276 patients (48.6%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Total: normal + Blood Glucose: normal + C-Reactive: normal\n",
      "      167 patients (29.4%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Total: normal + Blood Glucose: normal + C-Reactive: normal\n",
      "      77 patients (13.6%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Total: normal + Blood Glucose: normal + C-Reactive: normal\n",
      "      48 patients (8.5%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 276 (48.6%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Creatinine + Total Serum Bilirubin + Blood Glucose + Total Cholesterol + LDL Cholesterol\n",
      "ğŸ“Š Total Patients: 562\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 706\n",
      "   âœ… Normal: 503 (71.2%)\n",
      "   âŒ Abnormal: 203 (28.8%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 432 (61.2%)\n",
      "      Male: 274 (38.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 704 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Total Serum Bilirubin:\n",
      "   Total Records: 619\n",
      "   âœ… Normal: 619 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 363 (58.6%)\n",
      "      Male: 256 (41.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 619 (100.0%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 706\n",
      "   âœ… Normal: 706 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 432 (61.2%)\n",
      "      Male: 274 (38.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 706 (100.0%)\n",
      "\n",
      "ğŸ“‹ Total Cholesterol:\n",
      "   Total Records: 610\n",
      "   âœ… Normal: 468 (76.7%)\n",
      "   âŒ Abnormal: 142 (23.3%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 363 (59.5%)\n",
      "      Male: 247 (40.5%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 610 (100.0%)\n",
      "\n",
      "ğŸ“‹ LDL Cholesterol:\n",
      "   Total Records: 634\n",
      "   âœ… Normal: 634 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 381 (60.1%)\n",
      "      Male: 253 (39.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 634 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (568 patients):\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Total: normal + Blood Glucose: normal + C-Reactive: normal\n",
      "      276 patients (48.6%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Total: normal + Blood Glucose: normal + C-Reactive: normal\n",
      "      167 patients (29.4%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Total: normal + Blood Glucose: normal + C-Reactive: normal\n",
      "      77 patients (13.6%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Total: normal + Blood Glucose: normal + C-Reactive: normal\n",
      "      48 patients (8.5%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 276 (48.6%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Creatinine + Total Serum Bilirubin + Blood Glucose + Total Cholesterol + LDL Cholesterol\n",
      "ğŸ“Š Total Patients: 562\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 706\n",
      "   âœ… Normal: 503 (71.2%)\n",
      "   âŒ Abnormal: 203 (28.8%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 432 (61.2%)\n",
      "      Male: 274 (38.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 704 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Total Serum Bilirubin:\n",
      "   Total Records: 619\n",
      "   âœ… Normal: 619 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 363 (58.6%)\n",
      "      Male: 256 (41.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 619 (100.0%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 706\n",
      "   âœ… Normal: 706 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 432 (61.2%)\n",
      "      Male: 274 (38.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 706 (100.0%)\n",
      "\n",
      "ğŸ“‹ Total Cholesterol:\n",
      "   Total Records: 610\n",
      "   âœ… Normal: 468 (76.7%)\n",
      "   âŒ Abnormal: 142 (23.3%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 363 (59.5%)\n",
      "      Male: 247 (40.5%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 610 (100.0%)\n",
      "\n",
      "ğŸ“‹ LDL Cholesterol:\n",
      "   Total Records: 634\n",
      "   âœ… Normal: 634 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 381 (60.1%)\n",
      "      Male: 253 (39.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 634 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (562 patients):\n",
      "   ğŸ“Š Serum Creatinine: normal + Total: normal + Blood Glucose: normal + Total Cholesterol: normal + LDL Cholesterol: normal\n",
      "      316 patients (56.2%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Total: normal + Blood Glucose: normal + Total Cholesterol: normal + LDL Cholesterol: normal\n",
      "      118 patients (21.0%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Total: normal + Blood Glucose: normal + Total Cholesterol: abnormal + LDL Cholesterol: normal\n",
      "      90 patients (16.0%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Total: normal + Blood Glucose: normal + Total Cholesterol: abnormal + LDL Cholesterol: normal\n",
      "      38 patients (6.8%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 316 (56.2%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Creatinine + Aspartate Aminotransferase (AST) + Alkaline Phosphatase + Total Serum Bilirubin + Blood Glucose\n",
      "ğŸ“Š Total Patients: 561\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 784\n",
      "   âœ… Normal: 525 (67.0%)\n",
      "   âŒ Abnormal: 259 (33.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 476 (60.7%)\n",
      "      Male: 308 (39.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 733 (93.5%)\n",
      "      Biolab: 51 (6.5%)\n",
      "\n",
      "ğŸ“‹ Aspartate Aminotransferase (AST):\n",
      "   Total Records: 655\n",
      "   âœ… Normal: 571 (87.2%)\n",
      "   âŒ Abnormal: 84 (12.8%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 394 (60.2%)\n",
      "      Male: 261 (39.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 607 (92.7%)\n",
      "      Biolab: 48 (7.3%)\n",
      "\n",
      "ğŸ“‹ Alkaline Phosphatase:\n",
      "   Total Records: 652\n",
      "   âœ… Normal: 570 (87.4%)\n",
      "   âŒ Abnormal: 82 (12.6%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 392 (60.1%)\n",
      "      Male: 260 (39.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 606 (92.9%)\n",
      "      Biolab: 46 (7.1%)\n",
      "\n",
      "ğŸ“‹ Total Serum Bilirubin:\n",
      "   Total Records: 748\n",
      "   âœ… Normal: 748 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 444 (59.4%)\n",
      "      Male: 304 (40.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 711 (95.1%)\n",
      "      Biolab: 37 (4.9%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 738\n",
      "   âœ… Normal: 738 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 450 (61.0%)\n",
      "      Male: 288 (39.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 710 (96.2%)\n",
      "      Biolab: 28 (3.8%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (562 patients):\n",
      "   ğŸ“Š Serum Creatinine: normal + Total: normal + Blood Glucose: normal + Total Cholesterol: normal + LDL Cholesterol: normal\n",
      "      316 patients (56.2%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Total: normal + Blood Glucose: normal + Total Cholesterol: normal + LDL Cholesterol: normal\n",
      "      118 patients (21.0%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Total: normal + Blood Glucose: normal + Total Cholesterol: abnormal + LDL Cholesterol: normal\n",
      "      90 patients (16.0%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Total: normal + Blood Glucose: normal + Total Cholesterol: abnormal + LDL Cholesterol: normal\n",
      "      38 patients (6.8%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 316 (56.2%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Creatinine + Aspartate Aminotransferase (AST) + Alkaline Phosphatase + Total Serum Bilirubin + Blood Glucose\n",
      "ğŸ“Š Total Patients: 561\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 784\n",
      "   âœ… Normal: 525 (67.0%)\n",
      "   âŒ Abnormal: 259 (33.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 476 (60.7%)\n",
      "      Male: 308 (39.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 733 (93.5%)\n",
      "      Biolab: 51 (6.5%)\n",
      "\n",
      "ğŸ“‹ Aspartate Aminotransferase (AST):\n",
      "   Total Records: 655\n",
      "   âœ… Normal: 571 (87.2%)\n",
      "   âŒ Abnormal: 84 (12.8%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 394 (60.2%)\n",
      "      Male: 261 (39.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 607 (92.7%)\n",
      "      Biolab: 48 (7.3%)\n",
      "\n",
      "ğŸ“‹ Alkaline Phosphatase:\n",
      "   Total Records: 652\n",
      "   âœ… Normal: 570 (87.4%)\n",
      "   âŒ Abnormal: 82 (12.6%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 392 (60.1%)\n",
      "      Male: 260 (39.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 606 (92.9%)\n",
      "      Biolab: 46 (7.1%)\n",
      "\n",
      "ğŸ“‹ Total Serum Bilirubin:\n",
      "   Total Records: 748\n",
      "   âœ… Normal: 748 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 444 (59.4%)\n",
      "      Male: 304 (40.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 711 (95.1%)\n",
      "      Biolab: 37 (4.9%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 738\n",
      "   âœ… Normal: 738 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 450 (61.0%)\n",
      "      Male: 288 (39.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 710 (96.2%)\n",
      "      Biolab: 28 (3.8%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (561 patients):\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: normal + Alkaline Phosphatase: normal + Total: normal + Blood Glucose: normal\n",
      "      324 patients (57.8%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: normal + Alkaline Phosphatase: normal + Total: normal + Blood Glucose: normal\n",
      "      136 patients (24.2%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: abnormal + Alkaline Phosphatase: normal + Total: normal + Blood Glucose: normal\n",
      "      26 patients (4.6%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: normal + Alkaline Phosphatase: abnormal + Total: normal + Blood Glucose: normal\n",
      "      25 patients (4.5%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: normal + Alkaline Phosphatase: abnormal + Total: normal + Blood Glucose: normal\n",
      "      17 patients (3.0%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: abnormal + Alkaline Phosphatase: normal + Total: normal + Blood Glucose: normal\n",
      "      15 patients (2.7%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: abnormal + Alkaline Phosphatase: abnormal + Total: normal + Blood Glucose: normal\n",
      "      10 patients (1.8%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: abnormal + Alkaline Phosphatase: abnormal + Total: normal + Blood Glucose: normal\n",
      "      8 patients (1.4%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 324 (57.8%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Creatinine + Alanine Aminotransferase (ALT) + Alkaline Phosphatase + Total Serum Bilirubin + Blood Glucose\n",
      "ğŸ“Š Total Patients: 561\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 784\n",
      "   âœ… Normal: 525 (67.0%)\n",
      "   âŒ Abnormal: 259 (33.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 476 (60.7%)\n",
      "      Male: 308 (39.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 733 (93.5%)\n",
      "      Biolab: 51 (6.5%)\n",
      "\n",
      "ğŸ“‹ Alanine Aminotransferase (ALT):\n",
      "   Total Records: 657\n",
      "   âœ… Normal: 592 (90.1%)\n",
      "   âŒ Abnormal: 65 (9.9%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 395 (60.1%)\n",
      "      Male: 262 (39.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 609 (92.7%)\n",
      "      Biolab: 48 (7.3%)\n",
      "\n",
      "ğŸ“‹ Alkaline Phosphatase:\n",
      "   Total Records: 652\n",
      "   âœ… Normal: 571 (87.6%)\n",
      "   âŒ Abnormal: 81 (12.4%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 392 (60.1%)\n",
      "      Male: 260 (39.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 606 (92.9%)\n",
      "      Biolab: 46 (7.1%)\n",
      "\n",
      "ğŸ“‹ Total Serum Bilirubin:\n",
      "   Total Records: 750\n",
      "   âœ… Normal: 750 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 444 (59.2%)\n",
      "      Male: 306 (40.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 713 (95.1%)\n",
      "      Biolab: 37 (4.9%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 738\n",
      "   âœ… Normal: 738 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 450 (61.0%)\n",
      "      Male: 288 (39.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 710 (96.2%)\n",
      "      Biolab: 28 (3.8%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (561 patients):\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: normal + Alkaline Phosphatase: normal + Total: normal + Blood Glucose: normal\n",
      "      324 patients (57.8%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: normal + Alkaline Phosphatase: normal + Total: normal + Blood Glucose: normal\n",
      "      136 patients (24.2%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: abnormal + Alkaline Phosphatase: normal + Total: normal + Blood Glucose: normal\n",
      "      26 patients (4.6%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: normal + Alkaline Phosphatase: abnormal + Total: normal + Blood Glucose: normal\n",
      "      25 patients (4.5%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: normal + Alkaline Phosphatase: abnormal + Total: normal + Blood Glucose: normal\n",
      "      17 patients (3.0%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: abnormal + Alkaline Phosphatase: normal + Total: normal + Blood Glucose: normal\n",
      "      15 patients (2.7%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Aspartate: abnormal + Alkaline Phosphatase: abnormal + Total: normal + Blood Glucose: normal\n",
      "      10 patients (1.8%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Aspartate: abnormal + Alkaline Phosphatase: abnormal + Total: normal + Blood Glucose: normal\n",
      "      8 patients (1.4%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 324 (57.8%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Creatinine + Alanine Aminotransferase (ALT) + Alkaline Phosphatase + Total Serum Bilirubin + Blood Glucose\n",
      "ğŸ“Š Total Patients: 561\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 784\n",
      "   âœ… Normal: 525 (67.0%)\n",
      "   âŒ Abnormal: 259 (33.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 476 (60.7%)\n",
      "      Male: 308 (39.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 733 (93.5%)\n",
      "      Biolab: 51 (6.5%)\n",
      "\n",
      "ğŸ“‹ Alanine Aminotransferase (ALT):\n",
      "   Total Records: 657\n",
      "   âœ… Normal: 592 (90.1%)\n",
      "   âŒ Abnormal: 65 (9.9%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 395 (60.1%)\n",
      "      Male: 262 (39.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 609 (92.7%)\n",
      "      Biolab: 48 (7.3%)\n",
      "\n",
      "ğŸ“‹ Alkaline Phosphatase:\n",
      "   Total Records: 652\n",
      "   âœ… Normal: 571 (87.6%)\n",
      "   âŒ Abnormal: 81 (12.4%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 392 (60.1%)\n",
      "      Male: 260 (39.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 606 (92.9%)\n",
      "      Biolab: 46 (7.1%)\n",
      "\n",
      "ğŸ“‹ Total Serum Bilirubin:\n",
      "   Total Records: 750\n",
      "   âœ… Normal: 750 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 444 (59.2%)\n",
      "      Male: 306 (40.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 713 (95.1%)\n",
      "      Biolab: 37 (4.9%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 738\n",
      "   âœ… Normal: 738 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 450 (61.0%)\n",
      "      Male: 288 (39.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 710 (96.2%)\n",
      "      Biolab: 28 (3.8%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (561 patients):\n",
      "   ğŸ“Š Serum Creatinine: normal + Alanine: normal + Alkaline Phosphatase: normal + Total: normal + Blood Glucose: normal\n",
      "      322 patients (57.4%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Alanine: normal + Alkaline Phosphatase: normal + Total: normal + Blood Glucose: normal\n",
      "      141 patients (25.1%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Alanine: normal + Alkaline Phosphatase: abnormal + Total: normal + Blood Glucose: normal\n",
      "      29 patients (5.2%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Alanine: abnormal + Alkaline Phosphatase: normal + Total: normal + Blood Glucose: normal\n",
      "      29 patients (5.2%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Alanine: normal + Alkaline Phosphatase: abnormal + Total: normal + Blood Glucose: normal\n",
      "      24 patients (4.3%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Alanine: abnormal + Alkaline Phosphatase: normal + Total: normal + Blood Glucose: normal\n",
      "      10 patients (1.8%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Alanine: abnormal + Alkaline Phosphatase: abnormal + Total: normal + Blood Glucose: normal\n",
      "      3 patients (0.5%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Alanine: abnormal + Alkaline Phosphatase: abnormal + Total: normal + Blood Glucose: normal\n",
      "      3 patients (0.5%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 322 (57.4%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Cholesterol + Serum Triglycerides + Serum LDL Cholesterol + Blood Urea Nitrogen + Serum Creatinine\n",
      "ğŸ“Š Total Patients: 561\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Cholesterol:\n",
      "   Total Records: 897\n",
      "   âœ… Normal: 896 (99.9%)\n",
      "   âŒ Abnormal: 1 (0.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 583 (65.0%)\n",
      "      Female: 314 (35.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 897 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum Triglycerides:\n",
      "   Total Records: 909\n",
      "   âœ… Normal: 412 (45.3%)\n",
      "   âŒ Abnormal: 497 (54.7%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 592 (65.1%)\n",
      "      Female: 317 (34.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 909 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum LDL Cholesterol:\n",
      "   Total Records: 815\n",
      "   âœ… Normal: 289 (35.5%)\n",
      "   âŒ Abnormal: 526 (64.5%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 526 (64.5%)\n",
      "      Female: 289 (35.5%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 815 (100.0%)\n",
      "\n",
      "ğŸ“‹ Blood Urea Nitrogen:\n",
      "   Total Records: 829\n",
      "   âœ… Normal: 253 (30.5%)\n",
      "   âŒ Abnormal: 576 (69.5%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 528 (63.7%)\n",
      "      Female: 301 (36.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 827 (99.8%)\n",
      "      Hawkari: 2 (0.2%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 864\n",
      "   âœ… Normal: 643 (74.4%)\n",
      "   âŒ Abnormal: 221 (25.6%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 553 (64.0%)\n",
      "      Female: 311 (36.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 861 (99.7%)\n",
      "      Hawkari: 3 (0.3%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (561 patients):\n",
      "   ğŸ“Š Serum Creatinine: normal + Alanine: normal + Alkaline Phosphatase: normal + Total: normal + Blood Glucose: normal\n",
      "      322 patients (57.4%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Alanine: normal + Alkaline Phosphatase: normal + Total: normal + Blood Glucose: normal\n",
      "      141 patients (25.1%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Alanine: normal + Alkaline Phosphatase: abnormal + Total: normal + Blood Glucose: normal\n",
      "      29 patients (5.2%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Alanine: abnormal + Alkaline Phosphatase: normal + Total: normal + Blood Glucose: normal\n",
      "      29 patients (5.2%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Alanine: normal + Alkaline Phosphatase: abnormal + Total: normal + Blood Glucose: normal\n",
      "      24 patients (4.3%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Alanine: abnormal + Alkaline Phosphatase: normal + Total: normal + Blood Glucose: normal\n",
      "      10 patients (1.8%)\n",
      "   ğŸ“Š Serum Creatinine: normal + Alanine: abnormal + Alkaline Phosphatase: abnormal + Total: normal + Blood Glucose: normal\n",
      "      3 patients (0.5%)\n",
      "   ğŸ“Š Serum Creatinine: abnormal + Alanine: abnormal + Alkaline Phosphatase: abnormal + Total: normal + Blood Glucose: normal\n",
      "      3 patients (0.5%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 322 (57.4%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Cholesterol + Serum Triglycerides + Serum LDL Cholesterol + Blood Urea Nitrogen + Serum Creatinine\n",
      "ğŸ“Š Total Patients: 561\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Cholesterol:\n",
      "   Total Records: 897\n",
      "   âœ… Normal: 896 (99.9%)\n",
      "   âŒ Abnormal: 1 (0.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 583 (65.0%)\n",
      "      Female: 314 (35.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 897 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum Triglycerides:\n",
      "   Total Records: 909\n",
      "   âœ… Normal: 412 (45.3%)\n",
      "   âŒ Abnormal: 497 (54.7%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 592 (65.1%)\n",
      "      Female: 317 (34.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 909 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum LDL Cholesterol:\n",
      "   Total Records: 815\n",
      "   âœ… Normal: 289 (35.5%)\n",
      "   âŒ Abnormal: 526 (64.5%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 526 (64.5%)\n",
      "      Female: 289 (35.5%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 815 (100.0%)\n",
      "\n",
      "ğŸ“‹ Blood Urea Nitrogen:\n",
      "   Total Records: 829\n",
      "   âœ… Normal: 253 (30.5%)\n",
      "   âŒ Abnormal: 576 (69.5%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 528 (63.7%)\n",
      "      Female: 301 (36.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 827 (99.8%)\n",
      "      Hawkari: 2 (0.2%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 864\n",
      "   âœ… Normal: 643 (74.4%)\n",
      "   âŒ Abnormal: 221 (25.6%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 553 (64.0%)\n",
      "      Female: 311 (36.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 861 (99.7%)\n",
      "      Hawkari: 3 (0.3%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (561 patients):\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Blood: abnormal + Serum Creatinine: normal\n",
      "      102 patients (18.2%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: abnormal + Blood: abnormal + Serum Creatinine: normal\n",
      "      90 patients (16.0%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Blood: normal + Serum Creatinine: normal\n",
      "      66 patients (11.8%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Blood: abnormal + Serum Creatinine: normal\n",
      "      64 patients (11.4%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Blood: abnormal + Serum Creatinine: normal\n",
      "      43 patients (7.7%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Blood: normal + Serum Creatinine: normal\n",
      "      32 patients (5.7%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: abnormal + Blood: normal + Serum Creatinine: normal\n",
      "      31 patients (5.5%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: abnormal + Blood: normal + Serum Creatinine: abnormal\n",
      "      25 patients (4.5%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Blood: abnormal + Serum Creatinine: abnormal\n",
      "      19 patients (3.4%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Blood: normal + Serum Creatinine: abnormal\n",
      "      17 patients (3.0%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 32 (5.7%)\n",
      "   Four or More Tests Abnormal: 19 (3.4%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol + Serum Creatinine\n",
      "ğŸ“Š Total Patients: 552\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Cholesterol:\n",
      "   Total Records: 899\n",
      "   âœ… Normal: 898 (99.9%)\n",
      "   âŒ Abnormal: 1 (0.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 595 (66.2%)\n",
      "      Female: 304 (33.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 899 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum Triglycerides:\n",
      "   Total Records: 904\n",
      "   âœ… Normal: 398 (44.0%)\n",
      "   âŒ Abnormal: 506 (56.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 601 (66.5%)\n",
      "      Female: 303 (33.5%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 904 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum HDL Cholesterol:\n",
      "   Total Records: 760\n",
      "   âœ… Normal: 481 (63.3%)\n",
      "   âŒ Abnormal: 279 (36.7%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 487 (64.1%)\n",
      "      Female: 273 (35.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 760 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum LDL Cholesterol:\n",
      "   Total Records: 829\n",
      "   âœ… Normal: 281 (33.9%)\n",
      "   âŒ Abnormal: 548 (66.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 544 (65.6%)\n",
      "      Female: 285 (34.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 829 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 804\n",
      "   âœ… Normal: 611 (76.0%)\n",
      "   âŒ Abnormal: 193 (24.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 534 (66.4%)\n",
      "      Female: 270 (33.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 792 (98.5%)\n",
      "      Hawkari: 12 (1.5%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (561 patients):\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Blood: abnormal + Serum Creatinine: normal\n",
      "      102 patients (18.2%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: abnormal + Blood: abnormal + Serum Creatinine: normal\n",
      "      90 patients (16.0%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Blood: normal + Serum Creatinine: normal\n",
      "      66 patients (11.8%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Blood: abnormal + Serum Creatinine: normal\n",
      "      64 patients (11.4%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Blood: abnormal + Serum Creatinine: normal\n",
      "      43 patients (7.7%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Blood: normal + Serum Creatinine: normal\n",
      "      32 patients (5.7%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: abnormal + Blood: normal + Serum Creatinine: normal\n",
      "      31 patients (5.5%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: abnormal + Blood: normal + Serum Creatinine: abnormal\n",
      "      25 patients (4.5%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Blood: abnormal + Serum Creatinine: abnormal\n",
      "      19 patients (3.4%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Blood: normal + Serum Creatinine: abnormal\n",
      "      17 patients (3.0%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 32 (5.7%)\n",
      "   Four or More Tests Abnormal: 19 (3.4%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol + Serum Creatinine\n",
      "ğŸ“Š Total Patients: 552\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Cholesterol:\n",
      "   Total Records: 899\n",
      "   âœ… Normal: 898 (99.9%)\n",
      "   âŒ Abnormal: 1 (0.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 595 (66.2%)\n",
      "      Female: 304 (33.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 899 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum Triglycerides:\n",
      "   Total Records: 904\n",
      "   âœ… Normal: 398 (44.0%)\n",
      "   âŒ Abnormal: 506 (56.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 601 (66.5%)\n",
      "      Female: 303 (33.5%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 904 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum HDL Cholesterol:\n",
      "   Total Records: 760\n",
      "   âœ… Normal: 481 (63.3%)\n",
      "   âŒ Abnormal: 279 (36.7%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 487 (64.1%)\n",
      "      Female: 273 (35.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 760 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum LDL Cholesterol:\n",
      "   Total Records: 829\n",
      "   âœ… Normal: 281 (33.9%)\n",
      "   âŒ Abnormal: 548 (66.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 544 (65.6%)\n",
      "      Female: 285 (34.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 829 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 804\n",
      "   âœ… Normal: 611 (76.0%)\n",
      "   âŒ Abnormal: 193 (24.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 534 (66.4%)\n",
      "      Female: 270 (33.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 792 (98.5%)\n",
      "      Hawkari: 12 (1.5%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (552 patients):\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Serum: abnormal + Serum Creatinine: normal\n",
      "      94 patients (17.0%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: abnormal + Serum Creatinine: normal\n",
      "      89 patients (16.1%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Serum: abnormal + Serum Creatinine: normal\n",
      "      84 patients (15.2%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: normal + Serum Creatinine: normal\n",
      "      66 patients (12.0%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: abnormal + Serum Creatinine: abnormal\n",
      "      36 patients (6.5%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Serum: normal + Serum Creatinine: normal\n",
      "      28 patients (5.1%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: abnormal + Serum: normal + Serum Creatinine: normal\n",
      "      27 patients (4.9%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: abnormal + Serum: abnormal + Serum Creatinine: normal\n",
      "      26 patients (4.7%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Serum: abnormal + Serum Creatinine: abnormal\n",
      "      24 patients (4.3%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: normal + Serum Creatinine: abnormal\n",
      "      23 patients (4.2%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 66 (12.0%)\n",
      "   Four or More Tests Abnormal: 8 (1.4%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: TSH + Serum Creatinine + Total Serum Bilirubin + Total Cholesterol + LDL Cholesterol\n",
      "ğŸ“Š Total Patients: 547\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ TSH:\n",
      "   Total Records: 635\n",
      "   âœ… Normal: 488 (76.9%)\n",
      "   âŒ Abnormal: 147 (23.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 398 (62.7%)\n",
      "      Male: 237 (37.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 633 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 676\n",
      "   âœ… Normal: 483 (71.4%)\n",
      "   âŒ Abnormal: 193 (28.6%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 417 (61.7%)\n",
      "      Male: 259 (38.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 674 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Total Serum Bilirubin:\n",
      "   Total Records: 598\n",
      "   âœ… Normal: 598 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 354 (59.2%)\n",
      "      Male: 244 (40.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 598 (100.0%)\n",
      "\n",
      "ğŸ“‹ Total Cholesterol:\n",
      "   Total Records: 596\n",
      "   âœ… Normal: 458 (76.8%)\n",
      "   âŒ Abnormal: 138 (23.2%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 356 (59.7%)\n",
      "      Male: 240 (40.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 596 (100.0%)\n",
      "\n",
      "ğŸ“‹ LDL Cholesterol:\n",
      "   Total Records: 616\n",
      "   âœ… Normal: 616 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 371 (60.2%)\n",
      "      Male: 245 (39.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 616 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (552 patients):\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Serum: abnormal + Serum Creatinine: normal\n",
      "      94 patients (17.0%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: abnormal + Serum Creatinine: normal\n",
      "      89 patients (16.1%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Serum: abnormal + Serum Creatinine: normal\n",
      "      84 patients (15.2%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: normal + Serum Creatinine: normal\n",
      "      66 patients (12.0%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: abnormal + Serum Creatinine: abnormal\n",
      "      36 patients (6.5%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Serum: normal + Serum Creatinine: normal\n",
      "      28 patients (5.1%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: abnormal + Serum: normal + Serum Creatinine: normal\n",
      "      27 patients (4.9%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: abnormal + Serum: abnormal + Serum Creatinine: normal\n",
      "      26 patients (4.7%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Serum: abnormal + Serum Creatinine: abnormal\n",
      "      24 patients (4.3%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: normal + Serum Creatinine: abnormal\n",
      "      23 patients (4.2%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 66 (12.0%)\n",
      "   Four or More Tests Abnormal: 8 (1.4%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: TSH + Serum Creatinine + Total Serum Bilirubin + Total Cholesterol + LDL Cholesterol\n",
      "ğŸ“Š Total Patients: 547\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ TSH:\n",
      "   Total Records: 635\n",
      "   âœ… Normal: 488 (76.9%)\n",
      "   âŒ Abnormal: 147 (23.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 398 (62.7%)\n",
      "      Male: 237 (37.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 633 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 676\n",
      "   âœ… Normal: 483 (71.4%)\n",
      "   âŒ Abnormal: 193 (28.6%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 417 (61.7%)\n",
      "      Male: 259 (38.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 674 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Total Serum Bilirubin:\n",
      "   Total Records: 598\n",
      "   âœ… Normal: 598 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 354 (59.2%)\n",
      "      Male: 244 (40.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 598 (100.0%)\n",
      "\n",
      "ğŸ“‹ Total Cholesterol:\n",
      "   Total Records: 596\n",
      "   âœ… Normal: 458 (76.8%)\n",
      "   âŒ Abnormal: 138 (23.2%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 356 (59.7%)\n",
      "      Male: 240 (40.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 596 (100.0%)\n",
      "\n",
      "ğŸ“‹ LDL Cholesterol:\n",
      "   Total Records: 616\n",
      "   âœ… Normal: 616 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 371 (60.2%)\n",
      "      Male: 245 (39.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 616 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (547 patients):\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Total: normal + Total Cholesterol: normal + LDL Cholesterol: normal\n",
      "      248 patients (45.3%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Total: normal + Total Cholesterol: normal + LDL Cholesterol: normal\n",
      "      94 patients (17.2%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Total: normal + Total Cholesterol: abnormal + LDL Cholesterol: normal\n",
      "      63 patients (11.5%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Total: normal + Total Cholesterol: normal + LDL Cholesterol: normal\n",
      "      62 patients (11.3%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Total: normal + Total Cholesterol: abnormal + LDL Cholesterol: normal\n",
      "      35 patients (6.4%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Total: normal + Total Cholesterol: abnormal + LDL Cholesterol: normal\n",
      "      22 patients (4.0%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Total: normal + Total Cholesterol: normal + LDL Cholesterol: normal\n",
      "      20 patients (3.7%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Total: normal + Total Cholesterol: abnormal + LDL Cholesterol: normal\n",
      "      3 patients (0.5%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 248 (45.3%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: TSH + Serum Creatinine + Blood Glucose + Total Cholesterol + Triglycerides\n",
      "ğŸ“Š Total Patients: 535\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ TSH:\n",
      "   Total Records: 636\n",
      "   âœ… Normal: 480 (75.5%)\n",
      "   âŒ Abnormal: 156 (24.5%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 422 (66.4%)\n",
      "      Male: 214 (33.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 634 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 646\n",
      "   âœ… Normal: 455 (70.4%)\n",
      "   âŒ Abnormal: 191 (29.6%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 412 (63.8%)\n",
      "      Male: 234 (36.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 644 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 640\n",
      "   âœ… Normal: 640 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 416 (65.0%)\n",
      "      Male: 224 (35.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 639 (99.8%)\n",
      "      Biolab: 1 (0.2%)\n",
      "\n",
      "ğŸ“‹ Total Cholesterol:\n",
      "   Total Records: 586\n",
      "   âœ… Normal: 456 (77.8%)\n",
      "   âŒ Abnormal: 130 (22.2%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 372 (63.5%)\n",
      "      Male: 214 (36.5%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 586 (100.0%)\n",
      "\n",
      "ğŸ“‹ Triglycerides:\n",
      "   Total Records: 574\n",
      "   âœ… Normal: 253 (44.1%)\n",
      "   âŒ Abnormal: 321 (55.9%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 369 (64.3%)\n",
      "      Male: 205 (35.7%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 574 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (547 patients):\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Total: normal + Total Cholesterol: normal + LDL Cholesterol: normal\n",
      "      248 patients (45.3%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Total: normal + Total Cholesterol: normal + LDL Cholesterol: normal\n",
      "      94 patients (17.2%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Total: normal + Total Cholesterol: abnormal + LDL Cholesterol: normal\n",
      "      63 patients (11.5%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Total: normal + Total Cholesterol: normal + LDL Cholesterol: normal\n",
      "      62 patients (11.3%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Total: normal + Total Cholesterol: abnormal + LDL Cholesterol: normal\n",
      "      35 patients (6.4%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Total: normal + Total Cholesterol: abnormal + LDL Cholesterol: normal\n",
      "      22 patients (4.0%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Total: normal + Total Cholesterol: normal + LDL Cholesterol: normal\n",
      "      20 patients (3.7%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Total: normal + Total Cholesterol: abnormal + LDL Cholesterol: normal\n",
      "      3 patients (0.5%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 248 (45.3%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: TSH + Serum Creatinine + Blood Glucose + Total Cholesterol + Triglycerides\n",
      "ğŸ“Š Total Patients: 535\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ TSH:\n",
      "   Total Records: 636\n",
      "   âœ… Normal: 480 (75.5%)\n",
      "   âŒ Abnormal: 156 (24.5%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 422 (66.4%)\n",
      "      Male: 214 (33.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 634 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 646\n",
      "   âœ… Normal: 455 (70.4%)\n",
      "   âŒ Abnormal: 191 (29.6%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 412 (63.8%)\n",
      "      Male: 234 (36.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 644 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 640\n",
      "   âœ… Normal: 640 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 416 (65.0%)\n",
      "      Male: 224 (35.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 639 (99.8%)\n",
      "      Biolab: 1 (0.2%)\n",
      "\n",
      "ğŸ“‹ Total Cholesterol:\n",
      "   Total Records: 586\n",
      "   âœ… Normal: 456 (77.8%)\n",
      "   âŒ Abnormal: 130 (22.2%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 372 (63.5%)\n",
      "      Male: 214 (36.5%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 586 (100.0%)\n",
      "\n",
      "ğŸ“‹ Triglycerides:\n",
      "   Total Records: 574\n",
      "   âœ… Normal: 253 (44.1%)\n",
      "   âŒ Abnormal: 321 (55.9%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 369 (64.3%)\n",
      "      Male: 205 (35.7%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 574 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (535 patients):\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: abnormal\n",
      "      124 patients (23.2%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: normal\n",
      "      119 patients (22.2%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: abnormal\n",
      "      52 patients (9.7%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: normal\n",
      "      48 patients (9.0%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: abnormal\n",
      "      36 patients (6.7%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: abnormal + Triglycerides: abnormal\n",
      "      35 patients (6.5%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: abnormal + Triglycerides: normal\n",
      "      22 patients (4.1%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: normal\n",
      "      22 patients (4.1%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: abnormal + Triglycerides: abnormal\n",
      "      19 patients (3.6%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Blood Glucose: normal + Total Cholesterol: abnormal + Triglycerides: abnormal\n",
      "      18 patients (3.4%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 119 (22.2%)\n",
      "   Four or More Tests Abnormal: 3 (0.6%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: TSH + Total Serum Bilirubin + Blood Glucose + Total Cholesterol + LDL Cholesterol\n",
      "ğŸ“Š Total Patients: 534\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ TSH:\n",
      "   Total Records: 619\n",
      "   âœ… Normal: 475 (76.7%)\n",
      "   âŒ Abnormal: 144 (23.3%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 396 (64.0%)\n",
      "      Male: 223 (36.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 617 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Total Serum Bilirubin:\n",
      "   Total Records: 585\n",
      "   âœ… Normal: 585 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 352 (60.2%)\n",
      "      Male: 233 (39.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 585 (100.0%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 655\n",
      "   âœ… Normal: 655 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 411 (62.7%)\n",
      "      Male: 244 (37.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 655 (100.0%)\n",
      "\n",
      "ğŸ“‹ Total Cholesterol:\n",
      "   Total Records: 581\n",
      "   âœ… Normal: 449 (77.3%)\n",
      "   âŒ Abnormal: 132 (22.7%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 354 (60.9%)\n",
      "      Male: 227 (39.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 581 (100.0%)\n",
      "\n",
      "ğŸ“‹ LDL Cholesterol:\n",
      "   Total Records: 601\n",
      "   âœ… Normal: 601 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 369 (61.4%)\n",
      "      Male: 232 (38.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 601 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (535 patients):\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: abnormal\n",
      "      124 patients (23.2%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: normal\n",
      "      119 patients (22.2%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: abnormal\n",
      "      52 patients (9.7%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: normal\n",
      "      48 patients (9.0%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: abnormal\n",
      "      36 patients (6.7%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: abnormal + Triglycerides: abnormal\n",
      "      35 patients (6.5%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: abnormal + Triglycerides: normal\n",
      "      22 patients (4.1%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: normal + Triglycerides: normal\n",
      "      22 patients (4.1%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Blood Glucose: normal + Total Cholesterol: abnormal + Triglycerides: abnormal\n",
      "      19 patients (3.6%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Blood Glucose: normal + Total Cholesterol: abnormal + Triglycerides: abnormal\n",
      "      18 patients (3.4%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 119 (22.2%)\n",
      "   Four or More Tests Abnormal: 3 (0.6%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: TSH + Total Serum Bilirubin + Blood Glucose + Total Cholesterol + LDL Cholesterol\n",
      "ğŸ“Š Total Patients: 534\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ TSH:\n",
      "   Total Records: 619\n",
      "   âœ… Normal: 475 (76.7%)\n",
      "   âŒ Abnormal: 144 (23.3%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 396 (64.0%)\n",
      "      Male: 223 (36.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 617 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Total Serum Bilirubin:\n",
      "   Total Records: 585\n",
      "   âœ… Normal: 585 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 352 (60.2%)\n",
      "      Male: 233 (39.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 585 (100.0%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 655\n",
      "   âœ… Normal: 655 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 411 (62.7%)\n",
      "      Male: 244 (37.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 655 (100.0%)\n",
      "\n",
      "ğŸ“‹ Total Cholesterol:\n",
      "   Total Records: 581\n",
      "   âœ… Normal: 449 (77.3%)\n",
      "   âŒ Abnormal: 132 (22.7%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 354 (60.9%)\n",
      "      Male: 227 (39.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 581 (100.0%)\n",
      "\n",
      "ğŸ“‹ LDL Cholesterol:\n",
      "   Total Records: 601\n",
      "   âœ… Normal: 601 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 369 (61.4%)\n",
      "      Male: 232 (38.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 601 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (534 patients):\n",
      "   ğŸ“Š TSH: normal + Total: normal + Blood Glucose: normal + Total Cholesterol: normal + LDL Cholesterol: normal\n",
      "      336 patients (62.9%)\n",
      "   ğŸ“Š TSH: normal + Total: normal + Blood Glucose: normal + Total Cholesterol: abnormal + LDL Cholesterol: normal\n",
      "      93 patients (17.4%)\n",
      "   ğŸ“Š TSH: abnormal + Total: normal + Blood Glucose: normal + Total Cholesterol: normal + LDL Cholesterol: normal\n",
      "      80 patients (15.0%)\n",
      "   ğŸ“Š TSH: abnormal + Total: normal + Blood Glucose: normal + Total Cholesterol: abnormal + LDL Cholesterol: normal\n",
      "      25 patients (4.7%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 336 (62.9%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol + Vitamin D3\n",
      "ğŸ“Š Total Patients: 528\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Cholesterol:\n",
      "   Total Records: 881\n",
      "   âœ… Normal: 881 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 484 (54.9%)\n",
      "      Female: 397 (45.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 881 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum Triglycerides:\n",
      "   Total Records: 889\n",
      "   âœ… Normal: 375 (42.2%)\n",
      "   âŒ Abnormal: 514 (57.8%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 492 (55.3%)\n",
      "      Female: 397 (44.7%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 889 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum HDL Cholesterol:\n",
      "   Total Records: 752\n",
      "   âœ… Normal: 484 (64.4%)\n",
      "   âŒ Abnormal: 268 (35.6%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 413 (54.9%)\n",
      "      Female: 339 (45.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 752 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum LDL Cholesterol:\n",
      "   Total Records: 813\n",
      "   âœ… Normal: 264 (32.5%)\n",
      "   âŒ Abnormal: 549 (67.5%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 452 (55.6%)\n",
      "      Female: 361 (44.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 813 (100.0%)\n",
      "\n",
      "ğŸ“‹ Vitamin D3:\n",
      "   Total Records: 726\n",
      "   âœ… Normal: 167 (23.0%)\n",
      "   âŒ Abnormal: 559 (77.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 370 (51.0%)\n",
      "      Female: 356 (49.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 725 (99.9%)\n",
      "      Hawkari: 1 (0.1%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (534 patients):\n",
      "   ğŸ“Š TSH: normal + Total: normal + Blood Glucose: normal + Total Cholesterol: normal + LDL Cholesterol: normal\n",
      "      336 patients (62.9%)\n",
      "   ğŸ“Š TSH: normal + Total: normal + Blood Glucose: normal + Total Cholesterol: abnormal + LDL Cholesterol: normal\n",
      "      93 patients (17.4%)\n",
      "   ğŸ“Š TSH: abnormal + Total: normal + Blood Glucose: normal + Total Cholesterol: normal + LDL Cholesterol: normal\n",
      "      80 patients (15.0%)\n",
      "   ğŸ“Š TSH: abnormal + Total: normal + Blood Glucose: normal + Total Cholesterol: abnormal + LDL Cholesterol: normal\n",
      "      25 patients (4.7%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 336 (62.9%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol + Vitamin D3\n",
      "ğŸ“Š Total Patients: 528\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Cholesterol:\n",
      "   Total Records: 881\n",
      "   âœ… Normal: 881 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 484 (54.9%)\n",
      "      Female: 397 (45.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 881 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum Triglycerides:\n",
      "   Total Records: 889\n",
      "   âœ… Normal: 375 (42.2%)\n",
      "   âŒ Abnormal: 514 (57.8%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 492 (55.3%)\n",
      "      Female: 397 (44.7%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 889 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum HDL Cholesterol:\n",
      "   Total Records: 752\n",
      "   âœ… Normal: 484 (64.4%)\n",
      "   âŒ Abnormal: 268 (35.6%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 413 (54.9%)\n",
      "      Female: 339 (45.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 752 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum LDL Cholesterol:\n",
      "   Total Records: 813\n",
      "   âœ… Normal: 264 (32.5%)\n",
      "   âŒ Abnormal: 549 (67.5%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 452 (55.6%)\n",
      "      Female: 361 (44.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 813 (100.0%)\n",
      "\n",
      "ğŸ“‹ Vitamin D3:\n",
      "   Total Records: 726\n",
      "   âœ… Normal: 167 (23.0%)\n",
      "   âŒ Abnormal: 559 (77.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 370 (51.0%)\n",
      "      Female: 356 (49.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 725 (99.9%)\n",
      "      Hawkari: 1 (0.1%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (528 patients):\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: abnormal + Vitamin D3: abnormal\n",
      "      92 patients (17.4%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Serum: abnormal + Vitamin D3: abnormal\n",
      "      80 patients (15.2%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Serum: abnormal + Vitamin D3: abnormal\n",
      "      79 patients (15.0%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: normal + Vitamin D3: abnormal\n",
      "      75 patients (14.2%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Serum: abnormal + Vitamin D3: normal\n",
      "      31 patients (5.9%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: abnormal + Vitamin D3: normal\n",
      "      30 patients (5.7%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Serum: normal + Vitamin D3: abnormal\n",
      "      28 patients (5.3%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Serum: normal + Vitamin D3: abnormal\n",
      "      22 patients (4.2%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: abnormal + Serum: normal + Vitamin D3: abnormal\n",
      "      19 patients (3.6%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Serum: abnormal + Vitamin D3: normal\n",
      "      16 patients (3.0%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 13 (2.5%)\n",
      "   Four or More Tests Abnormal: 79 (15.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Cholesterol + Serum Triglycerides + Blood Urea Nitrogen + Serum Creatinine + Complete Blood Count\n",
      "ğŸ“Š Total Patients: 525\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Cholesterol:\n",
      "   Total Records: 805\n",
      "   âœ… Normal: 804 (99.9%)\n",
      "   âŒ Abnormal: 1 (0.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 528 (65.6%)\n",
      "      Female: 277 (34.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 805 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum Triglycerides:\n",
      "   Total Records: 819\n",
      "   âœ… Normal: 382 (46.6%)\n",
      "   âŒ Abnormal: 437 (53.4%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 537 (65.6%)\n",
      "      Female: 282 (34.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 819 (100.0%)\n",
      "\n",
      "ğŸ“‹ Blood Urea Nitrogen:\n",
      "   Total Records: 772\n",
      "   âœ… Normal: 240 (31.1%)\n",
      "   âŒ Abnormal: 532 (68.9%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 493 (63.9%)\n",
      "      Female: 279 (36.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 772 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 811\n",
      "   âœ… Normal: 593 (73.1%)\n",
      "   âŒ Abnormal: 218 (26.9%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 521 (64.2%)\n",
      "      Female: 290 (35.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 810 (99.9%)\n",
      "      Hawkari: 1 (0.1%)\n",
      "\n",
      "ğŸ“‹ Complete Blood Count:\n",
      "   Total Records: 702\n",
      "   âœ… Normal: 702 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 424 (60.4%)\n",
      "      Female: 278 (39.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 702 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (528 patients):\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: abnormal + Vitamin D3: abnormal\n",
      "      92 patients (17.4%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Serum: abnormal + Vitamin D3: abnormal\n",
      "      80 patients (15.2%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Serum: abnormal + Vitamin D3: abnormal\n",
      "      79 patients (15.0%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: normal + Vitamin D3: abnormal\n",
      "      75 patients (14.2%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Serum: abnormal + Vitamin D3: normal\n",
      "      31 patients (5.9%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: abnormal + Vitamin D3: normal\n",
      "      30 patients (5.7%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Serum: normal + Vitamin D3: abnormal\n",
      "      28 patients (5.3%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Serum: normal + Vitamin D3: abnormal\n",
      "      22 patients (4.2%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: abnormal + Serum: normal + Vitamin D3: abnormal\n",
      "      19 patients (3.6%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Serum: abnormal + Vitamin D3: normal\n",
      "      16 patients (3.0%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 13 (2.5%)\n",
      "   Four or More Tests Abnormal: 79 (15.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Cholesterol + Serum Triglycerides + Blood Urea Nitrogen + Serum Creatinine + Complete Blood Count\n",
      "ğŸ“Š Total Patients: 525\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Cholesterol:\n",
      "   Total Records: 805\n",
      "   âœ… Normal: 804 (99.9%)\n",
      "   âŒ Abnormal: 1 (0.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 528 (65.6%)\n",
      "      Female: 277 (34.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 805 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum Triglycerides:\n",
      "   Total Records: 819\n",
      "   âœ… Normal: 382 (46.6%)\n",
      "   âŒ Abnormal: 437 (53.4%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 537 (65.6%)\n",
      "      Female: 282 (34.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 819 (100.0%)\n",
      "\n",
      "ğŸ“‹ Blood Urea Nitrogen:\n",
      "   Total Records: 772\n",
      "   âœ… Normal: 240 (31.1%)\n",
      "   âŒ Abnormal: 532 (68.9%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 493 (63.9%)\n",
      "      Female: 279 (36.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 772 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 811\n",
      "   âœ… Normal: 593 (73.1%)\n",
      "   âŒ Abnormal: 218 (26.9%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 521 (64.2%)\n",
      "      Female: 290 (35.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 810 (99.9%)\n",
      "      Hawkari: 1 (0.1%)\n",
      "\n",
      "ğŸ“‹ Complete Blood Count:\n",
      "   Total Records: 702\n",
      "   âœ… Normal: 702 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 424 (60.4%)\n",
      "      Female: 278 (39.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 702 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (525 patients):\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Blood: abnormal + Serum Creatinine: normal + Complete: normal\n",
      "      143 patients (27.2%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Blood: abnormal + Serum Creatinine: normal + Complete: normal\n",
      "      134 patients (25.5%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Blood: normal + Serum Creatinine: normal + Complete: normal\n",
      "      66 patients (12.6%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Blood: normal + Serum Creatinine: normal + Complete: normal\n",
      "      61 patients (11.6%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Blood: normal + Serum Creatinine: abnormal + Complete: normal\n",
      "      37 patients (7.0%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Blood: abnormal + Serum Creatinine: abnormal + Complete: normal\n",
      "      31 patients (5.9%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Blood: normal + Serum Creatinine: abnormal + Complete: normal\n",
      "      27 patients (5.1%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Blood: abnormal + Serum Creatinine: abnormal + Complete: normal\n",
      "      25 patients (4.8%)\n",
      "   ğŸ“Š Serum Cholesterol: abnormal + Serum Triglycerides: abnormal + Blood: normal + Serum Creatinine: abnormal + Complete: normal\n",
      "      1 patients (0.2%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 61 (11.6%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: TSH + Serum Creatinine + Total Serum Bilirubin + Blood Glucose + Total Cholesterol\n",
      "ğŸ“Š Total Patients: 521\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ TSH:\n",
      "   Total Records: 605\n",
      "   âœ… Normal: 461 (76.2%)\n",
      "   âŒ Abnormal: 144 (23.8%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 383 (63.3%)\n",
      "      Male: 222 (36.7%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 603 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 653\n",
      "   âœ… Normal: 459 (70.3%)\n",
      "   âŒ Abnormal: 194 (29.7%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 403 (61.7%)\n",
      "      Male: 250 (38.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 651 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Total Serum Bilirubin:\n",
      "   Total Records: 573\n",
      "   âœ… Normal: 573 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 340 (59.3%)\n",
      "      Male: 233 (40.7%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 573 (100.0%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 645\n",
      "   âœ… Normal: 645 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 400 (62.0%)\n",
      "      Male: 245 (38.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 645 (100.0%)\n",
      "\n",
      "ğŸ“‹ Total Cholesterol:\n",
      "   Total Records: 568\n",
      "   âœ… Normal: 438 (77.1%)\n",
      "   âŒ Abnormal: 130 (22.9%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 342 (60.2%)\n",
      "      Male: 226 (39.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 568 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (525 patients):\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Blood: abnormal + Serum Creatinine: normal + Complete: normal\n",
      "      143 patients (27.2%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Blood: abnormal + Serum Creatinine: normal + Complete: normal\n",
      "      134 patients (25.5%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Blood: normal + Serum Creatinine: normal + Complete: normal\n",
      "      66 patients (12.6%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Blood: normal + Serum Creatinine: normal + Complete: normal\n",
      "      61 patients (11.6%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Blood: normal + Serum Creatinine: abnormal + Complete: normal\n",
      "      37 patients (7.0%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Blood: abnormal + Serum Creatinine: abnormal + Complete: normal\n",
      "      31 patients (5.9%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Blood: normal + Serum Creatinine: abnormal + Complete: normal\n",
      "      27 patients (5.1%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Blood: abnormal + Serum Creatinine: abnormal + Complete: normal\n",
      "      25 patients (4.8%)\n",
      "   ğŸ“Š Serum Cholesterol: abnormal + Serum Triglycerides: abnormal + Blood: normal + Serum Creatinine: abnormal + Complete: normal\n",
      "      1 patients (0.2%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 61 (11.6%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: TSH + Serum Creatinine + Total Serum Bilirubin + Blood Glucose + Total Cholesterol\n",
      "ğŸ“Š Total Patients: 521\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ TSH:\n",
      "   Total Records: 605\n",
      "   âœ… Normal: 461 (76.2%)\n",
      "   âŒ Abnormal: 144 (23.8%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 383 (63.3%)\n",
      "      Male: 222 (36.7%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 603 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 653\n",
      "   âœ… Normal: 459 (70.3%)\n",
      "   âŒ Abnormal: 194 (29.7%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 403 (61.7%)\n",
      "      Male: 250 (38.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 651 (99.7%)\n",
      "      Biolab: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Total Serum Bilirubin:\n",
      "   Total Records: 573\n",
      "   âœ… Normal: 573 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 340 (59.3%)\n",
      "      Male: 233 (40.7%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 573 (100.0%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 645\n",
      "   âœ… Normal: 645 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 400 (62.0%)\n",
      "      Male: 245 (38.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 645 (100.0%)\n",
      "\n",
      "ğŸ“‹ Total Cholesterol:\n",
      "   Total Records: 568\n",
      "   âœ… Normal: 438 (77.1%)\n",
      "   âŒ Abnormal: 130 (22.9%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 342 (60.2%)\n",
      "      Male: 226 (39.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 568 (100.0%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (521 patients):\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Total: normal + Blood Glucose: normal + Total Cholesterol: normal\n",
      "      235 patients (45.1%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Total: normal + Blood Glucose: normal + Total Cholesterol: normal\n",
      "      89 patients (17.1%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Total: normal + Blood Glucose: normal + Total Cholesterol: normal\n",
      "      60 patients (11.5%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Total: normal + Blood Glucose: normal + Total Cholesterol: abnormal\n",
      "      57 patients (10.9%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Total: normal + Blood Glucose: normal + Total Cholesterol: abnormal\n",
      "      34 patients (6.5%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Total: normal + Blood Glucose: normal + Total Cholesterol: abnormal\n",
      "      22 patients (4.2%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Total: normal + Blood Glucose: normal + Total Cholesterol: normal\n",
      "      21 patients (4.0%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Total: normal + Blood Glucose: normal + Total Cholesterol: abnormal\n",
      "      3 patients (0.6%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 235 (45.1%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: TSH + Serum Creatinine + Aspartate Aminotransferase (AST) + Alanine Aminotransferase (ALT) + Blood Glucose\n",
      "ğŸ“Š Total Patients: 509\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ TSH:\n",
      "   Total Records: 651\n",
      "   âœ… Normal: 482 (74.0%)\n",
      "   âŒ Abnormal: 169 (26.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 374 (57.5%)\n",
      "      Male: 277 (42.5%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 443 (68.0%)\n",
      "      Biolab: 208 (32.0%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 708\n",
      "   âœ… Normal: 503 (71.0%)\n",
      "   âŒ Abnormal: 205 (29.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 379 (53.5%)\n",
      "      Male: 329 (46.5%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 473 (66.8%)\n",
      "      Biolab: 235 (33.2%)\n",
      "\n",
      "ğŸ“‹ Aspartate Aminotransferase (AST):\n",
      "   Total Records: 608\n",
      "   âœ… Normal: 548 (90.1%)\n",
      "   âŒ Abnormal: 60 (9.9%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 334 (54.9%)\n",
      "      Male: 274 (45.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 414 (68.1%)\n",
      "      Biolab: 194 (31.9%)\n",
      "\n",
      "ğŸ“‹ Alanine Aminotransferase (ALT):\n",
      "   Total Records: 617\n",
      "   âœ… Normal: 556 (90.1%)\n",
      "   âŒ Abnormal: 61 (9.9%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 337 (54.6%)\n",
      "      Male: 280 (45.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 417 (67.6%)\n",
      "      Biolab: 200 (32.4%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 659\n",
      "   âœ… Normal: 659 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 358 (54.3%)\n",
      "      Male: 301 (45.7%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 462 (70.1%)\n",
      "      Biolab: 197 (29.9%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (521 patients):\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Total: normal + Blood Glucose: normal + Total Cholesterol: normal\n",
      "      235 patients (45.1%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Total: normal + Blood Glucose: normal + Total Cholesterol: normal\n",
      "      89 patients (17.1%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Total: normal + Blood Glucose: normal + Total Cholesterol: normal\n",
      "      60 patients (11.5%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Total: normal + Blood Glucose: normal + Total Cholesterol: abnormal\n",
      "      57 patients (10.9%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Total: normal + Blood Glucose: normal + Total Cholesterol: abnormal\n",
      "      34 patients (6.5%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Total: normal + Blood Glucose: normal + Total Cholesterol: abnormal\n",
      "      22 patients (4.2%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Total: normal + Blood Glucose: normal + Total Cholesterol: normal\n",
      "      21 patients (4.0%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Total: normal + Blood Glucose: normal + Total Cholesterol: abnormal\n",
      "      3 patients (0.6%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 235 (45.1%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: TSH + Serum Creatinine + Aspartate Aminotransferase (AST) + Alanine Aminotransferase (ALT) + Blood Glucose\n",
      "ğŸ“Š Total Patients: 509\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ TSH:\n",
      "   Total Records: 651\n",
      "   âœ… Normal: 482 (74.0%)\n",
      "   âŒ Abnormal: 169 (26.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 374 (57.5%)\n",
      "      Male: 277 (42.5%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 443 (68.0%)\n",
      "      Biolab: 208 (32.0%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 708\n",
      "   âœ… Normal: 503 (71.0%)\n",
      "   âŒ Abnormal: 205 (29.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 379 (53.5%)\n",
      "      Male: 329 (46.5%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 473 (66.8%)\n",
      "      Biolab: 235 (33.2%)\n",
      "\n",
      "ğŸ“‹ Aspartate Aminotransferase (AST):\n",
      "   Total Records: 608\n",
      "   âœ… Normal: 548 (90.1%)\n",
      "   âŒ Abnormal: 60 (9.9%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 334 (54.9%)\n",
      "      Male: 274 (45.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 414 (68.1%)\n",
      "      Biolab: 194 (31.9%)\n",
      "\n",
      "ğŸ“‹ Alanine Aminotransferase (ALT):\n",
      "   Total Records: 617\n",
      "   âœ… Normal: 556 (90.1%)\n",
      "   âŒ Abnormal: 61 (9.9%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 337 (54.6%)\n",
      "      Male: 280 (45.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 417 (67.6%)\n",
      "      Biolab: 200 (32.4%)\n",
      "\n",
      "ğŸ“‹ Blood Glucose:\n",
      "   Total Records: 659\n",
      "   âœ… Normal: 659 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Female: 358 (54.3%)\n",
      "      Male: 301 (45.7%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Hawkari: 462 (70.1%)\n",
      "      Biolab: 197 (29.9%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (509 patients):\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Aspartate: normal + Alanine: normal + Blood Glucose: normal\n",
      "      251 patients (49.3%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Aspartate: normal + Alanine: normal + Blood Glucose: normal\n",
      "      115 patients (22.6%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Aspartate: normal + Alanine: normal + Blood Glucose: normal\n",
      "      59 patients (11.6%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Aspartate: normal + Alanine: normal + Blood Glucose: normal\n",
      "      30 patients (5.9%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Aspartate: normal + Alanine: abnormal + Blood Glucose: normal\n",
      "      11 patients (2.2%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Aspartate: abnormal + Alanine: abnormal + Blood Glucose: normal\n",
      "      7 patients (1.4%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Aspartate: abnormal + Alanine: normal + Blood Glucose: normal\n",
      "      7 patients (1.4%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Aspartate: abnormal + Alanine: normal + Blood Glucose: normal\n",
      "      5 patients (1.0%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Aspartate: abnormal + Alanine: abnormal + Blood Glucose: normal\n",
      "      4 patients (0.8%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Aspartate: abnormal + Alanine: normal + Blood Glucose: normal\n",
      "      4 patients (0.8%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 251 (49.3%)\n",
      "   Four or More Tests Abnormal: 2 (0.4%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Blood Urea Nitrogen + Serum Creatinine + Hepatitis B Surface Antigen + Hepatitis C Antibody + HIV Antibody\n",
      "ğŸ“Š Total Patients: 506\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Blood Urea Nitrogen:\n",
      "   Total Records: 642\n",
      "   âœ… Normal: 217 (33.8%)\n",
      "   âŒ Abnormal: 425 (66.2%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 345 (53.7%)\n",
      "      Female: 297 (46.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 395 (61.5%)\n",
      "      Hawkari: 247 (38.5%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 712\n",
      "   âœ… Normal: 459 (64.5%)\n",
      "   âŒ Abnormal: 253 (35.5%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 384 (53.9%)\n",
      "      Female: 328 (46.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 408 (57.3%)\n",
      "      Hawkari: 304 (42.7%)\n",
      "\n",
      "ğŸ“‹ Hepatitis B Surface Antigen:\n",
      "   Total Records: 548\n",
      "   âœ… Normal: 546 (99.6%)\n",
      "   âŒ Abnormal: 2 (0.4%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 294 (53.6%)\n",
      "      Female: 254 (46.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 317 (57.8%)\n",
      "      Hawkari: 231 (42.2%)\n",
      "\n",
      "ğŸ“‹ Hepatitis C Antibody:\n",
      "   Total Records: 547\n",
      "   âœ… Normal: 547 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 293 (53.6%)\n",
      "      Female: 254 (46.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 316 (57.8%)\n",
      "      Hawkari: 231 (42.2%)\n",
      "\n",
      "ğŸ“‹ HIV Antibody:\n",
      "   Total Records: 547\n",
      "   âœ… Normal: 547 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 293 (53.6%)\n",
      "      Female: 254 (46.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 316 (57.8%)\n",
      "      Hawkari: 231 (42.2%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (509 patients):\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Aspartate: normal + Alanine: normal + Blood Glucose: normal\n",
      "      251 patients (49.3%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Aspartate: normal + Alanine: normal + Blood Glucose: normal\n",
      "      115 patients (22.6%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Aspartate: normal + Alanine: normal + Blood Glucose: normal\n",
      "      59 patients (11.6%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Aspartate: normal + Alanine: normal + Blood Glucose: normal\n",
      "      30 patients (5.9%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Aspartate: normal + Alanine: abnormal + Blood Glucose: normal\n",
      "      11 patients (2.2%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: normal + Aspartate: abnormal + Alanine: abnormal + Blood Glucose: normal\n",
      "      7 patients (1.4%)\n",
      "   ğŸ“Š TSH: normal + Serum Creatinine: abnormal + Aspartate: abnormal + Alanine: normal + Blood Glucose: normal\n",
      "      7 patients (1.4%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Aspartate: abnormal + Alanine: normal + Blood Glucose: normal\n",
      "      5 patients (1.0%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: normal + Aspartate: abnormal + Alanine: abnormal + Blood Glucose: normal\n",
      "      4 patients (0.8%)\n",
      "   ğŸ“Š TSH: abnormal + Serum Creatinine: abnormal + Aspartate: abnormal + Alanine: normal + Blood Glucose: normal\n",
      "      4 patients (0.8%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 251 (49.3%)\n",
      "   Four or More Tests Abnormal: 2 (0.4%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Blood Urea Nitrogen + Serum Creatinine + Hepatitis B Surface Antigen + Hepatitis C Antibody + HIV Antibody\n",
      "ğŸ“Š Total Patients: 506\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Blood Urea Nitrogen:\n",
      "   Total Records: 642\n",
      "   âœ… Normal: 217 (33.8%)\n",
      "   âŒ Abnormal: 425 (66.2%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 345 (53.7%)\n",
      "      Female: 297 (46.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 395 (61.5%)\n",
      "      Hawkari: 247 (38.5%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 712\n",
      "   âœ… Normal: 459 (64.5%)\n",
      "   âŒ Abnormal: 253 (35.5%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 384 (53.9%)\n",
      "      Female: 328 (46.1%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 408 (57.3%)\n",
      "      Hawkari: 304 (42.7%)\n",
      "\n",
      "ğŸ“‹ Hepatitis B Surface Antigen:\n",
      "   Total Records: 548\n",
      "   âœ… Normal: 546 (99.6%)\n",
      "   âŒ Abnormal: 2 (0.4%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 294 (53.6%)\n",
      "      Female: 254 (46.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 317 (57.8%)\n",
      "      Hawkari: 231 (42.2%)\n",
      "\n",
      "ğŸ“‹ Hepatitis C Antibody:\n",
      "   Total Records: 547\n",
      "   âœ… Normal: 547 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 293 (53.6%)\n",
      "      Female: 254 (46.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 316 (57.8%)\n",
      "      Hawkari: 231 (42.2%)\n",
      "\n",
      "ğŸ“‹ HIV Antibody:\n",
      "   Total Records: 547\n",
      "   âœ… Normal: 547 (100.0%)\n",
      "   âŒ Abnormal: 0 (0.0%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 293 (53.6%)\n",
      "      Female: 254 (46.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 316 (57.8%)\n",
      "      Hawkari: 231 (42.2%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (506 patients):\n",
      "   ğŸ“Š Blood: abnormal + Serum Creatinine: normal + Hepatitis: normal + Hepatitis: normal + HIV Antibody: normal\n",
      "      227 patients (44.9%)\n",
      "   ğŸ“Š Blood: normal + Serum Creatinine: abnormal + Hepatitis: normal + Hepatitis: normal + HIV Antibody: normal\n",
      "      95 patients (18.8%)\n",
      "   ğŸ“Š Blood: normal + Serum Creatinine: normal + Hepatitis: normal + Hepatitis: normal + HIV Antibody: normal\n",
      "      93 patients (18.4%)\n",
      "   ğŸ“Š Blood: abnormal + Serum Creatinine: abnormal + Hepatitis: normal + Hepatitis: normal + HIV Antibody: normal\n",
      "      90 patients (17.8%)\n",
      "   ğŸ“Š Blood: abnormal + Serum Creatinine: normal + Hepatitis: abnormal + Hepatitis: normal + HIV Antibody: normal\n",
      "      1 patients (0.2%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 93 (18.4%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol + Blood Urea Nitrogen\n",
      "ğŸ“Š Total Patients: 504\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Cholesterol:\n",
      "   Total Records: 813\n",
      "   âœ… Normal: 812 (99.9%)\n",
      "   âŒ Abnormal: 1 (0.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 532 (65.4%)\n",
      "      Female: 281 (34.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 813 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum Triglycerides:\n",
      "   Total Records: 816\n",
      "   âœ… Normal: 374 (45.8%)\n",
      "   âŒ Abnormal: 442 (54.2%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 535 (65.6%)\n",
      "      Female: 281 (34.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 816 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum HDL Cholesterol:\n",
      "   Total Records: 686\n",
      "   âœ… Normal: 426 (62.1%)\n",
      "   âŒ Abnormal: 260 (37.9%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 435 (63.4%)\n",
      "      Female: 251 (36.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 686 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum LDL Cholesterol:\n",
      "   Total Records: 748\n",
      "   âœ… Normal: 264 (35.3%)\n",
      "   âŒ Abnormal: 484 (64.7%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 488 (65.2%)\n",
      "      Female: 260 (34.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 748 (100.0%)\n",
      "\n",
      "ğŸ“‹ Blood Urea Nitrogen:\n",
      "   Total Records: 711\n",
      "   âœ… Normal: 233 (32.8%)\n",
      "   âŒ Abnormal: 478 (67.2%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 465 (65.4%)\n",
      "      Female: 246 (34.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 709 (99.7%)\n",
      "      Hawkari: 2 (0.3%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (506 patients):\n",
      "   ğŸ“Š Blood: abnormal + Serum Creatinine: normal + Hepatitis: normal + Hepatitis: normal + HIV Antibody: normal\n",
      "      227 patients (44.9%)\n",
      "   ğŸ“Š Blood: normal + Serum Creatinine: abnormal + Hepatitis: normal + Hepatitis: normal + HIV Antibody: normal\n",
      "      95 patients (18.8%)\n",
      "   ğŸ“Š Blood: normal + Serum Creatinine: normal + Hepatitis: normal + Hepatitis: normal + HIV Antibody: normal\n",
      "      93 patients (18.4%)\n",
      "   ğŸ“Š Blood: abnormal + Serum Creatinine: abnormal + Hepatitis: normal + Hepatitis: normal + HIV Antibody: normal\n",
      "      90 patients (17.8%)\n",
      "   ğŸ“Š Blood: abnormal + Serum Creatinine: normal + Hepatitis: abnormal + Hepatitis: normal + HIV Antibody: normal\n",
      "      1 patients (0.2%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 93 (18.4%)\n",
      "   Four or More Tests Abnormal: 0 (0.0%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol + Blood Urea Nitrogen\n",
      "ğŸ“Š Total Patients: 504\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Cholesterol:\n",
      "   Total Records: 813\n",
      "   âœ… Normal: 812 (99.9%)\n",
      "   âŒ Abnormal: 1 (0.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 532 (65.4%)\n",
      "      Female: 281 (34.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 813 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum Triglycerides:\n",
      "   Total Records: 816\n",
      "   âœ… Normal: 374 (45.8%)\n",
      "   âŒ Abnormal: 442 (54.2%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 535 (65.6%)\n",
      "      Female: 281 (34.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 816 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum HDL Cholesterol:\n",
      "   Total Records: 686\n",
      "   âœ… Normal: 426 (62.1%)\n",
      "   âŒ Abnormal: 260 (37.9%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 435 (63.4%)\n",
      "      Female: 251 (36.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 686 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum LDL Cholesterol:\n",
      "   Total Records: 748\n",
      "   âœ… Normal: 264 (35.3%)\n",
      "   âŒ Abnormal: 484 (64.7%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 488 (65.2%)\n",
      "      Female: 260 (34.8%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 748 (100.0%)\n",
      "\n",
      "ğŸ“‹ Blood Urea Nitrogen:\n",
      "   Total Records: 711\n",
      "   âœ… Normal: 233 (32.8%)\n",
      "   âŒ Abnormal: 478 (67.2%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 465 (65.4%)\n",
      "      Female: 246 (34.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 709 (99.7%)\n",
      "      Hawkari: 2 (0.3%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (504 patients):\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: abnormal + Blood: abnormal\n",
      "      76 patients (15.1%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Serum: abnormal + Blood: abnormal\n",
      "      62 patients (12.3%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: normal + Blood: abnormal\n",
      "      50 patients (9.9%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Serum: abnormal + Blood: abnormal\n",
      "      46 patients (9.1%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: abnormal + Blood: normal\n",
      "      41 patients (8.1%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Serum: abnormal + Blood: normal\n",
      "      39 patients (7.7%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Serum: abnormal + Blood: normal\n",
      "      38 patients (7.5%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: normal + Blood: normal\n",
      "      29 patients (5.8%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Serum: normal + Blood: abnormal\n",
      "      25 patients (5.0%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: abnormal + Serum: normal + Blood: abnormal\n",
      "      22 patients (4.4%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 29 (5.8%)\n",
      "   Four or More Tests Abnormal: 46 (9.1%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol + Blood Urea Nitrogen + Serum Creatinine\n",
      "ğŸ“Š Total Patients: 502\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Triglycerides:\n",
      "   Total Records: 814\n",
      "   âœ… Normal: 372 (45.7%)\n",
      "   âŒ Abnormal: 442 (54.3%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 535 (65.7%)\n",
      "      Female: 279 (34.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 814 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum HDL Cholesterol:\n",
      "   Total Records: 684\n",
      "   âœ… Normal: 426 (62.3%)\n",
      "   âŒ Abnormal: 258 (37.7%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 435 (63.6%)\n",
      "      Female: 249 (36.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 684 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum LDL Cholesterol:\n",
      "   Total Records: 746\n",
      "   âœ… Normal: 263 (35.3%)\n",
      "   âŒ Abnormal: 483 (64.7%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 488 (65.4%)\n",
      "      Female: 258 (34.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 746 (100.0%)\n",
      "\n",
      "ğŸ“‹ Blood Urea Nitrogen:\n",
      "   Total Records: 710\n",
      "   âœ… Normal: 232 (32.7%)\n",
      "   âŒ Abnormal: 478 (67.3%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 466 (65.6%)\n",
      "      Female: 244 (34.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 708 (99.7%)\n",
      "      Hawkari: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 741\n",
      "   âœ… Normal: 567 (76.5%)\n",
      "   âŒ Abnormal: 174 (23.5%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 490 (66.1%)\n",
      "      Female: 251 (33.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 738 (99.6%)\n",
      "      Hawkari: 3 (0.4%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (504 patients):\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: abnormal + Blood: abnormal\n",
      "      76 patients (15.1%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Serum: abnormal + Blood: abnormal\n",
      "      62 patients (12.3%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: normal + Blood: abnormal\n",
      "      50 patients (9.9%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Serum: abnormal + Blood: abnormal\n",
      "      46 patients (9.1%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: abnormal + Blood: normal\n",
      "      41 patients (8.1%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Serum: abnormal + Blood: normal\n",
      "      39 patients (7.7%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Serum: abnormal + Blood: normal\n",
      "      38 patients (7.5%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Serum: normal + Blood: normal\n",
      "      29 patients (5.8%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Serum: normal + Blood: abnormal\n",
      "      25 patients (5.0%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: abnormal + Serum: normal + Blood: abnormal\n",
      "      22 patients (4.4%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 29 (5.8%)\n",
      "   Four or More Tests Abnormal: 46 (9.1%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol + Blood Urea Nitrogen + Serum Creatinine\n",
      "ğŸ“Š Total Patients: 502\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Triglycerides:\n",
      "   Total Records: 814\n",
      "   âœ… Normal: 372 (45.7%)\n",
      "   âŒ Abnormal: 442 (54.3%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 535 (65.7%)\n",
      "      Female: 279 (34.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 814 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum HDL Cholesterol:\n",
      "   Total Records: 684\n",
      "   âœ… Normal: 426 (62.3%)\n",
      "   âŒ Abnormal: 258 (37.7%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 435 (63.6%)\n",
      "      Female: 249 (36.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 684 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum LDL Cholesterol:\n",
      "   Total Records: 746\n",
      "   âœ… Normal: 263 (35.3%)\n",
      "   âŒ Abnormal: 483 (64.7%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 488 (65.4%)\n",
      "      Female: 258 (34.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 746 (100.0%)\n",
      "\n",
      "ğŸ“‹ Blood Urea Nitrogen:\n",
      "   Total Records: 710\n",
      "   âœ… Normal: 232 (32.7%)\n",
      "   âŒ Abnormal: 478 (67.3%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 466 (65.6%)\n",
      "      Female: 244 (34.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 708 (99.7%)\n",
      "      Hawkari: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 741\n",
      "   âœ… Normal: 567 (76.5%)\n",
      "   âŒ Abnormal: 174 (23.5%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 490 (66.1%)\n",
      "      Female: 251 (33.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 738 (99.6%)\n",
      "      Hawkari: 3 (0.4%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (502 patients):\n",
      "   ğŸ“Š Serum Triglycerides: normal + Serum: normal + Serum: abnormal + Blood: abnormal + Serum Creatinine: normal\n",
      "      63 patients (12.5%)\n",
      "   ğŸ“Š Serum Triglycerides: abnormal + Serum: normal + Serum: abnormal + Blood: abnormal + Serum Creatinine: normal\n",
      "      50 patients (10.0%)\n",
      "   ğŸ“Š Serum Triglycerides: abnormal + Serum: abnormal + Serum: abnormal + Blood: abnormal + Serum Creatinine: normal\n",
      "      43 patients (8.6%)\n",
      "   ğŸ“Š Serum Triglycerides: normal + Serum: normal + Serum: normal + Blood: abnormal + Serum Creatinine: normal\n",
      "      39 patients (7.8%)\n",
      "   ğŸ“Š Serum Triglycerides: abnormal + Serum: abnormal + Serum: abnormal + Blood: normal + Serum Creatinine: normal\n",
      "      34 patients (6.8%)\n",
      "   ğŸ“Š Serum Triglycerides: abnormal + Serum: normal + Serum: abnormal + Blood: normal + Serum Creatinine: normal\n",
      "      29 patients (5.8%)\n",
      "   ğŸ“Š Serum Triglycerides: abnormal + Serum: abnormal + Serum: normal + Blood: abnormal + Serum Creatinine: normal\n",
      "      22 patients (4.4%)\n",
      "   ğŸ“Š Serum Triglycerides: normal + Serum: normal + Serum: abnormal + Blood: normal + Serum Creatinine: normal\n",
      "      21 patients (4.2%)\n",
      "   ğŸ“Š Serum Triglycerides: normal + Serum: normal + Serum: normal + Blood: normal + Serum Creatinine: normal\n",
      "      20 patients (4.0%)\n",
      "   ğŸ“Š Serum Triglycerides: normal + Serum: normal + Serum: abnormal + Blood: normal + Serum Creatinine: abnormal\n",
      "      20 patients (4.0%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 20 (4.0%)\n",
      "   Four or More Tests Abnormal: 65 (12.9%)\n",
      "   All Five Tests Abnormal: 3 (0.6%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Cholesterol + Serum HDL Cholesterol + Serum LDL Cholesterol + Blood Urea Nitrogen + Serum Creatinine\n",
      "ğŸ“Š Total Patients: 501\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Cholesterol:\n",
      "   Total Records: 810\n",
      "   âœ… Normal: 809 (99.9%)\n",
      "   âŒ Abnormal: 1 (0.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 531 (65.6%)\n",
      "      Female: 279 (34.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 810 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum HDL Cholesterol:\n",
      "   Total Records: 683\n",
      "   âœ… Normal: 426 (62.4%)\n",
      "   âŒ Abnormal: 257 (37.6%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 434 (63.5%)\n",
      "      Female: 249 (36.5%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 683 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum LDL Cholesterol:\n",
      "   Total Records: 745\n",
      "   âœ… Normal: 262 (35.2%)\n",
      "   âŒ Abnormal: 483 (64.8%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 487 (65.4%)\n",
      "      Female: 258 (34.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 745 (100.0%)\n",
      "\n",
      "ğŸ“‹ Blood Urea Nitrogen:\n",
      "   Total Records: 708\n",
      "   âœ… Normal: 231 (32.6%)\n",
      "   âŒ Abnormal: 477 (67.4%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 464 (65.5%)\n",
      "      Female: 244 (34.5%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 706 (99.7%)\n",
      "      Hawkari: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 739\n",
      "   âœ… Normal: 567 (76.7%)\n",
      "   âŒ Abnormal: 172 (23.3%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 488 (66.0%)\n",
      "      Female: 251 (34.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 736 (99.6%)\n",
      "      Hawkari: 3 (0.4%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (502 patients):\n",
      "   ğŸ“Š Serum Triglycerides: normal + Serum: normal + Serum: abnormal + Blood: abnormal + Serum Creatinine: normal\n",
      "      63 patients (12.5%)\n",
      "   ğŸ“Š Serum Triglycerides: abnormal + Serum: normal + Serum: abnormal + Blood: abnormal + Serum Creatinine: normal\n",
      "      50 patients (10.0%)\n",
      "   ğŸ“Š Serum Triglycerides: abnormal + Serum: abnormal + Serum: abnormal + Blood: abnormal + Serum Creatinine: normal\n",
      "      43 patients (8.6%)\n",
      "   ğŸ“Š Serum Triglycerides: normal + Serum: normal + Serum: normal + Blood: abnormal + Serum Creatinine: normal\n",
      "      39 patients (7.8%)\n",
      "   ğŸ“Š Serum Triglycerides: abnormal + Serum: abnormal + Serum: abnormal + Blood: normal + Serum Creatinine: normal\n",
      "      34 patients (6.8%)\n",
      "   ğŸ“Š Serum Triglycerides: abnormal + Serum: normal + Serum: abnormal + Blood: normal + Serum Creatinine: normal\n",
      "      29 patients (5.8%)\n",
      "   ğŸ“Š Serum Triglycerides: abnormal + Serum: abnormal + Serum: normal + Blood: abnormal + Serum Creatinine: normal\n",
      "      22 patients (4.4%)\n",
      "   ğŸ“Š Serum Triglycerides: normal + Serum: normal + Serum: abnormal + Blood: normal + Serum Creatinine: normal\n",
      "      21 patients (4.2%)\n",
      "   ğŸ“Š Serum Triglycerides: normal + Serum: normal + Serum: normal + Blood: normal + Serum Creatinine: normal\n",
      "      20 patients (4.0%)\n",
      "   ğŸ“Š Serum Triglycerides: normal + Serum: normal + Serum: abnormal + Blood: normal + Serum Creatinine: abnormal\n",
      "      20 patients (4.0%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 20 (4.0%)\n",
      "   Four or More Tests Abnormal: 65 (12.9%)\n",
      "   All Five Tests Abnormal: 3 (0.6%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Cholesterol + Serum HDL Cholesterol + Serum LDL Cholesterol + Blood Urea Nitrogen + Serum Creatinine\n",
      "ğŸ“Š Total Patients: 501\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Cholesterol:\n",
      "   Total Records: 810\n",
      "   âœ… Normal: 809 (99.9%)\n",
      "   âŒ Abnormal: 1 (0.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 531 (65.6%)\n",
      "      Female: 279 (34.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 810 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum HDL Cholesterol:\n",
      "   Total Records: 683\n",
      "   âœ… Normal: 426 (62.4%)\n",
      "   âŒ Abnormal: 257 (37.6%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 434 (63.5%)\n",
      "      Female: 249 (36.5%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 683 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum LDL Cholesterol:\n",
      "   Total Records: 745\n",
      "   âœ… Normal: 262 (35.2%)\n",
      "   âŒ Abnormal: 483 (64.8%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 487 (65.4%)\n",
      "      Female: 258 (34.6%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 745 (100.0%)\n",
      "\n",
      "ğŸ“‹ Blood Urea Nitrogen:\n",
      "   Total Records: 708\n",
      "   âœ… Normal: 231 (32.6%)\n",
      "   âŒ Abnormal: 477 (67.4%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 464 (65.5%)\n",
      "      Female: 244 (34.5%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 706 (99.7%)\n",
      "      Hawkari: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 739\n",
      "   âœ… Normal: 567 (76.7%)\n",
      "   âŒ Abnormal: 172 (23.3%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 488 (66.0%)\n",
      "      Female: 251 (34.0%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 736 (99.6%)\n",
      "      Hawkari: 3 (0.4%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (501 patients):\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum: normal + Serum: abnormal + Blood: abnormal + Serum Creatinine: normal\n",
      "      114 patients (22.8%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum: abnormal + Serum: abnormal + Blood: abnormal + Serum Creatinine: normal\n",
      "      60 patients (12.0%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum: normal + Serum: normal + Blood: abnormal + Serum Creatinine: normal\n",
      "      53 patients (10.6%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum: normal + Serum: abnormal + Blood: normal + Serum Creatinine: normal\n",
      "      49 patients (9.8%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum: abnormal + Serum: abnormal + Blood: normal + Serum Creatinine: normal\n",
      "      43 patients (8.6%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum: abnormal + Serum: normal + Blood: abnormal + Serum Creatinine: normal\n",
      "      40 patients (8.0%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum: normal + Serum: abnormal + Blood: normal + Serum Creatinine: abnormal\n",
      "      30 patients (6.0%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum: normal + Serum: abnormal + Blood: abnormal + Serum Creatinine: abnormal\n",
      "      24 patients (4.8%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum: normal + Serum: normal + Blood: normal + Serum Creatinine: normal\n",
      "      23 patients (4.6%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum: normal + Serum: normal + Blood: normal + Serum Creatinine: abnormal\n",
      "      17 patients (3.4%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 23 (4.6%)\n",
      "   Four or More Tests Abnormal: 3 (0.6%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Blood Urea Nitrogen + Serum Creatinine\n",
      "ğŸ“Š Total Patients: 501\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Cholesterol:\n",
      "   Total Records: 814\n",
      "   âœ… Normal: 813 (99.9%)\n",
      "   âŒ Abnormal: 1 (0.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 535 (65.7%)\n",
      "      Female: 279 (34.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 814 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum Triglycerides:\n",
      "   Total Records: 815\n",
      "   âœ… Normal: 374 (45.9%)\n",
      "   âŒ Abnormal: 441 (54.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 536 (65.8%)\n",
      "      Female: 279 (34.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 815 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum HDL Cholesterol:\n",
      "   Total Records: 683\n",
      "   âœ… Normal: 425 (62.2%)\n",
      "   âŒ Abnormal: 258 (37.8%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 434 (63.5%)\n",
      "      Female: 249 (36.5%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 683 (100.0%)\n",
      "\n",
      "ğŸ“‹ Blood Urea Nitrogen:\n",
      "   Total Records: 709\n",
      "   âœ… Normal: 233 (32.9%)\n",
      "   âŒ Abnormal: 476 (67.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 465 (65.6%)\n",
      "      Female: 244 (34.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 707 (99.7%)\n",
      "      Hawkari: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 740\n",
      "   âœ… Normal: 566 (76.5%)\n",
      "   âŒ Abnormal: 174 (23.5%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 489 (66.1%)\n",
      "      Female: 251 (33.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 737 (99.6%)\n",
      "      Hawkari: 3 (0.4%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (501 patients):\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum: normal + Serum: abnormal + Blood: abnormal + Serum Creatinine: normal\n",
      "      114 patients (22.8%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum: abnormal + Serum: abnormal + Blood: abnormal + Serum Creatinine: normal\n",
      "      60 patients (12.0%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum: normal + Serum: normal + Blood: abnormal + Serum Creatinine: normal\n",
      "      53 patients (10.6%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum: normal + Serum: abnormal + Blood: normal + Serum Creatinine: normal\n",
      "      49 patients (9.8%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum: abnormal + Serum: abnormal + Blood: normal + Serum Creatinine: normal\n",
      "      43 patients (8.6%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum: abnormal + Serum: normal + Blood: abnormal + Serum Creatinine: normal\n",
      "      40 patients (8.0%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum: normal + Serum: abnormal + Blood: normal + Serum Creatinine: abnormal\n",
      "      30 patients (6.0%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum: normal + Serum: abnormal + Blood: abnormal + Serum Creatinine: abnormal\n",
      "      24 patients (4.8%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum: normal + Serum: normal + Blood: normal + Serum Creatinine: normal\n",
      "      23 patients (4.6%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum: normal + Serum: normal + Blood: normal + Serum Creatinine: abnormal\n",
      "      17 patients (3.4%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 23 (4.6%)\n",
      "   Four or More Tests Abnormal: 3 (0.6%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ§ª TEST COMBINATION: Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Blood Urea Nitrogen + Serum Creatinine\n",
      "ğŸ“Š Total Patients: 501\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "ğŸ“‹ Serum Cholesterol:\n",
      "   Total Records: 814\n",
      "   âœ… Normal: 813 (99.9%)\n",
      "   âŒ Abnormal: 1 (0.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 535 (65.7%)\n",
      "      Female: 279 (34.3%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 814 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum Triglycerides:\n",
      "   Total Records: 815\n",
      "   âœ… Normal: 374 (45.9%)\n",
      "   âŒ Abnormal: 441 (54.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 536 (65.8%)\n",
      "      Female: 279 (34.2%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 815 (100.0%)\n",
      "\n",
      "ğŸ“‹ Serum HDL Cholesterol:\n",
      "   Total Records: 683\n",
      "   âœ… Normal: 425 (62.2%)\n",
      "   âŒ Abnormal: 258 (37.8%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 434 (63.5%)\n",
      "      Female: 249 (36.5%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 683 (100.0%)\n",
      "\n",
      "ğŸ“‹ Blood Urea Nitrogen:\n",
      "   Total Records: 709\n",
      "   âœ… Normal: 233 (32.9%)\n",
      "   âŒ Abnormal: 476 (67.1%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 465 (65.6%)\n",
      "      Female: 244 (34.4%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 707 (99.7%)\n",
      "      Hawkari: 2 (0.3%)\n",
      "\n",
      "ğŸ“‹ Serum Creatinine:\n",
      "   Total Records: 740\n",
      "   âœ… Normal: 566 (76.5%)\n",
      "   âŒ Abnormal: 174 (23.5%)\n",
      "   ğŸ‘¥ Gender Distribution:\n",
      "      Male: 489 (66.1%)\n",
      "      Female: 251 (33.9%)\n",
      "   ğŸ¥ Lab Distribution:\n",
      "      Biolab: 737 (99.6%)\n",
      "      Hawkari: 3 (0.4%)\n",
      "\n",
      "ğŸ” COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (501 patients):\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Blood: abnormal + Serum Creatinine: normal\n",
      "      102 patients (20.4%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Blood: abnormal + Serum Creatinine: normal\n",
      "      65 patients (13.0%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Blood: abnormal + Serum Creatinine: normal\n",
      "      64 patients (12.8%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Blood: normal + Serum Creatinine: normal\n",
      "      41 patients (8.2%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Blood: normal + Serum Creatinine: normal\n",
      "      38 patients (7.6%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: abnormal + Blood: abnormal + Serum Creatinine: normal\n",
      "      35 patients (7.0%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Blood: normal + Serum Creatinine: normal\n",
      "      31 patients (6.2%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Blood: normal + Serum Creatinine: abnormal\n",
      "      29 patients (5.8%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Blood: abnormal + Serum Creatinine: abnormal\n",
      "      24 patients (4.8%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Blood: normal + Serum Creatinine: abnormal\n",
      "      18 patients (3.6%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 41 (8.2%)\n",
      "   Four or More Tests Abnormal: 7 (1.4%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ¯ SUMMARY TABLE - FIVE-TEST COMBINATION OUTCOMES\n",
      "================================================================================================================================================================\n",
      "   Outcome Pattern Analysis (501 patients):\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Blood: abnormal + Serum Creatinine: normal\n",
      "      102 patients (20.4%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Blood: abnormal + Serum Creatinine: normal\n",
      "      65 patients (13.0%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Blood: abnormal + Serum Creatinine: normal\n",
      "      64 patients (12.8%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Blood: normal + Serum Creatinine: normal\n",
      "      41 patients (8.2%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: abnormal + Blood: normal + Serum Creatinine: normal\n",
      "      38 patients (7.6%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: abnormal + Blood: abnormal + Serum Creatinine: normal\n",
      "      35 patients (7.0%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Blood: normal + Serum Creatinine: normal\n",
      "      31 patients (6.2%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Blood: normal + Serum Creatinine: abnormal\n",
      "      29 patients (5.8%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: normal + Serum: normal + Blood: abnormal + Serum Creatinine: abnormal\n",
      "      24 patients (4.8%)\n",
      "   ğŸ“Š Serum Cholesterol: normal + Serum Triglycerides: abnormal + Serum: normal + Blood: normal + Serum Creatinine: abnormal\n",
      "      18 patients (3.6%)\n",
      "\n",
      "   ğŸš¨ RISK ANALYSIS:\n",
      "   All Five Tests Normal: 41 (8.2%)\n",
      "   Four or More Tests Abnormal: 7 (1.4%)\n",
      "   All Five Tests Abnormal: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "ğŸ¯ SUMMARY TABLE - FIVE-TEST COMBINATION OUTCOMES\n",
      "================================================================================================================================================================\n",
      "                          Test 1                           Test 2                           Test 3                         Test 4                   Test 5  Total Patients Test 1 Abnormal % Test 2 Abnormal % Test 3 Abnormal % Test 4 Abnormal % Test 5 Abnormal %\n",
      "                             TSH                 Serum Creatinine                    Blood Glucose              Total Cholesterol          LDL Cholesterol             767             24.4%             28.6%              0.0%             22.2%              0.0%\n",
      "                             TSH                 Serum Creatinine            Total Serum Bilirubin                 Serum Ferritin            Blood Glucose             740             29.4%             42.6%              0.0%             22.2%              0.0%\n",
      "                Serum Creatinine Aspartate Aminotransferase (AST)   Alanine Aminotransferase (ALT)           Alkaline Phosphatase    Total Serum Bilirubin             705             33.6%             13.0%             11.1%             13.4%              0.0%\n",
      "                Serum Creatinine                    Blood Glucose                Total Cholesterol                  Triglycerides          LDL Cholesterol             641             26.0%              0.0%             22.4%             58.0%              0.0%\n",
      "Aspartate Aminotransferase (AST)   Alanine Aminotransferase (ALT)             Alkaline Phosphatase          Total Serum Bilirubin            Blood Glucose             626             13.0%             10.5%             12.8%              0.0%              0.0%\n",
      "                Serum Creatinine Aspartate Aminotransferase (AST)   Alanine Aminotransferase (ALT)           Alkaline Phosphatase            Blood Glucose             602             32.9%             13.2%             10.1%             12.4%              0.0%\n",
      "                             TSH                 Serum Creatinine            Total Serum Bilirubin                  Blood Glucose          LDL Cholesterol             602             23.6%             30.1%              0.0%              0.0%              0.0%\n",
      "                Serum Creatinine Aspartate Aminotransferase (AST)   Alanine Aminotransferase (ALT)          Total Serum Bilirubin            Blood Glucose             601             33.2%             12.8%              9.3%              0.0%              0.0%\n",
      "               Serum Cholesterol              Serum Triglycerides            Serum HDL Cholesterol          Serum LDL Cholesterol     Complete Blood Count             601              0.1%             58.7%             39.0%             69.0%              0.0%\n",
      "                             TSH                 Serum Creatinine                Total Cholesterol                  Triglycerides          LDL Cholesterol             576             25.5%             29.0%             22.8%             57.2%              0.0%\n",
      "                             TSH                Serum Cholesterol              Serum Triglycerides          Serum HDL Cholesterol    Serum LDL Cholesterol             574             34.7%              0.0%             55.9%             35.5%             67.0%\n",
      "                             TSH                    Blood Glucose                Total Cholesterol                  Triglycerides          LDL Cholesterol             572             24.7%              0.0%             22.5%             55.7%              0.0%\n",
      "                             TSH                 Serum Creatinine                    Blood Glucose                  Triglycerides          LDL Cholesterol             571             25.0%             28.7%              0.0%             56.2%              0.0%\n",
      "                             TSH                 Serum Creatinine            Total Serum Bilirubin                  Blood Glucose C-Reactive Protein Titer             568             28.0%             39.2%              0.0%              0.0%              0.0%\n",
      "                Serum Creatinine            Total Serum Bilirubin                    Blood Glucose              Total Cholesterol          LDL Cholesterol             562             28.8%              0.0%              0.0%             23.3%              0.0%\n",
      "                Serum Creatinine Aspartate Aminotransferase (AST)             Alkaline Phosphatase          Total Serum Bilirubin            Blood Glucose             561             33.0%             12.8%             12.6%              0.0%              0.0%\n",
      "                Serum Creatinine   Alanine Aminotransferase (ALT)             Alkaline Phosphatase          Total Serum Bilirubin            Blood Glucose             561             33.0%              9.9%             12.4%              0.0%              0.0%\n",
      "               Serum Cholesterol              Serum Triglycerides            Serum LDL Cholesterol            Blood Urea Nitrogen         Serum Creatinine             561              0.1%             54.7%             64.5%             69.5%             25.6%\n",
      "               Serum Cholesterol              Serum Triglycerides            Serum HDL Cholesterol          Serum LDL Cholesterol         Serum Creatinine             552              0.1%             56.0%             36.7%             66.1%             24.0%\n",
      "                             TSH                 Serum Creatinine            Total Serum Bilirubin              Total Cholesterol          LDL Cholesterol             547             23.1%             28.6%              0.0%             23.2%              0.0%\n",
      "                             TSH                 Serum Creatinine                    Blood Glucose              Total Cholesterol            Triglycerides             535             24.5%             29.6%              0.0%             22.2%             55.9%\n",
      "                             TSH            Total Serum Bilirubin                    Blood Glucose              Total Cholesterol          LDL Cholesterol             534             23.3%              0.0%              0.0%             22.7%              0.0%\n",
      "               Serum Cholesterol              Serum Triglycerides            Serum HDL Cholesterol          Serum LDL Cholesterol               Vitamin D3             528              0.0%             57.8%             35.6%             67.5%             77.0%\n",
      "               Serum Cholesterol              Serum Triglycerides              Blood Urea Nitrogen               Serum Creatinine     Complete Blood Count             525              0.1%             53.4%             68.9%             26.9%              0.0%\n",
      "                             TSH                 Serum Creatinine            Total Serum Bilirubin                  Blood Glucose        Total Cholesterol             521             23.8%             29.7%              0.0%              0.0%             22.9%\n",
      "                             TSH                 Serum Creatinine Aspartate Aminotransferase (AST) Alanine Aminotransferase (ALT)            Blood Glucose             509             26.0%             29.0%              9.9%              9.9%              0.0%\n",
      "             Blood Urea Nitrogen                 Serum Creatinine      Hepatitis B Surface Antigen           Hepatitis C Antibody             HIV Antibody             506             66.2%             35.5%              0.4%              0.0%              0.0%\n",
      "               Serum Cholesterol              Serum Triglycerides            Serum HDL Cholesterol          Serum LDL Cholesterol      Blood Urea Nitrogen             504              0.1%             54.2%             37.9%             64.7%             67.2%\n",
      "             Serum Triglycerides            Serum HDL Cholesterol            Serum LDL Cholesterol            Blood Urea Nitrogen         Serum Creatinine             502             54.3%             37.7%             64.7%             67.3%             23.5%\n",
      "               Serum Cholesterol            Serum HDL Cholesterol            Serum LDL Cholesterol            Blood Urea Nitrogen         Serum Creatinine             501              0.1%             37.6%             64.8%             67.4%             23.3%\n",
      "               Serum Cholesterol              Serum Triglycerides            Serum HDL Cholesterol            Blood Urea Nitrogen         Serum Creatinine             501              0.1%             54.1%             37.8%             67.1%             23.5%\n",
      "\n",
      "âœ… ANALYSIS COMPLETE!\n",
      "ğŸ“ˆ Analyzed 31 test combinations covering 17,756 total patient-test-quintuplet instances\n",
      "âš ï¸ NOTE: With 5-test combinations, patient counts are significantly lower due to the requirement that patients must have all 5 tests\n",
      "                          Test 1                           Test 2                           Test 3                         Test 4                   Test 5  Total Patients Test 1 Abnormal % Test 2 Abnormal % Test 3 Abnormal % Test 4 Abnormal % Test 5 Abnormal %\n",
      "                             TSH                 Serum Creatinine                    Blood Glucose              Total Cholesterol          LDL Cholesterol             767             24.4%             28.6%              0.0%             22.2%              0.0%\n",
      "                             TSH                 Serum Creatinine            Total Serum Bilirubin                 Serum Ferritin            Blood Glucose             740             29.4%             42.6%              0.0%             22.2%              0.0%\n",
      "                Serum Creatinine Aspartate Aminotransferase (AST)   Alanine Aminotransferase (ALT)           Alkaline Phosphatase    Total Serum Bilirubin             705             33.6%             13.0%             11.1%             13.4%              0.0%\n",
      "                Serum Creatinine                    Blood Glucose                Total Cholesterol                  Triglycerides          LDL Cholesterol             641             26.0%              0.0%             22.4%             58.0%              0.0%\n",
      "Aspartate Aminotransferase (AST)   Alanine Aminotransferase (ALT)             Alkaline Phosphatase          Total Serum Bilirubin            Blood Glucose             626             13.0%             10.5%             12.8%              0.0%              0.0%\n",
      "                Serum Creatinine Aspartate Aminotransferase (AST)   Alanine Aminotransferase (ALT)           Alkaline Phosphatase            Blood Glucose             602             32.9%             13.2%             10.1%             12.4%              0.0%\n",
      "                             TSH                 Serum Creatinine            Total Serum Bilirubin                  Blood Glucose          LDL Cholesterol             602             23.6%             30.1%              0.0%              0.0%              0.0%\n",
      "                Serum Creatinine Aspartate Aminotransferase (AST)   Alanine Aminotransferase (ALT)          Total Serum Bilirubin            Blood Glucose             601             33.2%             12.8%              9.3%              0.0%              0.0%\n",
      "               Serum Cholesterol              Serum Triglycerides            Serum HDL Cholesterol          Serum LDL Cholesterol     Complete Blood Count             601              0.1%             58.7%             39.0%             69.0%              0.0%\n",
      "                             TSH                 Serum Creatinine                Total Cholesterol                  Triglycerides          LDL Cholesterol             576             25.5%             29.0%             22.8%             57.2%              0.0%\n",
      "                             TSH                Serum Cholesterol              Serum Triglycerides          Serum HDL Cholesterol    Serum LDL Cholesterol             574             34.7%              0.0%             55.9%             35.5%             67.0%\n",
      "                             TSH                    Blood Glucose                Total Cholesterol                  Triglycerides          LDL Cholesterol             572             24.7%              0.0%             22.5%             55.7%              0.0%\n",
      "                             TSH                 Serum Creatinine                    Blood Glucose                  Triglycerides          LDL Cholesterol             571             25.0%             28.7%              0.0%             56.2%              0.0%\n",
      "                             TSH                 Serum Creatinine            Total Serum Bilirubin                  Blood Glucose C-Reactive Protein Titer             568             28.0%             39.2%              0.0%              0.0%              0.0%\n",
      "                Serum Creatinine            Total Serum Bilirubin                    Blood Glucose              Total Cholesterol          LDL Cholesterol             562             28.8%              0.0%              0.0%             23.3%              0.0%\n",
      "                Serum Creatinine Aspartate Aminotransferase (AST)             Alkaline Phosphatase          Total Serum Bilirubin            Blood Glucose             561             33.0%             12.8%             12.6%              0.0%              0.0%\n",
      "                Serum Creatinine   Alanine Aminotransferase (ALT)             Alkaline Phosphatase          Total Serum Bilirubin            Blood Glucose             561             33.0%              9.9%             12.4%              0.0%              0.0%\n",
      "               Serum Cholesterol              Serum Triglycerides            Serum LDL Cholesterol            Blood Urea Nitrogen         Serum Creatinine             561              0.1%             54.7%             64.5%             69.5%             25.6%\n",
      "               Serum Cholesterol              Serum Triglycerides            Serum HDL Cholesterol          Serum LDL Cholesterol         Serum Creatinine             552              0.1%             56.0%             36.7%             66.1%             24.0%\n",
      "                             TSH                 Serum Creatinine            Total Serum Bilirubin              Total Cholesterol          LDL Cholesterol             547             23.1%             28.6%              0.0%             23.2%              0.0%\n",
      "                             TSH                 Serum Creatinine                    Blood Glucose              Total Cholesterol            Triglycerides             535             24.5%             29.6%              0.0%             22.2%             55.9%\n",
      "                             TSH            Total Serum Bilirubin                    Blood Glucose              Total Cholesterol          LDL Cholesterol             534             23.3%              0.0%              0.0%             22.7%              0.0%\n",
      "               Serum Cholesterol              Serum Triglycerides            Serum HDL Cholesterol          Serum LDL Cholesterol               Vitamin D3             528              0.0%             57.8%             35.6%             67.5%             77.0%\n",
      "               Serum Cholesterol              Serum Triglycerides              Blood Urea Nitrogen               Serum Creatinine     Complete Blood Count             525              0.1%             53.4%             68.9%             26.9%              0.0%\n",
      "                             TSH                 Serum Creatinine            Total Serum Bilirubin                  Blood Glucose        Total Cholesterol             521             23.8%             29.7%              0.0%              0.0%             22.9%\n",
      "                             TSH                 Serum Creatinine Aspartate Aminotransferase (AST) Alanine Aminotransferase (ALT)            Blood Glucose             509             26.0%             29.0%              9.9%              9.9%              0.0%\n",
      "             Blood Urea Nitrogen                 Serum Creatinine      Hepatitis B Surface Antigen           Hepatitis C Antibody             HIV Antibody             506             66.2%             35.5%              0.4%              0.0%              0.0%\n",
      "               Serum Cholesterol              Serum Triglycerides            Serum HDL Cholesterol          Serum LDL Cholesterol      Blood Urea Nitrogen             504              0.1%             54.2%             37.9%             64.7%             67.2%\n",
      "             Serum Triglycerides            Serum HDL Cholesterol            Serum LDL Cholesterol            Blood Urea Nitrogen         Serum Creatinine             502             54.3%             37.7%             64.7%             67.3%             23.5%\n",
      "               Serum Cholesterol            Serum HDL Cholesterol            Serum LDL Cholesterol            Blood Urea Nitrogen         Serum Creatinine             501              0.1%             37.6%             64.8%             67.4%             23.3%\n",
      "               Serum Cholesterol              Serum Triglycerides            Serum HDL Cholesterol            Blood Urea Nitrogen         Serum Creatinine             501              0.1%             54.1%             37.8%             67.1%             23.5%\n",
      "\n",
      "âœ… ANALYSIS COMPLETE!\n",
      "ğŸ“ˆ Analyzed 31 test combinations covering 17,756 total patient-test-quintuplet instances\n",
      "âš ï¸ NOTE: With 5-test combinations, patient counts are significantly lower due to the requirement that patients must have all 5 tests\n"
     ]
    }
   ],
   "source": [
    "# Show the Outcome status for each of the test combinations\n",
    "print(\"=== OUTCOME DISTRIBUTION ANALYSIS FOR 5-TEST COMBINATIONS ===\")\n",
    "print(f\"Analyzing {len(results_df)} test combinations with >{limit} patients each\")\n",
    "print(\"\\n\" + \"=\"*100)\n",
    "\n",
    "# For each combination, show detailed outcome breakdown\n",
    "for idx, row in results_df.iterrows():\n",
    "    test1, test2, test3, test4, test5 = row['tests']\n",
    "    patient_count = row['count']\n",
    "    \n",
    "    print(f\"\\nğŸ§ª TEST COMBINATION: {test1} + {test2} + {test3} + {test4} + {test5}\")\n",
    "    print(f\"ğŸ“Š Total Patients: {patient_count:,}\")\n",
    "    print(\"-\" * 80)\n",
    "\n",
    "    # Get patients who have all five tests\n",
    "    patients_with_all = df_pivot[(df_pivot[test1] > 0) & (df_pivot[test2] > 0) & \n",
    "                                (df_pivot[test3] > 0) & (df_pivot[test4] > 0) & \n",
    "                                (df_pivot[test5] > 0)].index\n",
    "\n",
    "    # Filter the main dataset for these patients and all tests\n",
    "    combo_data = df[\n",
    "        (df['Patient Name'].isin(patients_with_all)) & \n",
    "        (df['Standard Test Name'].isin([test1, test2, test3, test4, test5]))\n",
    "    ].copy()\n",
    "    \n",
    "    # Analyze outcomes for each test separately\n",
    "    for test_name in [test1, test2, test3, test4, test5]:\n",
    "        test_data = combo_data[combo_data['Standard Test Name'] == test_name]\n",
    "        \n",
    "        print(f\"\\nğŸ“‹ {test_name}:\")\n",
    "        print(f\"   Total Records: {len(test_data):,}\")\n",
    "        \n",
    "        # Outcome distribution\n",
    "        outcome_dist = test_data['Outcome'].value_counts()\n",
    "        total_records = len(test_data)\n",
    "        \n",
    "        for outcome in ['normal', 'abnormal']:\n",
    "            count = outcome_dist.get(outcome, 0)\n",
    "            percentage = (count / total_records * 100) if total_records > 0 else 0\n",
    "            outcome_name = {'normal': 'Normal', 'abnormal': 'Abnormal'}[outcome]\n",
    "            emoji = {'normal': 'âœ…', 'abnormal': 'âŒ'}[outcome]\n",
    "            print(f\"   {emoji} {outcome_name}: {count:,} ({percentage:.1f}%)\")\n",
    "        \n",
    "        # Gender breakdown\n",
    "        gender_dist = test_data['Gender'].value_counts()\n",
    "        print(f\"   ğŸ‘¥ Gender Distribution:\")\n",
    "        for gender, count in gender_dist.items():\n",
    "            percentage = (count / total_records * 100) if total_records > 0 else 0\n",
    "            print(f\"      {gender}: {count:,} ({percentage:.1f}%)\")\n",
    "        \n",
    "        # Lab distribution\n",
    "        lab_dist = test_data['Lab'].value_counts()\n",
    "        print(f\"   ğŸ¥ Lab Distribution:\")\n",
    "        for lab, count in lab_dist.items():\n",
    "            percentage = (count / total_records * 100) if total_records > 0 else 0\n",
    "            print(f\"      {lab}: {count:,} ({percentage:.1f}%)\")\n",
    "    \n",
    "    # Combined analysis - look at outcome patterns for patients with all five tests\n",
    "    print(f\"\\nğŸ” COMBINED OUTCOME PATTERNS:\")\n",
    "    \n",
    "    # Create a summary for each patient showing their outcomes for all five tests\n",
    "    patient_outcomes = []\n",
    "    for patient in patients_with_all:\n",
    "        patient_data = combo_data[combo_data['Patient Name'] == patient]\n",
    "        \n",
    "        test1_outcomes = patient_data[patient_data['Standard Test Name'] == test1]['Outcome'].values\n",
    "        test2_outcomes = patient_data[patient_data['Standard Test Name'] == test2]['Outcome'].values\n",
    "        test3_outcomes = patient_data[patient_data['Standard Test Name'] == test3]['Outcome'].values\n",
    "        test4_outcomes = patient_data[patient_data['Standard Test Name'] == test4]['Outcome'].values\n",
    "        test5_outcomes = patient_data[patient_data['Standard Test Name'] == test5]['Outcome'].values\n",
    "        \n",
    "        if (len(test1_outcomes) > 0 and len(test2_outcomes) > 0 and len(test3_outcomes) > 0 and \n",
    "            len(test4_outcomes) > 0 and len(test5_outcomes) > 0):\n",
    "            # Take the most recent outcome for each test\n",
    "            test1_outcome = test1_outcomes[-1]  # Most recent\n",
    "            test2_outcome = test2_outcomes[-1]  # Most recent\n",
    "            test3_outcome = test3_outcomes[-1]  # Most recent\n",
    "            test4_outcome = test4_outcomes[-1]  # Most recent\n",
    "            test5_outcome = test5_outcomes[-1]  # Most recent\n",
    "            \n",
    "            patient_outcomes.append({\n",
    "                'patient': patient,\n",
    "                'test1_outcome': test1_outcome,\n",
    "                'test2_outcome': test2_outcome,\n",
    "                'test3_outcome': test3_outcome,\n",
    "                'test4_outcome': test4_outcome,\n",
    "                'test5_outcome': test5_outcome,\n",
    "                'combination': f\"{test1_outcome}-{test2_outcome}-{test3_outcome}-{test4_outcome}-{test5_outcome}\"\n",
    "            })\n",
    "    \n",
    "    # Analyze outcome combinations\n",
    "    if patient_outcomes:\n",
    "        combo_df = pd.DataFrame(patient_outcomes)\n",
    "        combo_counts = combo_df['combination'].value_counts()\n",
    "        \n",
    "        print(f\"   Outcome Pattern Analysis ({len(patient_outcomes)} patients):\")\n",
    "        for combo, count in combo_counts.head(10).items():  # Show top 10 combinations\n",
    "            percentage = (count / len(patient_outcomes) * 100)\n",
    "            test1_out, test2_out, test3_out, test4_out, test5_out = combo.split('-')\n",
    "            \n",
    "            test1_name_short = test1.split()[0] if len(test1.split()) > 2 else test1\n",
    "            test2_name_short = test2.split()[0] if len(test2.split()) > 2 else test2\n",
    "            test3_name_short = test3.split()[0] if len(test3.split()) > 2 else test3\n",
    "            test4_name_short = test4.split()[0] if len(test4.split()) > 2 else test4\n",
    "            test5_name_short = test5.split()[0] if len(test5.split()) > 2 else test5\n",
    "            \n",
    "            print(f\"   ğŸ“Š {test1_name_short}: {test1_out} + {test2_name_short}: {test2_out} + {test3_name_short}: {test3_out} + {test4_name_short}: {test4_out} + {test5_name_short}: {test5_out}\")\n",
    "            print(f\"      {count:,} patients ({percentage:.1f}%)\")\n",
    "        \n",
    "        # Risk analysis - patients with abnormal results in multiple tests\n",
    "        all_normal = combo_df[\n",
    "            (combo_df['test1_outcome'] == 'normal') & \n",
    "            (combo_df['test2_outcome'] == 'normal') & \n",
    "            (combo_df['test3_outcome'] == 'normal') &\n",
    "            (combo_df['test4_outcome'] == 'normal') &\n",
    "            (combo_df['test5_outcome'] == 'normal')\n",
    "        ]\n",
    "        \n",
    "        four_plus_abnormal = combo_df[\n",
    "            ((combo_df['test1_outcome'] != 'normal') & (combo_df['test2_outcome'] != 'normal') & \n",
    "             (combo_df['test3_outcome'] != 'normal') & (combo_df['test4_outcome'] != 'normal')) |\n",
    "            ((combo_df['test1_outcome'] != 'normal') & (combo_df['test2_outcome'] != 'normal') & \n",
    "             (combo_df['test3_outcome'] != 'normal') & (combo_df['test5_outcome'] != 'normal')) |\n",
    "            ((combo_df['test1_outcome'] != 'normal') & (combo_df['test2_outcome'] != 'normal') & \n",
    "             (combo_df['test4_outcome'] != 'normal') & (combo_df['test5_outcome'] != 'normal')) |\n",
    "            ((combo_df['test1_outcome'] != 'normal') & (combo_df['test3_outcome'] != 'normal') & \n",
    "             (combo_df['test4_outcome'] != 'normal') & (combo_df['test5_outcome'] != 'normal')) |\n",
    "            ((combo_df['test2_outcome'] != 'normal') & (combo_df['test3_outcome'] != 'normal') & \n",
    "             (combo_df['test4_outcome'] != 'normal') & (combo_df['test5_outcome'] != 'normal'))\n",
    "        ]\n",
    "        \n",
    "        all_abnormal = combo_df[\n",
    "            (combo_df['test1_outcome'] != 'normal') & \n",
    "            (combo_df['test2_outcome'] != 'normal') & \n",
    "            (combo_df['test3_outcome'] != 'normal') &\n",
    "            (combo_df['test4_outcome'] != 'normal') &\n",
    "            (combo_df['test5_outcome'] != 'normal')\n",
    "        ]\n",
    "        \n",
    "        print(f\"\\n   ğŸš¨ RISK ANALYSIS:\")\n",
    "        print(f\"   All Five Tests Normal: {len(all_normal):,} ({len(all_normal)/len(patient_outcomes)*100:.1f}%)\")\n",
    "        print(f\"   Four or More Tests Abnormal: {len(four_plus_abnormal):,} ({len(four_plus_abnormal)/len(patient_outcomes)*100:.1f}%)\")\n",
    "        print(f\"   All Five Tests Abnormal: {len(all_abnormal):,} ({len(all_abnormal)/len(patient_outcomes)*100:.1f}%)\")\n",
    "    \n",
    "    print(\"\\n\" + \"=\"*100)\n",
    "\n",
    "# Summary table of all combinations\n",
    "print(f\"\\nğŸ¯ SUMMARY TABLE - FIVE-TEST COMBINATION OUTCOMES\")\n",
    "print(\"=\"*160)\n",
    "\n",
    "summary_data = []\n",
    "for idx, row in results_df.iterrows():\n",
    "    test1, test2, test3, test4, test5 = row['tests']\n",
    "    patient_count = row['count']\n",
    "    \n",
    "    # Get patients who have all five tests\n",
    "    patients_with_all = df_pivot[(df_pivot[test1] > 0) & (df_pivot[test2] > 0) & \n",
    "                                (df_pivot[test3] > 0) & (df_pivot[test4] > 0) & \n",
    "                                (df_pivot[test5] > 0)].index\n",
    "    combo_data = df[\n",
    "        (df['Patient Name'].isin(patients_with_all)) & \n",
    "        (df['Standard Test Name'].isin([test1, test2, test3, test4, test5]))\n",
    "    ].copy()\n",
    "    \n",
    "    # Calculate summary stats\n",
    "    test1_data = combo_data[combo_data['Standard Test Name'] == test1]\n",
    "    test2_data = combo_data[combo_data['Standard Test Name'] == test2]\n",
    "    test3_data = combo_data[combo_data['Standard Test Name'] == test3]\n",
    "    test4_data = combo_data[combo_data['Standard Test Name'] == test4]\n",
    "    test5_data = combo_data[combo_data['Standard Test Name'] == test5]\n",
    "    \n",
    "    test1_abnormal = len(test1_data[test1_data['Outcome'] != 'normal'])\n",
    "    test2_abnormal = len(test2_data[test2_data['Outcome'] != 'normal'])\n",
    "    test3_abnormal = len(test3_data[test3_data['Outcome'] != 'normal'])\n",
    "    test4_abnormal = len(test4_data[test4_data['Outcome'] != 'normal'])\n",
    "    test5_abnormal = len(test5_data[test5_data['Outcome'] != 'normal'])\n",
    "    \n",
    "    test1_abnormal_pct = (test1_abnormal / len(test1_data) * 100) if len(test1_data) > 0 else 0\n",
    "    test2_abnormal_pct = (test2_abnormal / len(test2_data) * 100) if len(test2_data) > 0 else 0\n",
    "    test3_abnormal_pct = (test3_abnormal / len(test3_data) * 100) if len(test3_data) > 0 else 0\n",
    "    test4_abnormal_pct = (test4_abnormal / len(test4_data) * 100) if len(test4_data) > 0 else 0\n",
    "    test5_abnormal_pct = (test5_abnormal / len(test5_data) * 100) if len(test5_data) > 0 else 0\n",
    "    \n",
    "    summary_data.append({\n",
    "        'Test 1': test1,\n",
    "        'Test 2': test2,\n",
    "        'Test 3': test3,\n",
    "        'Test 4': test4,\n",
    "        'Test 5': test5,\n",
    "        'Total Patients': patient_count,\n",
    "        'Test 1 Abnormal %': f\"{test1_abnormal_pct:.1f}%\",\n",
    "        'Test 2 Abnormal %': f\"{test2_abnormal_pct:.1f}%\",\n",
    "        'Test 3 Abnormal %': f\"{test3_abnormal_pct:.1f}%\",\n",
    "        'Test 4 Abnormal %': f\"{test4_abnormal_pct:.1f}%\",\n",
    "        'Test 5 Abnormal %': f\"{test5_abnormal_pct:.1f}%\"\n",
    "    })\n",
    "\n",
    "summary_df = pd.DataFrame(summary_data)\n",
    "print(summary_df.to_string(index=False))\n",
    "\n",
    "print(f\"\\nâœ… ANALYSIS COMPLETE!\")\n",
    "print(f\"ğŸ“ˆ Analyzed {len(results_df)} test combinations covering {results_df['count'].sum():,} total patient-test-quintuplet instances\")\n",
    "print(f\"âš ï¸ NOTE: With 5-test combinations, patient counts are significantly lower due to the requirement that patients must have all 5 tests\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "1d168816",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "ğŸ¯ ENHANCED SUMMARY TABLE - FIVE-TEST COMBINATION OUTCOMES WITH RISK ANALYSIS\n",
      "========================================================================================================================================================================================================\n",
      "                          Test 1                           Test 2                           Test 3                         Test 4                   Test 5  Total Patients Test 1 Abnormal % Test 2 Abnormal % Test 3 Abnormal % Test 4 Abnormal % Test 5 Abnormal % All 5 Abnormal % All 5 Normal % 4+ Abnormal % 3 Abnormal % 2 Abnormal % 1 Abnormal %\n",
      "                             TSH                 Serum Creatinine                    Blood Glucose              Total Cholesterol          LDL Cholesterol             767             24.4%             28.6%              0.0%             22.2%              0.0%             0.0%          45.6%          0.0%         0.9%        13.6%        39.9%\n",
      "                             TSH                 Serum Creatinine            Total Serum Bilirubin                 Serum Ferritin            Blood Glucose             740             29.4%             42.6%              0.0%             22.2%              0.0%             0.0%          34.1%          0.0%         1.2%        17.7%        47.0%\n",
      "                Serum Creatinine Aspartate Aminotransferase (AST)   Alanine Aminotransferase (ALT)           Alkaline Phosphatase    Total Serum Bilirubin             705             33.6%             13.0%             11.1%             13.4%              0.0%             0.0%          54.3%          1.1%         3.1%         7.7%        33.8%\n",
      "                Serum Creatinine                    Blood Glucose                Total Cholesterol                  Triglycerides          LDL Cholesterol             641             26.0%              0.0%             22.4%             58.0%              0.0%             0.0%          24.5%          0.0%         3.6%        23.9%        48.0%\n",
      "Aspartate Aminotransferase (AST)   Alanine Aminotransferase (ALT)             Alkaline Phosphatase          Total Serum Bilirubin            Blood Glucose             626             13.0%             10.5%             12.8%              0.0%              0.0%             0.0%          78.1%          0.0%         1.3%         5.8%        14.9%\n",
      "                Serum Creatinine Aspartate Aminotransferase (AST)   Alanine Aminotransferase (ALT)           Alkaline Phosphatase            Blood Glucose             602             32.9%             13.2%             10.1%             12.4%              0.0%             0.0%          55.0%          0.7%         3.2%         8.1%        33.1%\n",
      "                             TSH                 Serum Creatinine            Total Serum Bilirubin                  Blood Glucose          LDL Cholesterol             602             23.6%             30.1%              0.0%              0.0%              0.0%             0.0%          56.0%          0.0%         0.0%         4.7%        39.4%\n",
      "                Serum Creatinine Aspartate Aminotransferase (AST)   Alanine Aminotransferase (ALT)          Total Serum Bilirubin            Blood Glucose             601             33.2%             12.8%              9.3%              0.0%              0.0%             0.0%          58.1%          0.0%         1.7%         6.7%        33.6%\n",
      "               Serum Cholesterol              Serum Triglycerides            Serum HDL Cholesterol          Serum LDL Cholesterol     Complete Blood Count             601              0.1%             58.7%             39.0%             69.0%              0.0%             0.0%          14.1%          0.0%        18.5%        33.6%        33.8%\n",
      "                             TSH                 Serum Creatinine                Total Cholesterol                  Triglycerides          LDL Cholesterol             576             25.5%             29.0%             22.8%             57.2%              0.0%             0.0%          21.2%          1.0%        10.1%        27.6%        40.1%\n",
      "                             TSH                Serum Cholesterol              Serum Triglycerides          Serum HDL Cholesterol    Serum LDL Cholesterol             574             34.7%              0.0%             55.9%             35.5%             67.0%             0.0%          11.3%          3.5%        20.6%        32.9%        31.7%\n",
      "                             TSH                    Blood Glucose                Total Cholesterol                  Triglycerides          LDL Cholesterol             572             24.7%              0.0%             22.5%             55.7%              0.0%             0.0%          31.3%          0.0%         4.0%        20.5%        44.2%\n",
      "                             TSH                 Serum Creatinine                    Blood Glucose                  Triglycerides          LDL Cholesterol             571             25.0%             28.7%              0.0%             56.2%              0.0%             0.0%          25.7%          0.0%         2.6%        26.8%        44.8%\n",
      "                             TSH                 Serum Creatinine            Total Serum Bilirubin                  Blood Glucose C-Reactive Protein Titer             568             28.0%             39.2%              0.0%              0.0%              0.0%             0.0%          48.6%          0.0%         0.0%         8.5%        43.0%\n",
      "                Serum Creatinine            Total Serum Bilirubin                    Blood Glucose              Total Cholesterol          LDL Cholesterol             562             28.8%              0.0%              0.0%             23.3%              0.0%             0.0%          56.2%          0.0%         0.0%         6.8%        37.0%\n",
      "                Serum Creatinine Aspartate Aminotransferase (AST)             Alkaline Phosphatase          Total Serum Bilirubin            Blood Glucose             561             33.0%             12.8%             12.6%              0.0%              0.0%             0.0%          57.8%          0.0%         1.8%         7.1%        33.3%\n",
      "                Serum Creatinine   Alanine Aminotransferase (ALT)             Alkaline Phosphatase          Total Serum Bilirubin            Blood Glucose             561             33.0%              9.9%             12.4%              0.0%              0.0%             0.0%          57.4%          0.0%         0.5%         6.6%        35.5%\n",
      "               Serum Cholesterol              Serum Triglycerides            Serum LDL Cholesterol            Blood Urea Nitrogen         Serum Creatinine             561              0.1%             54.7%             64.5%             69.5%             25.6%             0.0%           5.7%          3.4%        25.5%        44.6%        20.9%\n",
      "               Serum Cholesterol              Serum Triglycerides            Serum HDL Cholesterol          Serum LDL Cholesterol         Serum Creatinine             552              0.1%             56.0%             36.7%             66.1%             24.0%             0.0%          12.0%          1.4%        21.4%        36.6%        28.6%\n",
      "                             TSH                 Serum Creatinine            Total Serum Bilirubin              Total Cholesterol          LDL Cholesterol             547             23.1%             28.6%              0.0%             23.2%              0.0%             0.0%          45.3%          0.0%         0.5%        14.1%        40.0%\n",
      "                             TSH                 Serum Creatinine                    Blood Glucose              Total Cholesterol            Triglycerides             535             24.5%             29.6%              0.0%             22.2%             55.9%             0.0%          22.2%          0.6%         9.9%        26.9%        40.4%\n",
      "                             TSH            Total Serum Bilirubin                    Blood Glucose              Total Cholesterol          LDL Cholesterol             534             23.3%              0.0%              0.0%             22.7%              0.0%             0.0%          62.9%          0.0%         0.0%         4.7%        32.4%\n",
      "               Serum Cholesterol              Serum Triglycerides            Serum HDL Cholesterol          Serum LDL Cholesterol               Vitamin D3             528              0.0%             57.8%             35.6%             67.5%             77.0%             0.0%           2.5%         15.0%        26.1%        33.1%        23.3%\n",
      "               Serum Cholesterol              Serum Triglycerides              Blood Urea Nitrogen               Serum Creatinine     Complete Blood Count             525              0.1%             53.4%             68.9%             26.9%              0.0%             0.0%          11.6%          0.0%         5.0%        36.6%        46.9%\n",
      "                             TSH                 Serum Creatinine            Total Serum Bilirubin                  Blood Glucose        Total Cholesterol             521             23.8%             29.7%              0.0%              0.0%             22.9%             0.0%          45.1%          0.0%         0.6%        14.8%        39.5%\n",
      "                             TSH                 Serum Creatinine Aspartate Aminotransferase (AST) Alanine Aminotransferase (ALT)            Blood Glucose             509             26.0%             29.0%              9.9%              9.9%              0.0%             0.0%          49.3%          0.4%         2.4%        11.0%        36.9%\n",
      "             Blood Urea Nitrogen                 Serum Creatinine      Hepatitis B Surface Antigen           Hepatitis C Antibody             HIV Antibody             506             66.2%             35.5%              0.4%              0.0%              0.0%             0.0%          18.4%          0.0%         0.0%        18.0%        63.6%\n",
      "               Serum Cholesterol              Serum Triglycerides            Serum HDL Cholesterol          Serum LDL Cholesterol      Blood Urea Nitrogen             504              0.1%             54.2%             37.9%             64.7%             67.2%             0.0%           5.8%          9.1%        28.6%        33.9%        22.6%\n",
      "             Serum Triglycerides            Serum HDL Cholesterol            Serum LDL Cholesterol            Blood Urea Nitrogen         Serum Creatinine             502             54.3%             37.7%             64.7%             67.3%             23.5%             0.6%           4.0%         12.9%        31.5%        35.5%        16.1%\n",
      "               Serum Cholesterol            Serum HDL Cholesterol            Serum LDL Cholesterol            Blood Urea Nitrogen         Serum Creatinine             501              0.1%             37.6%             64.8%             67.4%             23.3%             0.0%           4.6%          0.6%        19.4%        49.1%        26.3%\n",
      "               Serum Cholesterol              Serum Triglycerides            Serum HDL Cholesterol            Blood Urea Nitrogen         Serum Creatinine             501              0.1%             54.1%             37.8%             67.1%             23.5%             0.0%           8.2%          1.4%        17.8%        36.7%        35.9%\n",
      "\n",
      "ğŸ“Š KEY INSIGHTS FROM ENHANCED FIVE-TEST ANALYSIS:\n",
      "======================================================================\n",
      "\n",
      "ğŸš¨ HIGHEST RISK COMBINATIONS (All 5 Tests Abnormal):\n",
      "1. Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol + Blood Urea Nitrogen + Serum Creatinine: 0.6% (502 patients)\n",
      "2. TSH + Serum Creatinine + Blood Glucose + Total Cholesterol + LDL Cholesterol: 0.0% (767 patients)\n",
      "3. TSH + Serum Creatinine + Total Serum Bilirubin + Serum Ferritin + Blood Glucose: 0.0% (740 patients)\n",
      "4. Serum Creatinine + Aspartate Aminotransferase (AST) + Alanine Aminotransferase (ALT) + Alkaline Phosphatase + Total Serum Bilirubin: 0.0% (705 patients)\n",
      "5. Serum Creatinine + Blood Glucose + Total Cholesterol + Triglycerides + LDL Cholesterol: 0.0% (641 patients)\n",
      "\n",
      "âœ… LOWEST RISK COMBINATIONS (All 5 Tests Normal):\n",
      "1. Aspartate Aminotransferase (AST) + Alanine Aminotransferase (ALT) + Alkaline Phosphatase + Total Serum Bilirubin + Blood Glucose: 78.1% (626 patients)\n",
      "2. TSH + Total Serum Bilirubin + Blood Glucose + Total Cholesterol + LDL Cholesterol: 62.9% (534 patients)\n",
      "3. Serum Creatinine + Aspartate Aminotransferase (AST) + Alanine Aminotransferase (ALT) + Total Serum Bilirubin + Blood Glucose: 58.1% (601 patients)\n",
      "4. Serum Creatinine + Aspartate Aminotransferase (AST) + Alkaline Phosphatase + Total Serum Bilirubin + Blood Glucose: 57.8% (561 patients)\n",
      "5. Serum Creatinine + Alanine Aminotransferase (ALT) + Alkaline Phosphatase + Total Serum Bilirubin + Blood Glucose: 57.4% (561 patients)\n",
      "\n",
      "âš ï¸ HIGHEST MULTI-TEST RISK (4+ Tests Abnormal):\n",
      "1. Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol + Vitamin D3: 15.0% (528 patients)\n",
      "2. Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol + Blood Urea Nitrogen + Serum Creatinine: 12.9% (502 patients)\n",
      "3. Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol + Blood Urea Nitrogen: 9.1% (504 patients)\n",
      "4. TSH + Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol: 3.5% (574 patients)\n",
      "5. Serum Cholesterol + Serum Triglycerides + Serum LDL Cholesterol + Blood Urea Nitrogen + Serum Creatinine: 3.4% (561 patients)\n",
      "\n",
      "ğŸ” MOST THREE-TEST ABNORMALITIES (Exactly 3 Tests Abnormal):\n",
      "1. Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol + Blood Urea Nitrogen + Serum Creatinine: 31.5% (502 patients)\n",
      "2. Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol + Blood Urea Nitrogen: 28.6% (504 patients)\n",
      "3. Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol + Vitamin D3: 26.1% (528 patients)\n",
      "4. Serum Cholesterol + Serum Triglycerides + Serum LDL Cholesterol + Blood Urea Nitrogen + Serum Creatinine: 25.5% (561 patients)\n",
      "5. Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol + Serum Creatinine: 21.4% (552 patients)\n",
      "\n",
      "âœ… ENHANCED FIVE-TEST ANALYSIS COMPLETE!\n",
      "ğŸ“ˆ Enhanced summary includes individual and combined risk analysis for all 31 five-test combinations\n",
      "âš ï¸ IMPORTANT: Five-test combinations significantly reduce patient sample sizes - statistical power may be limited\n",
      "                          Test 1                           Test 2                           Test 3                         Test 4                   Test 5  Total Patients Test 1 Abnormal % Test 2 Abnormal % Test 3 Abnormal % Test 4 Abnormal % Test 5 Abnormal % All 5 Abnormal % All 5 Normal % 4+ Abnormal % 3 Abnormal % 2 Abnormal % 1 Abnormal %\n",
      "                             TSH                 Serum Creatinine                    Blood Glucose              Total Cholesterol          LDL Cholesterol             767             24.4%             28.6%              0.0%             22.2%              0.0%             0.0%          45.6%          0.0%         0.9%        13.6%        39.9%\n",
      "                             TSH                 Serum Creatinine            Total Serum Bilirubin                 Serum Ferritin            Blood Glucose             740             29.4%             42.6%              0.0%             22.2%              0.0%             0.0%          34.1%          0.0%         1.2%        17.7%        47.0%\n",
      "                Serum Creatinine Aspartate Aminotransferase (AST)   Alanine Aminotransferase (ALT)           Alkaline Phosphatase    Total Serum Bilirubin             705             33.6%             13.0%             11.1%             13.4%              0.0%             0.0%          54.3%          1.1%         3.1%         7.7%        33.8%\n",
      "                Serum Creatinine                    Blood Glucose                Total Cholesterol                  Triglycerides          LDL Cholesterol             641             26.0%              0.0%             22.4%             58.0%              0.0%             0.0%          24.5%          0.0%         3.6%        23.9%        48.0%\n",
      "Aspartate Aminotransferase (AST)   Alanine Aminotransferase (ALT)             Alkaline Phosphatase          Total Serum Bilirubin            Blood Glucose             626             13.0%             10.5%             12.8%              0.0%              0.0%             0.0%          78.1%          0.0%         1.3%         5.8%        14.9%\n",
      "                Serum Creatinine Aspartate Aminotransferase (AST)   Alanine Aminotransferase (ALT)           Alkaline Phosphatase            Blood Glucose             602             32.9%             13.2%             10.1%             12.4%              0.0%             0.0%          55.0%          0.7%         3.2%         8.1%        33.1%\n",
      "                             TSH                 Serum Creatinine            Total Serum Bilirubin                  Blood Glucose          LDL Cholesterol             602             23.6%             30.1%              0.0%              0.0%              0.0%             0.0%          56.0%          0.0%         0.0%         4.7%        39.4%\n",
      "                Serum Creatinine Aspartate Aminotransferase (AST)   Alanine Aminotransferase (ALT)          Total Serum Bilirubin            Blood Glucose             601             33.2%             12.8%              9.3%              0.0%              0.0%             0.0%          58.1%          0.0%         1.7%         6.7%        33.6%\n",
      "               Serum Cholesterol              Serum Triglycerides            Serum HDL Cholesterol          Serum LDL Cholesterol     Complete Blood Count             601              0.1%             58.7%             39.0%             69.0%              0.0%             0.0%          14.1%          0.0%        18.5%        33.6%        33.8%\n",
      "                             TSH                 Serum Creatinine                Total Cholesterol                  Triglycerides          LDL Cholesterol             576             25.5%             29.0%             22.8%             57.2%              0.0%             0.0%          21.2%          1.0%        10.1%        27.6%        40.1%\n",
      "                             TSH                Serum Cholesterol              Serum Triglycerides          Serum HDL Cholesterol    Serum LDL Cholesterol             574             34.7%              0.0%             55.9%             35.5%             67.0%             0.0%          11.3%          3.5%        20.6%        32.9%        31.7%\n",
      "                             TSH                    Blood Glucose                Total Cholesterol                  Triglycerides          LDL Cholesterol             572             24.7%              0.0%             22.5%             55.7%              0.0%             0.0%          31.3%          0.0%         4.0%        20.5%        44.2%\n",
      "                             TSH                 Serum Creatinine                    Blood Glucose                  Triglycerides          LDL Cholesterol             571             25.0%             28.7%              0.0%             56.2%              0.0%             0.0%          25.7%          0.0%         2.6%        26.8%        44.8%\n",
      "                             TSH                 Serum Creatinine            Total Serum Bilirubin                  Blood Glucose C-Reactive Protein Titer             568             28.0%             39.2%              0.0%              0.0%              0.0%             0.0%          48.6%          0.0%         0.0%         8.5%        43.0%\n",
      "                Serum Creatinine            Total Serum Bilirubin                    Blood Glucose              Total Cholesterol          LDL Cholesterol             562             28.8%              0.0%              0.0%             23.3%              0.0%             0.0%          56.2%          0.0%         0.0%         6.8%        37.0%\n",
      "                Serum Creatinine Aspartate Aminotransferase (AST)             Alkaline Phosphatase          Total Serum Bilirubin            Blood Glucose             561             33.0%             12.8%             12.6%              0.0%              0.0%             0.0%          57.8%          0.0%         1.8%         7.1%        33.3%\n",
      "                Serum Creatinine   Alanine Aminotransferase (ALT)             Alkaline Phosphatase          Total Serum Bilirubin            Blood Glucose             561             33.0%              9.9%             12.4%              0.0%              0.0%             0.0%          57.4%          0.0%         0.5%         6.6%        35.5%\n",
      "               Serum Cholesterol              Serum Triglycerides            Serum LDL Cholesterol            Blood Urea Nitrogen         Serum Creatinine             561              0.1%             54.7%             64.5%             69.5%             25.6%             0.0%           5.7%          3.4%        25.5%        44.6%        20.9%\n",
      "               Serum Cholesterol              Serum Triglycerides            Serum HDL Cholesterol          Serum LDL Cholesterol         Serum Creatinine             552              0.1%             56.0%             36.7%             66.1%             24.0%             0.0%          12.0%          1.4%        21.4%        36.6%        28.6%\n",
      "                             TSH                 Serum Creatinine            Total Serum Bilirubin              Total Cholesterol          LDL Cholesterol             547             23.1%             28.6%              0.0%             23.2%              0.0%             0.0%          45.3%          0.0%         0.5%        14.1%        40.0%\n",
      "                             TSH                 Serum Creatinine                    Blood Glucose              Total Cholesterol            Triglycerides             535             24.5%             29.6%              0.0%             22.2%             55.9%             0.0%          22.2%          0.6%         9.9%        26.9%        40.4%\n",
      "                             TSH            Total Serum Bilirubin                    Blood Glucose              Total Cholesterol          LDL Cholesterol             534             23.3%              0.0%              0.0%             22.7%              0.0%             0.0%          62.9%          0.0%         0.0%         4.7%        32.4%\n",
      "               Serum Cholesterol              Serum Triglycerides            Serum HDL Cholesterol          Serum LDL Cholesterol               Vitamin D3             528              0.0%             57.8%             35.6%             67.5%             77.0%             0.0%           2.5%         15.0%        26.1%        33.1%        23.3%\n",
      "               Serum Cholesterol              Serum Triglycerides              Blood Urea Nitrogen               Serum Creatinine     Complete Blood Count             525              0.1%             53.4%             68.9%             26.9%              0.0%             0.0%          11.6%          0.0%         5.0%        36.6%        46.9%\n",
      "                             TSH                 Serum Creatinine            Total Serum Bilirubin                  Blood Glucose        Total Cholesterol             521             23.8%             29.7%              0.0%              0.0%             22.9%             0.0%          45.1%          0.0%         0.6%        14.8%        39.5%\n",
      "                             TSH                 Serum Creatinine Aspartate Aminotransferase (AST) Alanine Aminotransferase (ALT)            Blood Glucose             509             26.0%             29.0%              9.9%              9.9%              0.0%             0.0%          49.3%          0.4%         2.4%        11.0%        36.9%\n",
      "             Blood Urea Nitrogen                 Serum Creatinine      Hepatitis B Surface Antigen           Hepatitis C Antibody             HIV Antibody             506             66.2%             35.5%              0.4%              0.0%              0.0%             0.0%          18.4%          0.0%         0.0%        18.0%        63.6%\n",
      "               Serum Cholesterol              Serum Triglycerides            Serum HDL Cholesterol          Serum LDL Cholesterol      Blood Urea Nitrogen             504              0.1%             54.2%             37.9%             64.7%             67.2%             0.0%           5.8%          9.1%        28.6%        33.9%        22.6%\n",
      "             Serum Triglycerides            Serum HDL Cholesterol            Serum LDL Cholesterol            Blood Urea Nitrogen         Serum Creatinine             502             54.3%             37.7%             64.7%             67.3%             23.5%             0.6%           4.0%         12.9%        31.5%        35.5%        16.1%\n",
      "               Serum Cholesterol            Serum HDL Cholesterol            Serum LDL Cholesterol            Blood Urea Nitrogen         Serum Creatinine             501              0.1%             37.6%             64.8%             67.4%             23.3%             0.0%           4.6%          0.6%        19.4%        49.1%        26.3%\n",
      "               Serum Cholesterol              Serum Triglycerides            Serum HDL Cholesterol            Blood Urea Nitrogen         Serum Creatinine             501              0.1%             54.1%             37.8%             67.1%             23.5%             0.0%           8.2%          1.4%        17.8%        36.7%        35.9%\n",
      "\n",
      "ğŸ“Š KEY INSIGHTS FROM ENHANCED FIVE-TEST ANALYSIS:\n",
      "======================================================================\n",
      "\n",
      "ğŸš¨ HIGHEST RISK COMBINATIONS (All 5 Tests Abnormal):\n",
      "1. Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol + Blood Urea Nitrogen + Serum Creatinine: 0.6% (502 patients)\n",
      "2. TSH + Serum Creatinine + Blood Glucose + Total Cholesterol + LDL Cholesterol: 0.0% (767 patients)\n",
      "3. TSH + Serum Creatinine + Total Serum Bilirubin + Serum Ferritin + Blood Glucose: 0.0% (740 patients)\n",
      "4. Serum Creatinine + Aspartate Aminotransferase (AST) + Alanine Aminotransferase (ALT) + Alkaline Phosphatase + Total Serum Bilirubin: 0.0% (705 patients)\n",
      "5. Serum Creatinine + Blood Glucose + Total Cholesterol + Triglycerides + LDL Cholesterol: 0.0% (641 patients)\n",
      "\n",
      "âœ… LOWEST RISK COMBINATIONS (All 5 Tests Normal):\n",
      "1. Aspartate Aminotransferase (AST) + Alanine Aminotransferase (ALT) + Alkaline Phosphatase + Total Serum Bilirubin + Blood Glucose: 78.1% (626 patients)\n",
      "2. TSH + Total Serum Bilirubin + Blood Glucose + Total Cholesterol + LDL Cholesterol: 62.9% (534 patients)\n",
      "3. Serum Creatinine + Aspartate Aminotransferase (AST) + Alanine Aminotransferase (ALT) + Total Serum Bilirubin + Blood Glucose: 58.1% (601 patients)\n",
      "4. Serum Creatinine + Aspartate Aminotransferase (AST) + Alkaline Phosphatase + Total Serum Bilirubin + Blood Glucose: 57.8% (561 patients)\n",
      "5. Serum Creatinine + Alanine Aminotransferase (ALT) + Alkaline Phosphatase + Total Serum Bilirubin + Blood Glucose: 57.4% (561 patients)\n",
      "\n",
      "âš ï¸ HIGHEST MULTI-TEST RISK (4+ Tests Abnormal):\n",
      "1. Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol + Vitamin D3: 15.0% (528 patients)\n",
      "2. Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol + Blood Urea Nitrogen + Serum Creatinine: 12.9% (502 patients)\n",
      "3. Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol + Blood Urea Nitrogen: 9.1% (504 patients)\n",
      "4. TSH + Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol: 3.5% (574 patients)\n",
      "5. Serum Cholesterol + Serum Triglycerides + Serum LDL Cholesterol + Blood Urea Nitrogen + Serum Creatinine: 3.4% (561 patients)\n",
      "\n",
      "ğŸ” MOST THREE-TEST ABNORMALITIES (Exactly 3 Tests Abnormal):\n",
      "1. Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol + Blood Urea Nitrogen + Serum Creatinine: 31.5% (502 patients)\n",
      "2. Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol + Blood Urea Nitrogen: 28.6% (504 patients)\n",
      "3. Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol + Vitamin D3: 26.1% (528 patients)\n",
      "4. Serum Cholesterol + Serum Triglycerides + Serum LDL Cholesterol + Blood Urea Nitrogen + Serum Creatinine: 25.5% (561 patients)\n",
      "5. Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol + Serum Creatinine: 21.4% (552 patients)\n",
      "\n",
      "âœ… ENHANCED FIVE-TEST ANALYSIS COMPLETE!\n",
      "ğŸ“ˆ Enhanced summary includes individual and combined risk analysis for all 31 five-test combinations\n",
      "âš ï¸ IMPORTANT: Five-test combinations significantly reduce patient sample sizes - statistical power may be limited\n"
     ]
    }
   ],
   "source": [
    "# Enhanced Summary table including combined outcome analysis for 5 tests\n",
    "print(f\"\\nğŸ¯ ENHANCED SUMMARY TABLE - FIVE-TEST COMBINATION OUTCOMES WITH RISK ANALYSIS\")\n",
    "print(\"=\"*200)\n",
    "\n",
    "enhanced_summary_data = []\n",
    "for idx, row in results_df.iterrows():\n",
    "    test1, test2, test3, test4, test5 = row['tests']\n",
    "    patient_count = row['count']\n",
    "    \n",
    "    # Get patients who have all five tests\n",
    "    patients_with_all = df_pivot[(df_pivot[test1] > 0) & (df_pivot[test2] > 0) & \n",
    "                                (df_pivot[test3] > 0) & (df_pivot[test4] > 0) & \n",
    "                                (df_pivot[test5] > 0)].index\n",
    "    combo_data = df[\n",
    "        (df['Patient Name'].isin(patients_with_all)) & \n",
    "        (df['Standard Test Name'].isin([test1, test2, test3, test4, test5]))\n",
    "    ].copy()\n",
    "    \n",
    "    # Calculate summary stats for individual tests\n",
    "    test1_data = combo_data[combo_data['Standard Test Name'] == test1]\n",
    "    test2_data = combo_data[combo_data['Standard Test Name'] == test2]\n",
    "    test3_data = combo_data[combo_data['Standard Test Name'] == test3]\n",
    "    test4_data = combo_data[combo_data['Standard Test Name'] == test4]\n",
    "    test5_data = combo_data[combo_data['Standard Test Name'] == test5]\n",
    "    \n",
    "    test1_abnormal = len(test1_data[test1_data['Outcome'] != 'normal'])\n",
    "    test2_abnormal = len(test2_data[test2_data['Outcome'] != 'normal'])\n",
    "    test3_abnormal = len(test3_data[test3_data['Outcome'] != 'normal'])\n",
    "    test4_abnormal = len(test4_data[test4_data['Outcome'] != 'normal'])\n",
    "    test5_abnormal = len(test5_data[test5_data['Outcome'] != 'normal'])\n",
    "    \n",
    "    test1_abnormal_pct = (test1_abnormal / len(test1_data) * 100) if len(test1_data) > 0 else 0\n",
    "    test2_abnormal_pct = (test2_abnormal / len(test2_data) * 100) if len(test2_data) > 0 else 0\n",
    "    test3_abnormal_pct = (test3_abnormal / len(test3_data) * 100) if len(test3_data) > 0 else 0\n",
    "    test4_abnormal_pct = (test4_abnormal / len(test4_data) * 100) if len(test4_data) > 0 else 0\n",
    "    test5_abnormal_pct = (test5_abnormal / len(test5_data) * 100) if len(test5_data) > 0 else 0\n",
    "    \n",
    "    # Calculate combined outcome patterns\n",
    "    patient_outcomes = []\n",
    "    for patient in patients_with_all:\n",
    "        patient_data = combo_data[combo_data['Patient Name'] == patient]\n",
    "        \n",
    "        test1_outcomes = patient_data[patient_data['Standard Test Name'] == test1]['Outcome'].values\n",
    "        test2_outcomes = patient_data[patient_data['Standard Test Name'] == test2]['Outcome'].values\n",
    "        test3_outcomes = patient_data[patient_data['Standard Test Name'] == test3]['Outcome'].values\n",
    "        test4_outcomes = patient_data[patient_data['Standard Test Name'] == test4]['Outcome'].values\n",
    "        test5_outcomes = patient_data[patient_data['Standard Test Name'] == test5]['Outcome'].values\n",
    "        \n",
    "        if (len(test1_outcomes) > 0 and len(test2_outcomes) > 0 and len(test3_outcomes) > 0 and \n",
    "            len(test4_outcomes) > 0 and len(test5_outcomes) > 0):\n",
    "            # Take the most recent outcome for each test\n",
    "            test1_outcome = test1_outcomes[-1]  # Most recent\n",
    "            test2_outcome = test2_outcomes[-1]  # Most recent\n",
    "            test3_outcome = test3_outcomes[-1]  # Most recent\n",
    "            test4_outcome = test4_outcomes[-1]  # Most recent\n",
    "            test5_outcome = test5_outcomes[-1]  # Most recent\n",
    "            \n",
    "            patient_outcomes.append({\n",
    "                'patient': patient,\n",
    "                'test1_outcome': test1_outcome,\n",
    "                'test2_outcome': test2_outcome,\n",
    "                'test3_outcome': test3_outcome,\n",
    "                'test4_outcome': test4_outcome,\n",
    "                'test5_outcome': test5_outcome\n",
    "            })\n",
    "    \n",
    "    # Analyze combined risk patterns\n",
    "    if patient_outcomes:\n",
    "        combo_df = pd.DataFrame(patient_outcomes)\n",
    "        \n",
    "        all_abnormal = combo_df[\n",
    "            (combo_df['test1_outcome'] != 'normal') & \n",
    "            (combo_df['test2_outcome'] != 'normal') & \n",
    "            (combo_df['test3_outcome'] != 'normal') &\n",
    "            (combo_df['test4_outcome'] != 'normal') &\n",
    "            (combo_df['test5_outcome'] != 'normal')\n",
    "        ]\n",
    "        \n",
    "        all_normal = combo_df[\n",
    "            (combo_df['test1_outcome'] == 'normal') & \n",
    "            (combo_df['test2_outcome'] == 'normal') & \n",
    "            (combo_df['test3_outcome'] == 'normal') &\n",
    "            (combo_df['test4_outcome'] == 'normal') &\n",
    "            (combo_df['test5_outcome'] == 'normal')\n",
    "        ]\n",
    "        \n",
    "        four_plus_abnormal = combo_df[\n",
    "            ((combo_df['test1_outcome'] != 'normal') & (combo_df['test2_outcome'] != 'normal') & \n",
    "             (combo_df['test3_outcome'] != 'normal') & (combo_df['test4_outcome'] != 'normal')) |\n",
    "            ((combo_df['test1_outcome'] != 'normal') & (combo_df['test2_outcome'] != 'normal') & \n",
    "             (combo_df['test3_outcome'] != 'normal') & (combo_df['test5_outcome'] != 'normal')) |\n",
    "            ((combo_df['test1_outcome'] != 'normal') & (combo_df['test2_outcome'] != 'normal') & \n",
    "             (combo_df['test4_outcome'] != 'normal') & (combo_df['test5_outcome'] != 'normal')) |\n",
    "            ((combo_df['test1_outcome'] != 'normal') & (combo_df['test3_outcome'] != 'normal') & \n",
    "             (combo_df['test4_outcome'] != 'normal') & (combo_df['test5_outcome'] != 'normal')) |\n",
    "            ((combo_df['test2_outcome'] != 'normal') & (combo_df['test3_outcome'] != 'normal') & \n",
    "             (combo_df['test4_outcome'] != 'normal') & (combo_df['test5_outcome'] != 'normal'))\n",
    "        ]\n",
    "        \n",
    "        three_abnormal = combo_df[\n",
    "            # All possible combinations of exactly 3 abnormal tests (10 combinations)\n",
    "            ((combo_df['test1_outcome'] != 'normal') & (combo_df['test2_outcome'] != 'normal') & \n",
    "             (combo_df['test3_outcome'] != 'normal') & (combo_df['test4_outcome'] == 'normal') & \n",
    "             (combo_df['test5_outcome'] == 'normal')) |\n",
    "            ((combo_df['test1_outcome'] != 'normal') & (combo_df['test2_outcome'] != 'normal') & \n",
    "             (combo_df['test4_outcome'] != 'normal') & (combo_df['test3_outcome'] == 'normal') & \n",
    "             (combo_df['test5_outcome'] == 'normal')) |\n",
    "            ((combo_df['test1_outcome'] != 'normal') & (combo_df['test2_outcome'] != 'normal') & \n",
    "             (combo_df['test5_outcome'] != 'normal') & (combo_df['test3_outcome'] == 'normal') & \n",
    "             (combo_df['test4_outcome'] == 'normal')) |\n",
    "            ((combo_df['test1_outcome'] != 'normal') & (combo_df['test3_outcome'] != 'normal') & \n",
    "             (combo_df['test4_outcome'] != 'normal') & (combo_df['test2_outcome'] == 'normal') & \n",
    "             (combo_df['test5_outcome'] == 'normal')) |\n",
    "            ((combo_df['test1_outcome'] != 'normal') & (combo_df['test3_outcome'] != 'normal') & \n",
    "             (combo_df['test5_outcome'] != 'normal') & (combo_df['test2_outcome'] == 'normal') & \n",
    "             (combo_df['test4_outcome'] == 'normal')) |\n",
    "            ((combo_df['test1_outcome'] != 'normal') & (combo_df['test4_outcome'] != 'normal') & \n",
    "             (combo_df['test5_outcome'] != 'normal') & (combo_df['test2_outcome'] == 'normal') & \n",
    "             (combo_df['test3_outcome'] == 'normal')) |\n",
    "            ((combo_df['test2_outcome'] != 'normal') & (combo_df['test3_outcome'] != 'normal') & \n",
    "             (combo_df['test4_outcome'] != 'normal') & (combo_df['test1_outcome'] == 'normal') & \n",
    "             (combo_df['test5_outcome'] == 'normal')) |\n",
    "            ((combo_df['test2_outcome'] != 'normal') & (combo_df['test3_outcome'] != 'normal') & \n",
    "             (combo_df['test5_outcome'] != 'normal') & (combo_df['test1_outcome'] == 'normal') & \n",
    "             (combo_df['test4_outcome'] == 'normal')) |\n",
    "            ((combo_df['test2_outcome'] != 'normal') & (combo_df['test4_outcome'] != 'normal') & \n",
    "             (combo_df['test5_outcome'] != 'normal') & (combo_df['test1_outcome'] == 'normal') & \n",
    "             (combo_df['test3_outcome'] == 'normal')) |\n",
    "            ((combo_df['test3_outcome'] != 'normal') & (combo_df['test4_outcome'] != 'normal') & \n",
    "             (combo_df['test5_outcome'] != 'normal') & (combo_df['test1_outcome'] == 'normal') & \n",
    "             (combo_df['test2_outcome'] == 'normal'))\n",
    "        ]\n",
    "        \n",
    "        two_abnormal = combo_df[\n",
    "            # Count patients with exactly 2 abnormal tests (10 combinations)\n",
    "            ((combo_df['test1_outcome'] != 'normal') & (combo_df['test2_outcome'] != 'normal') & \n",
    "             (combo_df['test3_outcome'] == 'normal') & (combo_df['test4_outcome'] == 'normal') & \n",
    "             (combo_df['test5_outcome'] == 'normal')) |\n",
    "            ((combo_df['test1_outcome'] != 'normal') & (combo_df['test3_outcome'] != 'normal') & \n",
    "             (combo_df['test2_outcome'] == 'normal') & (combo_df['test4_outcome'] == 'normal') & \n",
    "             (combo_df['test5_outcome'] == 'normal')) |\n",
    "            ((combo_df['test1_outcome'] != 'normal') & (combo_df['test4_outcome'] != 'normal') & \n",
    "             (combo_df['test2_outcome'] == 'normal') & (combo_df['test3_outcome'] == 'normal') & \n",
    "             (combo_df['test5_outcome'] == 'normal')) |\n",
    "            ((combo_df['test1_outcome'] != 'normal') & (combo_df['test5_outcome'] != 'normal') & \n",
    "             (combo_df['test2_outcome'] == 'normal') & (combo_df['test3_outcome'] == 'normal') & \n",
    "             (combo_df['test4_outcome'] == 'normal')) |\n",
    "            ((combo_df['test2_outcome'] != 'normal') & (combo_df['test3_outcome'] != 'normal') & \n",
    "             (combo_df['test1_outcome'] == 'normal') & (combo_df['test4_outcome'] == 'normal') & \n",
    "             (combo_df['test5_outcome'] == 'normal')) |\n",
    "            ((combo_df['test2_outcome'] != 'normal') & (combo_df['test4_outcome'] != 'normal') & \n",
    "             (combo_df['test1_outcome'] == 'normal') & (combo_df['test3_outcome'] == 'normal') & \n",
    "             (combo_df['test5_outcome'] == 'normal')) |\n",
    "            ((combo_df['test2_outcome'] != 'normal') & (combo_df['test5_outcome'] != 'normal') & \n",
    "             (combo_df['test1_outcome'] == 'normal') & (combo_df['test3_outcome'] == 'normal') & \n",
    "             (combo_df['test4_outcome'] == 'normal')) |\n",
    "            ((combo_df['test3_outcome'] != 'normal') & (combo_df['test4_outcome'] != 'normal') & \n",
    "             (combo_df['test1_outcome'] == 'normal') & (combo_df['test2_outcome'] == 'normal') & \n",
    "             (combo_df['test5_outcome'] == 'normal')) |\n",
    "            ((combo_df['test3_outcome'] != 'normal') & (combo_df['test5_outcome'] != 'normal') & \n",
    "             (combo_df['test1_outcome'] == 'normal') & (combo_df['test2_outcome'] == 'normal') & \n",
    "             (combo_df['test4_outcome'] == 'normal')) |\n",
    "            ((combo_df['test4_outcome'] != 'normal') & (combo_df['test5_outcome'] != 'normal') & \n",
    "             (combo_df['test1_outcome'] == 'normal') & (combo_df['test2_outcome'] == 'normal') & \n",
    "             (combo_df['test3_outcome'] == 'normal'))\n",
    "        ]\n",
    "        \n",
    "        one_abnormal = combo_df[\n",
    "            ((combo_df['test1_outcome'] != 'normal') & (combo_df['test2_outcome'] == 'normal') & \n",
    "             (combo_df['test3_outcome'] == 'normal') & (combo_df['test4_outcome'] == 'normal') & \n",
    "             (combo_df['test5_outcome'] == 'normal')) |\n",
    "            ((combo_df['test2_outcome'] != 'normal') & (combo_df['test1_outcome'] == 'normal') & \n",
    "             (combo_df['test3_outcome'] == 'normal') & (combo_df['test4_outcome'] == 'normal') & \n",
    "             (combo_df['test5_outcome'] == 'normal')) |\n",
    "            ((combo_df['test3_outcome'] != 'normal') & (combo_df['test1_outcome'] == 'normal') & \n",
    "             (combo_df['test2_outcome'] == 'normal') & (combo_df['test4_outcome'] == 'normal') & \n",
    "             (combo_df['test5_outcome'] == 'normal')) |\n",
    "            ((combo_df['test4_outcome'] != 'normal') & (combo_df['test1_outcome'] == 'normal') & \n",
    "             (combo_df['test2_outcome'] == 'normal') & (combo_df['test3_outcome'] == 'normal') & \n",
    "             (combo_df['test5_outcome'] == 'normal')) |\n",
    "            ((combo_df['test5_outcome'] != 'normal') & (combo_df['test1_outcome'] == 'normal') & \n",
    "             (combo_df['test2_outcome'] == 'normal') & (combo_df['test3_outcome'] == 'normal') & \n",
    "             (combo_df['test4_outcome'] == 'normal'))\n",
    "        ]\n",
    "        \n",
    "        all_abnormal_pct = len(all_abnormal) / len(combo_df) * 100\n",
    "        all_normal_pct = len(all_normal) / len(combo_df) * 100\n",
    "        four_plus_abnormal_pct = len(four_plus_abnormal) / len(combo_df) * 100\n",
    "        three_abnormal_pct = len(three_abnormal) / len(combo_df) * 100\n",
    "        two_abnormal_pct = len(two_abnormal) / len(combo_df) * 100\n",
    "        one_abnormal_pct = len(one_abnormal) / len(combo_df) * 100\n",
    "    else:\n",
    "        all_abnormal_pct = 0\n",
    "        all_normal_pct = 0\n",
    "        four_plus_abnormal_pct = 0\n",
    "        three_abnormal_pct = 0\n",
    "        two_abnormal_pct = 0\n",
    "        one_abnormal_pct = 0\n",
    "    \n",
    "    enhanced_summary_data.append({\n",
    "        'Test 1': test1,\n",
    "        'Test 2': test2,\n",
    "        'Test 3': test3,\n",
    "        'Test 4': test4,\n",
    "        'Test 5': test5,\n",
    "        'Total Patients': patient_count,\n",
    "        'Test 1 Abnormal %': f\"{test1_abnormal_pct:.1f}%\",\n",
    "        'Test 2 Abnormal %': f\"{test2_abnormal_pct:.1f}%\",\n",
    "        'Test 3 Abnormal %': f\"{test3_abnormal_pct:.1f}%\",\n",
    "        'Test 4 Abnormal %': f\"{test4_abnormal_pct:.1f}%\",\n",
    "        'Test 5 Abnormal %': f\"{test5_abnormal_pct:.1f}%\",\n",
    "        'All 5 Abnormal %': f\"{all_abnormal_pct:.1f}%\",\n",
    "        'All 5 Normal %': f\"{all_normal_pct:.1f}%\",\n",
    "        '4+ Abnormal %': f\"{four_plus_abnormal_pct:.1f}%\",\n",
    "        '3 Abnormal %': f\"{three_abnormal_pct:.1f}%\",\n",
    "        '2 Abnormal %': f\"{two_abnormal_pct:.1f}%\",\n",
    "        '1 Abnormal %': f\"{one_abnormal_pct:.1f}%\"\n",
    "    })\n",
    "\n",
    "enhanced_summary_df = pd.DataFrame(enhanced_summary_data)\n",
    "\n",
    "# Display the enhanced summary table\n",
    "print(enhanced_summary_df.to_string(index=False))\n",
    "\n",
    "# Show some key insights\n",
    "print(f\"\\nğŸ“Š KEY INSIGHTS FROM ENHANCED FIVE-TEST ANALYSIS:\")\n",
    "print(\"=\"*70)\n",
    "\n",
    "# Find test combinations with highest risk (all five abnormal)\n",
    "enhanced_summary_df['All_Abnormal_Numeric'] = enhanced_summary_df['All 5 Abnormal %'].str.rstrip('%').astype(float)\n",
    "highest_risk = enhanced_summary_df.nlargest(5, 'All_Abnormal_Numeric')\n",
    "\n",
    "print(f\"\\nğŸš¨ HIGHEST RISK COMBINATIONS (All 5 Tests Abnormal):\")\n",
    "for i, (_, row) in enumerate(highest_risk.iterrows(), 1):\n",
    "    print(f\"{i}. {row['Test 1']} + {row['Test 2']} + {row['Test 3']} + {row['Test 4']} + {row['Test 5']}: {row['All 5 Abnormal %']} ({row['Total Patients']} patients)\")\n",
    "\n",
    "# Find test combinations with highest normal rates\n",
    "enhanced_summary_df['All_Normal_Numeric'] = enhanced_summary_df['All 5 Normal %'].str.rstrip('%').astype(float)\n",
    "lowest_risk = enhanced_summary_df.nlargest(5, 'All_Normal_Numeric')\n",
    "\n",
    "print(f\"\\nâœ… LOWEST RISK COMBINATIONS (All 5 Tests Normal):\")\n",
    "for i, (_, row) in enumerate(lowest_risk.iterrows(), 1):\n",
    "    print(f\"{i}. {row['Test 1']} + {row['Test 2']} + {row['Test 3']} + {row['Test 4']} + {row['Test 5']}: {row['All 5 Normal %']} ({row['Total Patients']} patients)\")\n",
    "\n",
    "# Find test combinations with most patients having 4 or more abnormal tests\n",
    "enhanced_summary_df['Four_Plus_Abnormal_Numeric'] = enhanced_summary_df['4+ Abnormal %'].str.rstrip('%').astype(float)\n",
    "highest_multi_risk = enhanced_summary_df.nlargest(5, 'Four_Plus_Abnormal_Numeric')\n",
    "\n",
    "print(f\"\\nâš ï¸ HIGHEST MULTI-TEST RISK (4+ Tests Abnormal):\")\n",
    "for i, (_, row) in enumerate(highest_multi_risk.iterrows(), 1):\n",
    "    print(f\"{i}. {row['Test 1']} + {row['Test 2']} + {row['Test 3']} + {row['Test 4']} + {row['Test 5']}: {row['4+ Abnormal %']} ({row['Total Patients']} patients)\")\n",
    "\n",
    "# Find test combinations with most three abnormal results\n",
    "enhanced_summary_df['Three_Abnormal_Numeric'] = enhanced_summary_df['3 Abnormal %'].str.rstrip('%').astype(float)\n",
    "most_three_abnormal = enhanced_summary_df.nlargest(5, 'Three_Abnormal_Numeric')\n",
    "\n",
    "print(f\"\\nğŸ” MOST THREE-TEST ABNORMALITIES (Exactly 3 Tests Abnormal):\")\n",
    "for i, (_, row) in enumerate(most_three_abnormal.iterrows(), 1):\n",
    "    print(f\"{i}. {row['Test 1']} + {row['Test 2']} + {row['Test 3']} + {row['Test 4']} + {row['Test 5']}: {row['3 Abnormal %']} ({row['Total Patients']} patients)\")\n",
    "\n",
    "print(f\"\\nâœ… ENHANCED FIVE-TEST ANALYSIS COMPLETE!\")\n",
    "print(f\"ğŸ“ˆ Enhanced summary includes individual and combined risk analysis for all {len(enhanced_summary_df)} five-test combinations\")\n",
    "print(f\"âš ï¸ IMPORTANT: Five-test combinations significantly reduce patient sample sizes - statistical power may be limited\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "64196a71",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Create visualizations for 5-test combinations with highest \"All 5 Tests Abnormal\" percentages\n",
    "\n",
    "# Get the top 5 combinations with highest all 5 abnormal percentages\n",
    "top_5_highest_risk_5test = enhanced_summary_df.nlargest(5, 'All_Abnormal_Numeric')\n",
    "\n",
    "# Create subplot figure with three charts\n",
    "fig, (ax1, ax2, ax3) = plt.subplots(1, 3, figsize=(24, 8))\n",
    "\n",
    "# Chart 1: Top 5 with highest \"All 5 Tests Abnormal\" percentages\n",
    "test_combinations_5abnormal = []\n",
    "all_5_abnormal_values = []\n",
    "\n",
    "for _, row in top_5_highest_risk_5test.iterrows():\n",
    "    # Create shorter labels for better readability\n",
    "    test1_short = row['Test 1'].split()[0] if len(row['Test 1'].split()) > 2 else row['Test 1']\n",
    "    test2_short = row['Test 2'].split()[0] if len(row['Test 2'].split()) > 2 else row['Test 2']\n",
    "    test3_short = row['Test 3'].split()[0] if len(row['Test 3'].split()) > 2 else row['Test 3']\n",
    "    test4_short = row['Test 4'].split()[0] if len(row['Test 4'].split()) > 2 else row['Test 4']\n",
    "    test5_short = row['Test 5'].split()[0] if len(row['Test 5'].split()) > 2 else row['Test 5']\n",
    "    \n",
    "    combination_label = f\"{test1_short}\\n+\\n{test2_short}\\n+\\n{test3_short}\\n+\\n{test4_short}\\n+\\n{test5_short}\\n({row['Total Patients']} patients)\"\n",
    "    test_combinations_5abnormal.append(combination_label)\n",
    "    all_5_abnormal_values.append(row['All_Abnormal_Numeric'])\n",
    "\n",
    "# Create the first bar chart\n",
    "bars1 = ax1.bar(range(len(test_combinations_5abnormal)), all_5_abnormal_values, \n",
    "                color=['#FF6B6B', '#4ECDC4', '#45B7D1', '#FFA07A', '#98D8C8'],\n",
    "                edgecolor='black', linewidth=1.5, alpha=0.8)\n",
    "\n",
    "# Customize the first chart\n",
    "ax1.set_title('Top Five-Test Combinations\\n\"All 5 Tests Abnormal\" Percentages', \n",
    "              fontsize=12, fontweight='bold', pad=20)\n",
    "ax1.set_xlabel('Test Combinations', fontsize=10, fontweight='bold')\n",
    "ax1.set_ylabel('All 5 Tests Abnormal (%)', fontsize=10, fontweight='bold')\n",
    "\n",
    "# Set x-axis labels for first chart\n",
    "ax1.set_xticks(range(len(test_combinations_5abnormal)))\n",
    "ax1.set_xticklabels(test_combinations_5abnormal, fontsize=6)\n",
    "\n",
    "# Add value labels on top of bars for first chart\n",
    "for i, (bar, value) in enumerate(zip(bars1, all_5_abnormal_values)):\n",
    "    ax1.text(bar.get_x() + bar.get_width()/2, bar.get_height() + 0.001, \n",
    "             f'{value:.2f}%', ha='center', va='bottom', fontweight='bold', fontsize=8)\n",
    "\n",
    "# Customize grid and layout for first chart\n",
    "ax1.grid(axis='y', alpha=0.3, linestyle='--')\n",
    "ax1.set_ylim(0, max(all_5_abnormal_values) * 1.15 if max(all_5_abnormal_values) > 0 else 0.1)\n",
    "ax1.set_facecolor('#F8F9FA')\n",
    "\n",
    "# Chart 2: \"4+ Tests Abnormal\" percentages for the same top 5 combinations\n",
    "four_plus_abnormal_values = []\n",
    "combination_labels_4plus = []\n",
    "\n",
    "for _, row in top_5_highest_risk_5test.iterrows():\n",
    "    four_plus_abnormal_values.append(row['Four_Plus_Abnormal_Numeric'])\n",
    "    \n",
    "    # Create shorter labels\n",
    "    test1_short = row['Test 1'].split()[0] if len(row['Test 1'].split()) > 2 else row['Test 1']\n",
    "    test2_short = row['Test 2'].split()[0] if len(row['Test 2'].split()) > 2 else row['Test 2']\n",
    "    test3_short = row['Test 3'].split()[0] if len(row['Test 3'].split()) > 2 else row['Test 3']\n",
    "    test4_short = row['Test 4'].split()[0] if len(row['Test 4'].split()) > 2 else row['Test 4']\n",
    "    test5_short = row['Test 5'].split()[0] if len(row['Test 5'].split()) > 2 else row['Test 5']\n",
    "    \n",
    "    combination_label = f\"{test1_short}\\n+\\n{test2_short}\\n+\\n{test3_short}\\n+\\n{test4_short}\\n+\\n{test5_short}\\n({row['Total Patients']} patients)\"\n",
    "    combination_labels_4plus.append(combination_label)\n",
    "\n",
    "# Create the second bar chart\n",
    "bars2 = ax2.bar(range(len(combination_labels_4plus)), four_plus_abnormal_values, \n",
    "                color=['#9B59B6', '#E74C3C', '#F39C12', '#2ECC71', '#3498DB'],\n",
    "                edgecolor='black', linewidth=1.5, alpha=0.8)\n",
    "\n",
    "# Customize the second chart\n",
    "ax2.set_title('Top Five-Test Combinations\\n\"4+ Tests Abnormal\" Percentages', \n",
    "              fontsize=12, fontweight='bold', pad=20)\n",
    "ax2.set_xlabel('Test Combinations', fontsize=10, fontweight='bold')\n",
    "ax2.set_ylabel('4+ Tests Abnormal (%)', fontsize=10, fontweight='bold')\n",
    "\n",
    "# Set x-axis labels for second chart\n",
    "ax2.set_xticks(range(len(combination_labels_4plus)))\n",
    "ax2.set_xticklabels(combination_labels_4plus, fontsize=6)\n",
    "\n",
    "# Add value labels on top of bars for second chart\n",
    "for i, (bar, value) in enumerate(zip(bars2, four_plus_abnormal_values)):\n",
    "    ax2.text(bar.get_x() + bar.get_width()/2, bar.get_height() + 0.05, \n",
    "             f'{value:.1f}%', ha='center', va='bottom', fontweight='bold', fontsize=8)\n",
    "\n",
    "# Customize grid and layout for second chart\n",
    "ax2.grid(axis='y', alpha=0.3, linestyle='--')\n",
    "ax2.set_ylim(0, max(four_plus_abnormal_values) * 1.15 if max(four_plus_abnormal_values) > 0 else 1)\n",
    "ax2.set_facecolor('#F8F9FA')\n",
    "\n",
    "# Chart 3: \"3+ Tests Abnormal\" percentages for the same top 5 combinations\n",
    "three_plus_abnormal_values = []\n",
    "combination_labels_3plus = []\n",
    "\n",
    "for _, row in top_5_highest_risk_5test.iterrows():\n",
    "    # Calculate 3+ abnormal by adding 3, 4+, and all 5 abnormal percentages\n",
    "    three_plus_abnormal = row['Three_Abnormal_Numeric'] + row['Four_Plus_Abnormal_Numeric'] + row['All_Abnormal_Numeric']\n",
    "    three_plus_abnormal_values.append(three_plus_abnormal)\n",
    "    \n",
    "    # Create shorter labels\n",
    "    test1_short = row['Test 1'].split()[0] if len(row['Test 1'].split()) > 2 else row['Test 1']\n",
    "    test2_short = row['Test 2'].split()[0] if len(row['Test 2'].split()) > 2 else row['Test 2']\n",
    "    test3_short = row['Test 3'].split()[0] if len(row['Test 3'].split()) > 2 else row['Test 3']\n",
    "    test4_short = row['Test 4'].split()[0] if len(row['Test 4'].split()) > 2 else row['Test 4']\n",
    "    test5_short = row['Test 5'].split()[0] if len(row['Test 5'].split()) > 2 else row['Test 5']\n",
    "    \n",
    "    combination_label = f\"{test1_short}\\n+\\n{test2_short}\\n+\\n{test3_short}\\n+\\n{test4_short}\\n+\\n{test5_short}\\n({row['Total Patients']} patients)\"\n",
    "    combination_labels_3plus.append(combination_label)\n",
    "\n",
    "# Create the third bar chart\n",
    "bars3 = ax3.bar(range(len(combination_labels_3plus)), three_plus_abnormal_values, \n",
    "                color=['#FF9F43', '#55A3FF', '#26C281', '#FD79A8', '#A29BFE'],\n",
    "                edgecolor='black', linewidth=1.5, alpha=0.8)\n",
    "\n",
    "# Customize the third chart\n",
    "ax3.set_title('Top Five-Test Combinations\\n\"3+ Tests Abnormal\" Percentages', \n",
    "              fontsize=12, fontweight='bold', pad=20)\n",
    "ax3.set_xlabel('Test Combinations', fontsize=10, fontweight='bold')\n",
    "ax3.set_ylabel('3+ Tests Abnormal (%)', fontsize=10, fontweight='bold')\n",
    "\n",
    "# Set x-axis labels for third chart\n",
    "ax3.set_xticks(range(len(combination_labels_3plus)))\n",
    "ax3.set_xticklabels(combination_labels_3plus, fontsize=6)\n",
    "\n",
    "# Add value labels on top of bars for third chart\n",
    "for i, (bar, value) in enumerate(zip(bars3, three_plus_abnormal_values)):\n",
    "    ax3.text(bar.get_x() + bar.get_width()/2, bar.get_height() + 0.05, \n",
    "             f'{value:.1f}%', ha='center', va='bottom', fontweight='bold', fontsize=8)\n",
    "\n",
    "# Customize grid and layout for third chart\n",
    "ax3.grid(axis='y', alpha=0.3, linestyle='--')\n",
    "ax3.set_ylim(0, max(three_plus_abnormal_values) * 1.15 if max(three_plus_abnormal_values) > 0 else 1)\n",
    "ax3.set_facecolor('#F8F9FA')\n",
    "\n",
    "# Adjust layout to prevent overlap\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# Print detailed analysis\n",
    "print(\"ğŸ¯ TOP FIVE-TEST COMBINATIONS WITH HIGHEST 'ALL 5 TESTS ABNORMAL' PERCENTAGES\")\n",
    "print(\"=\"*100)\n",
    "for i, (_, row) in enumerate(top_5_highest_risk_5test.iterrows(), 1):\n",
    "    test1_pct = float(row['Test 1 Abnormal %'].rstrip('%'))\n",
    "    test2_pct = float(row['Test 2 Abnormal %'].rstrip('%'))\n",
    "    test3_pct = float(row['Test 3 Abnormal %'].rstrip('%'))\n",
    "    test4_pct = float(row['Test 4 Abnormal %'].rstrip('%'))\n",
    "    test5_pct = float(row['Test 5 Abnormal %'].rstrip('%'))\n",
    "    avg_individual = (test1_pct + test2_pct + test3_pct + test4_pct + test5_pct) / 5\n",
    "    three_plus_abnormal = row['Three_Abnormal_Numeric'] + row['Four_Plus_Abnormal_Numeric'] + row['All_Abnormal_Numeric']\n",
    "    \n",
    "    print(f\"{i}. {row['Test 1']} + {row['Test 2']} + {row['Test 3']} + {row['Test 4']} + {row['Test 5']}\")\n",
    "    print(f\"   ğŸš¨ All 5 Tests Abnormal: {row['All 5 Abnormal %']}\")\n",
    "    print(f\"   âš ï¸  4+ Tests Abnormal: {row['4+ Abnormal %']}\")\n",
    "    print(f\"   ğŸ“Š 3+ Tests Abnormal: {three_plus_abnormal:.1f}%\")\n",
    "    print(f\"   ğŸ”¸ 3 Tests Abnormal: {row['3 Abnormal %']}\")\n",
    "    print(f\"   ğŸ‘¥ Total Patients: {row['Total Patients']:,}\")\n",
    "    print(f\"   ğŸ“Š Individual Abnormal Rates: {row['Test 1 Abnormal %']} | {row['Test 2 Abnormal %']} | {row['Test 3 Abnormal %']} | {row['Test 4 Abnormal %']} | {row['Test 5 Abnormal %']}\")\n",
    "    print(f\"   ğŸ“ˆ Average Individual Abnormal Rate: {avg_individual:.1f}%\")\n",
    "    print(f\"   ğŸ”„ Single Test Abnormal: {row['1 Abnormal %']}\")\n",
    "    print(f\"   âœ… All 5 Tests Normal: {row['All 5 Normal %']}\")\n",
    "    print()\n",
    "\n",
    "print(\"ğŸ’¡ KEY INSIGHTS FOR FIVE-TEST COMBINATIONS:\")\n",
    "print(\"- 'All 5 Tests Abnormal' rates are typically very low due to the multiplicative effect\")\n",
    "print(\"- '4+ Tests Abnormal' captures severe multi-system dysfunction\")\n",
    "print(\"- '3+ Tests Abnormal' shows broader high-risk patterns\")\n",
    "print(\"- Reduced patient sample sizes may limit statistical power for modeling\")\n",
    "print(\"- Complex patterns require larger datasets for reliable predictions\")\n",
    "\n",
    "# Additional analysis: Show warning about statistical power\n",
    "print(f\"\\nâš ï¸ STATISTICAL POWER WARNING FOR FIVE-TEST COMBINATIONS\")\n",
    "print(\"=\"*75)\n",
    "\n",
    "for i, (_, row) in enumerate(top_5_highest_risk_5test.iterrows(), 1):\n",
    "    three_plus_abnormal = row['Three_Abnormal_Numeric'] + row['Four_Plus_Abnormal_Numeric'] + row['All_Abnormal_Numeric']\n",
    "    \n",
    "    print(f\"\\n{i}. {row['Test 1']} + {row['Test 2']} + {row['Test 3']} + {row['Test 4']} + {row['Test 5']}\")\n",
    "    print(f\"   \udc65 Total Patients: {row['Total Patients']:,}\")\n",
    "    \n",
    "    # Calculate estimated sample sizes for different outcome groups\n",
    "    all_normal_count = int(float(row['All 5 Normal %'].rstrip('%')) * row['Total Patients'] / 100)\n",
    "    one_abnormal_count = int(float(row['1 Abnormal %'].rstrip('%')) * row['Total Patients'] / 100)\n",
    "    two_abnormal_count = int(float(row['2 Abnormal %'].rstrip('%')) * row['Total Patients'] / 100)\n",
    "    three_plus_count = int(three_plus_abnormal * row['Total Patients'] / 100)\n",
    "    \n",
    "    print(f\"   ğŸ“Š Estimated Sample Sizes:\")\n",
    "    print(f\"      âœ… All 5 Normal: ~{all_normal_count} patients\")\n",
    "    print(f\"      ğŸ”¸ 1 Abnormal: ~{one_abnormal_count} patients\")\n",
    "    print(f\"      ğŸ“Š 2 Abnormal: ~{two_abnormal_count} patients\")\n",
    "    print(f\"      âš ï¸  3+ Abnormal: ~{three_plus_count} patients\")\n",
    "    \n",
    "    # Statistical power assessment\n",
    "    min_recommended = 100  # Minimum recommended sample size per class\n",
    "    if three_plus_count < min_recommended:\n",
    "        print(f\"   ğŸš¨ WARNING: 3+ abnormal group ({three_plus_count}) below recommended minimum ({min_recommended}) for reliable modeling\")\n",
    "    if two_abnormal_count < min_recommended:\n",
    "        print(f\"   âš ï¸  CAUTION: 2 abnormal group ({two_abnormal_count}) below recommended minimum ({min_recommended})\")\n",
    "    if all_normal_count < min_recommended:\n",
    "        print(f\"   âš ï¸  CAUTION: All normal group ({all_normal_count}) below recommended minimum ({min_recommended})\")\n",
    "        \n",
    "print(f\"\\nğŸ“Š RECOMMENDATION: Consider reducing to 3-4 test combinations for better statistical power\")\n",
    "print(f\"                   Or combine datasets to increase sample sizes for 5-test analysis\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "be61efa2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 2000x1000 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ğŸ¯ ALL 4-TEST COMBINATIONS WITH '2+ TESTS ABNORMAL' PERCENTAGES\n",
      "=====================================================================================\n",
      "1. TSH + Serum Creatinine + Total Serum Bilirubin + Blood Glucose\n",
      "   âš ï¸  2+ Tests Abnormal: 7.9%\n",
      "   ğŸš¨ 3+ Tests Abnormal: 0.0%\n",
      "   ğŸ”¥ All 4 Tests Abnormal: 0.0%\n",
      "   ğŸ‘¥ Total Patients: 1,956\n",
      "   ğŸ“Š Individual Abnormal Rates: 27.1% | 38.3% | 0.0% | 0.0%\n",
      "   ğŸ“ˆ Average Individual Abnormal Rate: 16.4%\n",
      "   ğŸ”„ Single Test Abnormal: 44.3%\n",
      "   âœ… All 4 Tests Normal: 47.9%\n",
      "\n",
      "2. Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol\n",
      "   âš ï¸  2+ Tests Abnormal: 33.9%\n",
      "   ğŸš¨ 3+ Tests Abnormal: 18.7%\n",
      "   ğŸ”¥ All 4 Tests Abnormal: 0.0%\n",
      "   ğŸ‘¥ Total Patients: 1,568\n",
      "   ğŸ“Š Individual Abnormal Rates: 0.0% | 57.1% | 38.0% | 68.7%\n",
      "   ğŸ“ˆ Average Individual Abnormal Rate: 41.0%\n",
      "   ğŸ”„ Single Test Abnormal: 32.7%\n",
      "   âœ… All 4 Tests Normal: 14.7%\n",
      "\n",
      "3. Hepatitis B Surface Antigen + Hepatitis C Antibody + HIV Antibody + Blood Glucose\n",
      "   âš ï¸  2+ Tests Abnormal: 0.0%\n",
      "   ğŸš¨ 3+ Tests Abnormal: 0.0%\n",
      "   ğŸ”¥ All 4 Tests Abnormal: 0.0%\n",
      "   ğŸ‘¥ Total Patients: 1,034\n",
      "   ğŸ“Š Individual Abnormal Rates: 0.1% | 0.0% | 0.0% | 0.0%\n",
      "   ğŸ“ˆ Average Individual Abnormal Rate: 0.0%\n",
      "   ğŸ”„ Single Test Abnormal: 0.1%\n",
      "   âœ… All 4 Tests Normal: 99.9%\n",
      "\n",
      "ğŸ’¡ KEY INSIGHTS:\n",
      "- '2+ Tests Abnormal' shows combinations where patients often have multiple abnormal results\n",
      "- Higher percentages indicate stronger correlations between test abnormalities\n",
      "- Average individual abnormal rates show the baseline risk for each test type\n",
      "- These patterns can help identify patient risk profiles and comorbidities\n",
      "\n",
      "ğŸ“Š ALL COMBINATIONS RANKED BY AVERAGE INDIVIDUAL ABNORMAL RATES\n",
      "======================================================================\n",
      "1. Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol\n",
      "   ğŸ“ˆ Average Individual Abnormal Rate: 41.0%\n",
      "   âš ï¸  2+ Tests Abnormal: 33.9%\n",
      "   ğŸ‘¥ Total Patients: 1,568\n",
      "\n",
      "2. TSH + Serum Creatinine + Total Serum Bilirubin + Blood Glucose\n",
      "   ğŸ“ˆ Average Individual Abnormal Rate: 16.4%\n",
      "   âš ï¸  2+ Tests Abnormal: 7.9%\n",
      "   ğŸ‘¥ Total Patients: 1,956\n",
      "\n",
      "3. Hepatitis B Surface Antigen + Hepatitis C Antibody + HIV Antibody + Blood Glucose\n",
      "   ğŸ“ˆ Average Individual Abnormal Rate: 0.0%\n",
      "   âš ï¸  2+ Tests Abnormal: 0.0%\n",
      "   ğŸ‘¥ Total Patients: 1,034\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Create comprehensive visualizations for all 5-test combinations\n",
    "\n",
    "# Get all combinations for analysis\n",
    "all_combinations = enhanced_summary_df.copy()\n",
    "\n",
    "# Create subplot figure with two charts\n",
    "fig, (ax1, ax2) = plt.subplots(1, 2, figsize=(20, 10))\n",
    "\n",
    "# Chart 1: All combinations with \"3+ Abnormal\" percentages (more meaningful for 5-test combinations)\n",
    "test_combinations_3plus = []\n",
    "three_plus_abnormal_values = []\n",
    "\n",
    "for _, row in all_combinations.iterrows():\n",
    "    # Create shorter labels for better readability\n",
    "    test1_short = row['Test 1'].split()[0] if len(row['Test 1'].split()) > 2 else row['Test 1']\n",
    "    test2_short = row['Test 2'].split()[0] if len(row['Test 2'].split()) > 2 else row['Test 2']\n",
    "    test3_short = row['Test 3'].split()[0] if len(row['Test 3'].split()) > 2 else row['Test 3']\n",
    "    test4_short = row['Test 4'].split()[0] if len(row['Test 4'].split()) > 2 else row['Test 4']\n",
    "    test5_short = row['Test 5'].split()[0] if len(row['Test 5'].split()) > 2 else row['Test 5']\n",
    "    \n",
    "    combination_label = f\"{test1_short}\\n+\\n{test2_short}\\n+\\n{test3_short}\\n+\\n{test4_short}\\n+\\n{test5_short}\\n({row['Total Patients']} patients)\"\n",
    "    test_combinations_3plus.append(combination_label)\n",
    "    \n",
    "    # Calculate 3+ abnormal by adding 3, 4+, and all 5 abnormal percentages\n",
    "    three_plus_abnormal = row['Three_Abnormal_Numeric'] + row['Four_Plus_Abnormal_Numeric'] + row['All_Abnormal_Numeric']\n",
    "    three_plus_abnormal_values.append(three_plus_abnormal)\n",
    "\n",
    "# Create the first bar chart with different colors for each combination\n",
    "colors = plt.cm.Set3(np.linspace(0, 1, len(test_combinations_3plus)))\n",
    "bars1 = ax1.bar(range(len(test_combinations_3plus)), three_plus_abnormal_values, \n",
    "                color=colors, edgecolor='black', linewidth=1.5, alpha=0.8)\n",
    "\n",
    "# Customize the first chart\n",
    "ax1.set_title('All Five-Test Combinations\\n\"3+ Tests Abnormal\" Percentages', \n",
    "              fontsize=14, fontweight='bold', pad=20)\n",
    "ax1.set_xlabel('Test Combinations', fontsize=12, fontweight='bold')\n",
    "ax1.set_ylabel('3+ Tests Abnormal (%)', fontsize=12, fontweight='bold')\n",
    "\n",
    "# Set x-axis labels for first chart\n",
    "ax1.set_xticks(range(len(test_combinations_3plus)))\n",
    "ax1.set_xticklabels(test_combinations_3plus, fontsize=7, rotation=0)\n",
    "\n",
    "# Add value labels on top of bars for first chart\n",
    "for i, (bar, value) in enumerate(zip(bars1, three_plus_abnormal_values)):\n",
    "    ax1.text(bar.get_x() + bar.get_width()/2, bar.get_height() + 0.1, \n",
    "             f'{value:.1f}%', ha='center', va='bottom', fontweight='bold', fontsize=8)\n",
    "\n",
    "# Customize grid and layout for first chart\n",
    "ax1.grid(axis='y', alpha=0.3, linestyle='--')\n",
    "ax1.set_ylim(0, max(three_plus_abnormal_values) * 1.15 if max(three_plus_abnormal_values) > 0 else 1)\n",
    "ax1.set_facecolor('#F8F9FA')\n",
    "\n",
    "# Chart 2: Average of individual abnormal percentages for all combinations\n",
    "avg_individual_abnormal = []\n",
    "combination_labels_avg = []\n",
    "\n",
    "for _, row in all_combinations.iterrows():\n",
    "    # Calculate average of individual test abnormal percentages\n",
    "    test1_pct = float(row['Test 1 Abnormal %'].rstrip('%'))\n",
    "    test2_pct = float(row['Test 2 Abnormal %'].rstrip('%'))\n",
    "    test3_pct = float(row['Test 3 Abnormal %'].rstrip('%'))\n",
    "    test4_pct = float(row['Test 4 Abnormal %'].rstrip('%'))\n",
    "    test5_pct = float(row['Test 5 Abnormal %'].rstrip('%'))\n",
    "    \n",
    "    avg_pct = (test1_pct + test2_pct + test3_pct + test4_pct + test5_pct) / 5\n",
    "    avg_individual_abnormal.append(avg_pct)\n",
    "    \n",
    "    # Create shorter labels\n",
    "    test1_short = row['Test 1'].split()[0] if len(row['Test 1'].split()) > 2 else row['Test 1']\n",
    "    test2_short = row['Test 2'].split()[0] if len(row['Test 2'].split()) > 2 else row['Test 2']\n",
    "    test3_short = row['Test 3'].split()[0] if len(row['Test 3'].split()) > 2 else row['Test 3']\n",
    "    test4_short = row['Test 4'].split()[0] if len(row['Test 4'].split()) > 2 else row['Test 4']\n",
    "    test5_short = row['Test 5'].split()[0] if len(row['Test 5'].split()) > 2 else row['Test 5']\n",
    "    \n",
    "    combination_label = f\"{test1_short}\\n+\\n{test2_short}\\n+\\n{test3_short}\\n+\\n{test4_short}\\n+\\n{test5_short}\\n({row['Total Patients']} patients)\"\n",
    "    combination_labels_avg.append(combination_label)\n",
    "\n",
    "# Create the second bar chart with different colors\n",
    "colors2 = plt.cm.viridis(np.linspace(0, 1, len(combination_labels_avg)))\n",
    "bars2 = ax2.bar(range(len(combination_labels_avg)), avg_individual_abnormal, \n",
    "                color=colors2, edgecolor='black', linewidth=1.5, alpha=0.8)\n",
    "\n",
    "# Customize the second chart\n",
    "ax2.set_title('Average Individual Test Abnormal % for All 5-Test Combinations', \n",
    "              fontsize=14, fontweight='bold', pad=20)\n",
    "ax2.set_xlabel('Test Combinations', fontsize=12, fontweight='bold')\n",
    "ax2.set_ylabel('Average Individual Test Abnormal (%)', fontsize=12, fontweight='bold')\n",
    "\n",
    "# Set x-axis labels for second chart\n",
    "ax2.set_xticks(range(len(combination_labels_avg)))\n",
    "ax2.set_xticklabels(combination_labels_avg, fontsize=7, rotation=0)\n",
    "\n",
    "# Add value labels on top of bars for second chart\n",
    "for i, (bar, value) in enumerate(zip(bars2, avg_individual_abnormal)):\n",
    "    ax2.text(bar.get_x() + bar.get_width()/2, bar.get_height() + 0.5, \n",
    "             f'{value:.1f}%', ha='center', va='bottom', fontweight='bold', fontsize=8)\n",
    "\n",
    "# Customize grid and layout for second chart\n",
    "ax2.grid(axis='y', alpha=0.3, linestyle='--')\n",
    "ax2.set_ylim(0, max(avg_individual_abnormal) * 1.15)\n",
    "ax2.set_facecolor('#F8F9FA')\n",
    "\n",
    "# Adjust layout to prevent overlap\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# Print detailed analysis with focus on reduced sample sizes\n",
    "print(\"ğŸ¯ ALL 5-TEST COMBINATIONS WITH '3+ TESTS ABNORMAL' PERCENTAGES\")\n",
    "print(\"=\"*95)\n",
    "print(\"âš ï¸ CRITICAL NOTE: Five-test combinations have significantly reduced sample sizes!\")\n",
    "print(\"=\"*95)\n",
    "\n",
    "for i, (_, row) in enumerate(all_combinations.iterrows(), 1):\n",
    "    test1_pct = float(row['Test 1 Abnormal %'].rstrip('%'))\n",
    "    test2_pct = float(row['Test 2 Abnormal %'].rstrip('%'))\n",
    "    test3_pct = float(row['Test 3 Abnormal %'].rstrip('%'))\n",
    "    test4_pct = float(row['Test 4 Abnormal %'].rstrip('%'))\n",
    "    test5_pct = float(row['Test 5 Abnormal %'].rstrip('%'))\n",
    "    avg_individual = (test1_pct + test2_pct + test3_pct + test4_pct + test5_pct) / 5\n",
    "    three_plus_abnormal = row['Three_Abnormal_Numeric'] + row['Four_Plus_Abnormal_Numeric'] + row['All_Abnormal_Numeric']\n",
    "    \n",
    "    print(f\"{i}. {row['Test 1']} + {row['Test 2']} + {row['Test 3']} + {row['Test 4']} + {row['Test 5']}\")\n",
    "    print(f\"   ğŸ“Š 3+ Tests Abnormal: {three_plus_abnormal:.1f}%\")\n",
    "    print(f\"   ğŸš¨ 4+ Tests Abnormal: {row['4+ Abnormal %']}\")\n",
    "    print(f\"   ğŸ”¥ All 5 Tests Abnormal: {row['All 5 Abnormal %']}\")\n",
    "    print(f\"   ğŸ‘¥ Total Patients: {row['Total Patients']:,}\")\n",
    "    \n",
    "    # Calculate and show actual sample sizes for key groups\n",
    "    all_normal_count = int(float(row['All 5 Normal %'].rstrip('%')) * row['Total Patients'] / 100)\n",
    "    three_plus_count = int(three_plus_abnormal * row['Total Patients'] / 100)\n",
    "    \n",
    "    print(f\"   ğŸ“ˆ Sample Size Analysis:\")\n",
    "    print(f\"      âœ… All 5 Normal: ~{all_normal_count} patients\")\n",
    "    print(f\"      âš ï¸  3+ Abnormal: ~{three_plus_count} patients\")\n",
    "    \n",
    "    # Statistical adequacy assessment\n",
    "    if three_plus_count < 50:\n",
    "        print(f\"      \udea8 VERY LOW SAMPLE: 3+ abnormal group has only ~{three_plus_count} patients\")\n",
    "    elif three_plus_count < 100:\n",
    "        print(f\"      âš ï¸  LOW SAMPLE: 3+ abnormal group has only ~{three_plus_count} patients\")\n",
    "    else:\n",
    "        print(f\"      âœ… ADEQUATE SAMPLE: 3+ abnormal group has ~{three_plus_count} patients\")\n",
    "    \n",
    "    print(f\"   \ud83dğŸ“Š Individual Abnormal Rates: {row['Test 1 Abnormal %']} | {row['Test 2 Abnormal %']} | {row['Test 3 Abnormal %']} | {row['Test 4 Abnormal %']} | {row['Test 5 Abnormal %']}\")\n",
    "    print(f\"   ğŸ“ˆ Average Individual Abnormal Rate: {avg_individual:.1f}%\")\n",
    "    print()\n",
    "\n",
    "print(\"ğŸ’¡ KEY INSIGHTS FOR FIVE-TEST MODELING:\")\n",
    "print(\"=\"*60)\n",
    "print(\"âœ… ADVANTAGES:\")\n",
    "print(\"  - More comprehensive health assessment\")\n",
    "print(\"  - Can capture complex multi-system interactions\")\n",
    "print(\"  - Higher specificity for severe health conditions\")\n",
    "print()\n",
    "print(\"âš ï¸ CHALLENGES:\")\n",
    "print(\"  - Dramatically reduced sample sizes\")\n",
    "print(\"  - Very low rates of multiple abnormalities\")\n",
    "print(\"  - Statistical power limitations\")\n",
    "print(\"  - Risk of overfitting with small samples\")\n",
    "print()\n",
    "print(\"ğŸ¯ RECOMMENDATIONS:\")\n",
    "print(\"  - Consider pooling multiple datasets if available\")\n",
    "print(\"  - Use simpler models (fewer parameters)\")\n",
    "print(\"  - Focus on 2-3 test abnormalities rather than 4-5\")\n",
    "print(\"  - Validate models with cross-validation\")\n",
    "print(\"  - Consider dimensionality reduction techniques\")\n",
    "\n",
    "# Statistical adequacy summary\n",
    "print(f\"\\nğŸ“Š STATISTICAL ADEQUACY SUMMARY FOR FIVE-TEST COMBINATIONS\")\n",
    "print(\"=\"*75)\n",
    "\n",
    "adequate_combinations = 0\n",
    "low_sample_combinations = 0\n",
    "very_low_sample_combinations = 0\n",
    "\n",
    "for _, row in all_combinations.iterrows():\n",
    "    three_plus_abnormal = row['Three_Abnormal_Numeric'] + row['Four_Plus_Abnormal_Numeric'] + row['All_Abnormal_Numeric']\n",
    "    three_plus_count = int(three_plus_abnormal * row['Total Patients'] / 100)\n",
    "    \n",
    "    if three_plus_count >= 100:\n",
    "        adequate_combinations += 1\n",
    "    elif three_plus_count >= 50:\n",
    "        low_sample_combinations += 1\n",
    "    else:\n",
    "        very_low_sample_combinations += 1\n",
    "\n",
    "print(f\"ğŸ“ˆ SAMPLE SIZE DISTRIBUTION (for 3+ abnormal groups):\")\n",
    "print(f\"âœ… Adequate Sample (â‰¥100 patients): {adequate_combinations} combinations\")\n",
    "print(f\"âš ï¸  Low Sample (50-99 patients): {low_sample_combinations} combinations\") \n",
    "print(f\"ğŸš¨ Very Low Sample (<50 patients): {very_low_sample_combinations} combinations\")\n",
    "print(f\"ğŸ“Š Total Combinations: {len(all_combinations)}\")\n",
    "\n",
    "if adequate_combinations == 0:\n",
    "    print(f\"\\nğŸš¨ CRITICAL WARNING: No combinations have adequate sample sizes for reliable 5-test modeling!\")\n",
    "    print(f\"   Consider reducing to 3-4 test combinations or combining multiple datasets.\")\n",
    "elif adequate_combinations < len(all_combinations) / 2:\n",
    "    print(f\"\\nâš ï¸  WARNING: Only {adequate_combinations}/{len(all_combinations)} combinations have adequate sample sizes.\")\n",
    "    print(f\"   Proceed with caution and use robust validation techniques.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "27b2d2c6",
   "metadata": {},
   "outputs": [],
   "source": [
    "enhanced_summary_df.to_csv('../model_data_insight/enhanced_five_test_combination_summary.csv', index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "914d44c2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Test 1</th>\n",
       "      <th>Test 2</th>\n",
       "      <th>Test 3</th>\n",
       "      <th>Test 4</th>\n",
       "      <th>Total Patients</th>\n",
       "      <th>Test 1 Abnormal %</th>\n",
       "      <th>Test 2 Abnormal %</th>\n",
       "      <th>Test 3 Abnormal %</th>\n",
       "      <th>Test 4 Abnormal %</th>\n",
       "      <th>All 4 Abnormal %</th>\n",
       "      <th>All 4 Normal %</th>\n",
       "      <th>3+ Abnormal %</th>\n",
       "      <th>2 Abnormal %</th>\n",
       "      <th>1 Abnormal %</th>\n",
       "      <th>All_Abnormal_Numeric</th>\n",
       "      <th>All_Normal_Numeric</th>\n",
       "      <th>Three_Plus_Abnormal_Numeric</th>\n",
       "      <th>Two_Abnormal_Numeric</th>\n",
       "      <th>One_Abnormal_Numeric</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>TSH</td>\n",
       "      <td>Serum Creatinine</td>\n",
       "      <td>Total Serum Bilirubin</td>\n",
       "      <td>Blood Glucose</td>\n",
       "      <td>1956</td>\n",
       "      <td>27.1%</td>\n",
       "      <td>38.3%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>47.9%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>7.9%</td>\n",
       "      <td>44.3%</td>\n",
       "      <td>0.0</td>\n",
       "      <td>47.9</td>\n",
       "      <td>0.0</td>\n",
       "      <td>7.9</td>\n",
       "      <td>44.3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Serum Cholesterol</td>\n",
       "      <td>Serum Triglycerides</td>\n",
       "      <td>Serum HDL Cholesterol</td>\n",
       "      <td>Serum LDL Cholesterol</td>\n",
       "      <td>1568</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>57.1%</td>\n",
       "      <td>38.0%</td>\n",
       "      <td>68.7%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>14.7%</td>\n",
       "      <td>18.7%</td>\n",
       "      <td>33.9%</td>\n",
       "      <td>32.7%</td>\n",
       "      <td>0.0</td>\n",
       "      <td>14.7</td>\n",
       "      <td>18.7</td>\n",
       "      <td>33.9</td>\n",
       "      <td>32.7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Hepatitis B Surface Antigen</td>\n",
       "      <td>Hepatitis C Antibody</td>\n",
       "      <td>HIV Antibody</td>\n",
       "      <td>Blood Glucose</td>\n",
       "      <td>1034</td>\n",
       "      <td>0.1%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>99.9%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>0.1%</td>\n",
       "      <td>0.0</td>\n",
       "      <td>99.9</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                        Test 1                Test 2                 Test 3  \\\n",
       "0                          TSH      Serum Creatinine  Total Serum Bilirubin   \n",
       "1            Serum Cholesterol   Serum Triglycerides  Serum HDL Cholesterol   \n",
       "2  Hepatitis B Surface Antigen  Hepatitis C Antibody           HIV Antibody   \n",
       "\n",
       "                  Test 4  Total Patients Test 1 Abnormal % Test 2 Abnormal %  \\\n",
       "0          Blood Glucose            1956             27.1%             38.3%   \n",
       "1  Serum LDL Cholesterol            1568              0.0%             57.1%   \n",
       "2          Blood Glucose            1034              0.1%              0.0%   \n",
       "\n",
       "  Test 3 Abnormal % Test 4 Abnormal % All 4 Abnormal % All 4 Normal %  \\\n",
       "0              0.0%              0.0%             0.0%          47.9%   \n",
       "1             38.0%             68.7%             0.0%          14.7%   \n",
       "2              0.0%              0.0%             0.0%          99.9%   \n",
       "\n",
       "  3+ Abnormal % 2 Abnormal % 1 Abnormal %  All_Abnormal_Numeric  \\\n",
       "0          0.0%         7.9%        44.3%                   0.0   \n",
       "1         18.7%        33.9%        32.7%                   0.0   \n",
       "2          0.0%         0.0%         0.1%                   0.0   \n",
       "\n",
       "   All_Normal_Numeric  Three_Plus_Abnormal_Numeric  Two_Abnormal_Numeric  \\\n",
       "0                47.9                          0.0                   7.9   \n",
       "1                14.7                         18.7                  33.9   \n",
       "2                99.9                          0.0                   0.0   \n",
       "\n",
       "   One_Abnormal_Numeric  \n",
       "0                  44.3  \n",
       "1                  32.7  \n",
       "2                   0.1  "
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "enhanced_summary_df"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "52194415",
   "metadata": {},
   "source": [
    "# Criteria for Selecting Best Five-Test Combinations for Classification Model\n",
    "\n",
    "## Primary Selection Criteria\n",
    "\n",
    "When selecting the best five-test combinations for building a classification model, we should consider several key factors while being aware of the **dramatically reduced patient sample sizes**:\n",
    "\n",
    "### 1. **Statistical Significance & Sample Size** âš ï¸ **CRITICAL CONCERN**\n",
    "- **Minimum patient count**: â‰¥500 patients (lowered from typical thresholds due to 5-test constraints)\n",
    "- **Balanced representation**: Adequate samples across different outcome patterns\n",
    "- **Sample size warning**: Five-test combinations significantly reduce available patients compared to 3-4 test combinations\n",
    "\n",
    "### 2. **Outcome Distribution Quality**\n",
    "- **Balanced abnormal rates**: Individual test abnormal rates between 10-60% (wider range due to limited options)\n",
    "- **Meaningful variation**: Good mix of normal/abnormal combinations across patients\n",
    "- **Clinical relevance**: Combinations that represent real-world diagnostic scenarios\n",
    "- **Realistic expectations**: Accept lower abnormality rates due to multiplicative effect of 5 tests\n",
    "\n",
    "### 3. **Predictive Potential** âš ï¸ **MODIFIED FOR 5-TEST CONSTRAINTS**\n",
    "- **Moderate correlation**: 3+ abnormal rates between 5-25% (much lower than 3-4 test combinations)\n",
    "- **Discriminative power**: Focus on 2-3 test abnormalities rather than 4-5 test abnormalities\n",
    "- **Complementary information**: Tests that provide different diagnostic insights across multiple systems\n",
    "\n",
    "### 4. **Clinical Interpretability**\n",
    "- **Related organ systems**: Tests that logically group together (e.g., complete lipid panel + liver function)\n",
    "- **Common co-testing**: Combinations frequently ordered together in clinical practice\n",
    "- **Actionable insights**: Results that can inform comprehensive treatment decisions\n",
    "\n",
    "## Special Considerations for Five-Test Combinations\n",
    "\n",
    "### **Statistical Power Challenges** ğŸš¨\n",
    "- **Reduced sample sizes**: Patient counts drop dramatically when requiring all 5 tests\n",
    "- **Low abnormality rates**: Probability of multiple abnormalities decreases exponentially\n",
    "- **Model complexity**: Risk of overfitting with small sample sizes\n",
    "- **Validation challenges**: Limited data for robust cross-validation\n",
    "\n",
    "### **Recommended Modeling Approaches**\n",
    "1. **Simpler models**: Use fewer parameters to avoid overfitting\n",
    "2. **Dimensionality reduction**: Consider PCA or feature selection\n",
    "3. **Robust validation**: Use repeated cross-validation with small samples\n",
    "4. **Ensemble methods**: Combine multiple simple models\n",
    "5. **Conservative thresholds**: Lower classification thresholds due to sample limitations\n",
    "\n",
    "## Recommended Top Combinations for Five-Test Classification\n",
    "\n",
    "Based on the analysis, prioritize combinations with:\n",
    "\n",
    "1. **Largest patient populations** (â‰¥750 patients for five-test combinations)\n",
    "2. **Clinically coherent test panels** (complete organ system assessments)\n",
    "3. **Reasonable abnormality rates** (at least 10% combined abnormalities)\n",
    "4. **Statistical adequacy** (â‰¥50 patients in minority outcome groups)\n",
    "\n",
    "## Key Insights for Five-Test Classification Models\n",
    "\n",
    "- **Complex health patterns**: Five-test combinations capture multi-system health status\n",
    "- **Specificity over sensitivity**: Better at identifying severe multi-system dysfunction\n",
    "- **Clinical complexity**: Reflects comprehensive diagnostic workups\n",
    "- **Statistical limitations**: Require larger datasets or simpler modeling approaches\n",
    "- **Real-world applicability**: Most valuable for complex patients with multiple health concerns\n",
    "\n",
    "## âš ï¸ **CRITICAL RECOMMENDATION**\n",
    "\n",
    "**Consider reducing to 3-4 test combinations for better statistical power**, or combine multiple datasets to increase sample sizes for reliable five-test analysis. The dramatically reduced patient counts in five-test combinations may limit the reliability and generalizability of machine learning models.\n",
    "\n",
    "### Alternative Approaches:\n",
    "1. **Sequential modeling**: Build 3-test models first, then expand to 5-test for specific use cases\n",
    "2. **Hierarchical classification**: Use simpler models to identify high-risk patients, then apply 5-test analysis\n",
    "3. **Data augmentation**: Combine multiple similar datasets to increase sample sizes\n",
    "4. **Ensemble approaches**: Combine predictions from multiple smaller test combinations"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "09f72d36",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ğŸ¯ SELECTION CRITERIA FOR 4-TEST CLASSIFICATION MODEL\n",
      "======================================================================\n",
      "ğŸ“Š Using existing 4-test combinations from analysis...\n",
      "Available 4-test combinations: 3\n",
      "\n",
      "ğŸ“Š SCORING CRITERIA:\n",
      "1. Patient Count Score (25%): Higher patient count = better statistical power\n",
      "2. Balance Score (25%): Balanced abnormal rates (15-70%) across tests\n",
      "3. Predictive Score (25%): Good 2+ abnormal rate (20-50%) for discrimination\n",
      "4. Clinical Relevance Score (25%): Related tests that are commonly ordered together\n",
      "\n",
      "ğŸ† TOP 4-TEST CLASSIFICATION MODEL CANDIDATES\n",
      "====================================================================================================\n",
      "Selected 2 combinations with Overall Score â‰¥ 60\n",
      "\n",
      "1. Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol\n",
      "   ğŸ“Š Overall Score: 87.8/100\n",
      "   ğŸ‘¥ Patients: 1,568 (Score: 80.2)\n",
      "   âš–ï¸  Balance: 75.0 (Abnormal rates: 0.0% | 57.1% | 38.0% | 68.7%)\n",
      "   ğŸ¯ Predictive: 96.1 (2+ Abnormal: 52.6%)\n",
      "   ğŸ¥ Clinical: 100.0\n",
      "\n",
      "2. TSH + Serum Creatinine + Total Serum Bilirubin + Blood Glucose\n",
      "   ğŸ“Š Overall Score: 67.4/100\n",
      "   ğŸ‘¥ Patients: 1,956 (Score: 100.0)\n",
      "   âš–ï¸  Balance: 50.0 (Abnormal rates: 27.1% | 38.3% | 0.0% | 0.0%)\n",
      "   ğŸ¯ Predictive: 39.5 (2+ Abnormal: 7.9%)\n",
      "   ğŸ¥ Clinical: 80.0\n",
      "\n",
      "ğŸ“ˆ CANDIDATE SUMMARY:\n",
      "Total Candidates: 2\n",
      "Average Overall Score: 77.6\n",
      "Average Patient Count: 1762\n",
      "Score Range: 67.4 - 87.8\n",
      "\n",
      "ğŸ“‹ CLASSIFICATION_4_TEST_CANDIDATES DATAFRAME:\n",
      "Shape: (2, 30)\n",
      "Columns: ['Test 1', 'Test 2', 'Test 3', 'Test 4', 'Total Patients', 'Test 1 Abnormal %', 'Test 2 Abnormal %', 'Test 3 Abnormal %', 'Test 4 Abnormal %', 'All 4 Abnormal %', 'All 4 Normal %', '3+ Abnormal %', '2 Abnormal %', '1 Abnormal %', 'All_Abnormal_Numeric', 'All_Normal_Numeric', 'Three_Plus_Abnormal_Numeric', 'Two_Abnormal_Numeric', 'One_Abnormal_Numeric', 'Avg_Individual_Abnormal', 'Test_1_Abnormal_Numeric', 'Test_2_Abnormal_Numeric', 'Test_3_Abnormal_Numeric', 'Test_4_Abnormal_Numeric', 'Patient_Count_Score', 'Balance_Score', 'Two_Plus_Abnormal_Numeric', 'Predictive_Score', 'Clinical_Score', 'Overall_Score']\n",
      "\n",
      "ğŸ’¾ Results saved to '../model_data_insight/classification_4_test_candidates.csv'\n",
      "\n",
      "ğŸ¯ RECOMMENDED 4-TEST COMBINATIONS FOR CLASSIFICATION MODEL:\n",
      "================================================================================\n",
      "1. Serum Cholesterol + Serum Triglycerides + Serum HDL Cholesterol + Serum LDL Cholesterol\n",
      "   Score: 87.8 | Patients: 1,568 | 2+ Abnormal: 52.6%\n",
      "2. TSH + Serum Creatinine + Total Serum Bilirubin + Blood Glucose\n",
      "   Score: 67.4 | Patients: 1,956 | 2+ Abnormal: 7.9%\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Test 1</th>\n",
       "      <th>Test 2</th>\n",
       "      <th>Test 3</th>\n",
       "      <th>Test 4</th>\n",
       "      <th>Total Patients</th>\n",
       "      <th>Test 1 Abnormal %</th>\n",
       "      <th>Test 2 Abnormal %</th>\n",
       "      <th>Test 3 Abnormal %</th>\n",
       "      <th>Test 4 Abnormal %</th>\n",
       "      <th>All 4 Abnormal %</th>\n",
       "      <th>...</th>\n",
       "      <th>Test_1_Abnormal_Numeric</th>\n",
       "      <th>Test_2_Abnormal_Numeric</th>\n",
       "      <th>Test_3_Abnormal_Numeric</th>\n",
       "      <th>Test_4_Abnormal_Numeric</th>\n",
       "      <th>Patient_Count_Score</th>\n",
       "      <th>Balance_Score</th>\n",
       "      <th>Two_Plus_Abnormal_Numeric</th>\n",
       "      <th>Predictive_Score</th>\n",
       "      <th>Clinical_Score</th>\n",
       "      <th>Overall_Score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Serum Cholesterol</td>\n",
       "      <td>Serum Triglycerides</td>\n",
       "      <td>Serum HDL Cholesterol</td>\n",
       "      <td>Serum LDL Cholesterol</td>\n",
       "      <td>1568</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>57.1%</td>\n",
       "      <td>38.0%</td>\n",
       "      <td>68.7%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>57.1</td>\n",
       "      <td>38.0</td>\n",
       "      <td>68.7</td>\n",
       "      <td>80.163599</td>\n",
       "      <td>75.0</td>\n",
       "      <td>52.6</td>\n",
       "      <td>96.1</td>\n",
       "      <td>100</td>\n",
       "      <td>87.8159</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>TSH</td>\n",
       "      <td>Serum Creatinine</td>\n",
       "      <td>Total Serum Bilirubin</td>\n",
       "      <td>Blood Glucose</td>\n",
       "      <td>1956</td>\n",
       "      <td>27.1%</td>\n",
       "      <td>38.3%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>...</td>\n",
       "      <td>27.1</td>\n",
       "      <td>38.3</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>100.000000</td>\n",
       "      <td>50.0</td>\n",
       "      <td>7.9</td>\n",
       "      <td>39.5</td>\n",
       "      <td>80</td>\n",
       "      <td>67.3750</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>2 rows Ã— 30 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "              Test 1               Test 2                 Test 3  \\\n",
       "0  Serum Cholesterol  Serum Triglycerides  Serum HDL Cholesterol   \n",
       "1                TSH     Serum Creatinine  Total Serum Bilirubin   \n",
       "\n",
       "                  Test 4  Total Patients Test 1 Abnormal % Test 2 Abnormal %  \\\n",
       "0  Serum LDL Cholesterol            1568              0.0%             57.1%   \n",
       "1          Blood Glucose            1956             27.1%             38.3%   \n",
       "\n",
       "  Test 3 Abnormal % Test 4 Abnormal % All 4 Abnormal %  ...  \\\n",
       "0             38.0%             68.7%             0.0%  ...   \n",
       "1              0.0%              0.0%             0.0%  ...   \n",
       "\n",
       "  Test_1_Abnormal_Numeric Test_2_Abnormal_Numeric Test_3_Abnormal_Numeric  \\\n",
       "0                     0.0                    57.1                    38.0   \n",
       "1                    27.1                    38.3                     0.0   \n",
       "\n",
       "  Test_4_Abnormal_Numeric  Patient_Count_Score  Balance_Score  \\\n",
       "0                    68.7            80.163599           75.0   \n",
       "1                     0.0           100.000000           50.0   \n",
       "\n",
       "   Two_Plus_Abnormal_Numeric  Predictive_Score  Clinical_Score  Overall_Score  \n",
       "0                       52.6              96.1             100        87.8159  \n",
       "1                        7.9              39.5              80        67.3750  \n",
       "\n",
       "[2 rows x 30 columns]"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from itertools import combinations\n",
    "import pandas as pd\n",
    "\n",
    "print(\"ğŸ¯ SELECTION CRITERIA FOR 5-TEST CLASSIFICATION MODEL\")\n",
    "print(\"=\"*70)\n",
    "print(\"âš ï¸  CRITICAL NOTE: 5-test combinations have dramatically reduced sample sizes!\")\n",
    "print(\"=\"*70)\n",
    "\n",
    "# Use the existing enhanced_summary_df which contains our 5-test combinations\n",
    "print(\"ğŸ“Š Using existing 5-test combinations from analysis...\")\n",
    "print(f\"Available 5-test combinations: {len(enhanced_summary_df)}\")\n",
    "\n",
    "# Create a copy for scoring\n",
    "classification_5_test_candidates = enhanced_summary_df.copy()\n",
    "\n",
    "# Convert percentage strings to numeric values for calculations\n",
    "classification_5_test_candidates['Test_1_Abnormal_Numeric'] = classification_5_test_candidates['Test 1 Abnormal %'].str.rstrip('%').astype(float)\n",
    "classification_5_test_candidates['Test_2_Abnormal_Numeric'] = classification_5_test_candidates['Test 2 Abnormal %'].str.rstrip('%').astype(float)\n",
    "classification_5_test_candidates['Test_3_Abnormal_Numeric'] = classification_5_test_candidates['Test 3 Abnormal %'].str.rstrip('%').astype(float)\n",
    "classification_5_test_candidates['Test_4_Abnormal_Numeric'] = classification_5_test_candidates['Test 4 Abnormal %'].str.rstrip('%').astype(float)\n",
    "classification_5_test_candidates['Test_5_Abnormal_Numeric'] = classification_5_test_candidates['Test 5 Abnormal %'].str.rstrip('%').astype(float)\n",
    "\n",
    "# Calculate derived metrics\n",
    "classification_5_test_candidates['Three_Plus_Abnormal_Numeric'] = (\n",
    "    classification_5_test_candidates['Three_Abnormal_Numeric'] + \n",
    "    classification_5_test_candidates['Four_Plus_Abnormal_Numeric'] + \n",
    "    classification_5_test_candidates['All_Abnormal_Numeric']\n",
    ")\n",
    "\n",
    "# Calculate scoring criteria (adjusted for 5-test constraints)\n",
    "print(\"\\nğŸ“Š SCORING CRITERIA (ADJUSTED FOR 5-TEST CONSTRAINTS):\")\n",
    "print(\"1. Patient Count Score (30%): Higher patient count = better statistical power (CRITICAL for 5-test)\")\n",
    "print(\"2. Balance Score (20%): Balanced abnormal rates (10-60%) across tests (adjusted range)\")\n",
    "print(\"3. Predictive Score (25%): Good 3+ abnormal rate (5-25%) for discrimination (lowered expectations)\")\n",
    "print(\"4. Clinical Relevance Score (25%): Related tests that are commonly ordered together\")\n",
    "\n",
    "# 1. Patient Count Score (normalized 0-100) - INCREASED WEIGHT due to critical importance\n",
    "max_patients = classification_5_test_candidates['Total Patients'].max()\n",
    "classification_5_test_candidates['Patient_Count_Score'] = (classification_5_test_candidates['Total Patients'] / max_patients) * 100\n",
    "\n",
    "# 2. Balance Score: Penalize extreme abnormal rates (prefer 10-60% range for 5-test)\n",
    "def calculate_balance_score_5test(test1_pct, test2_pct, test3_pct, test4_pct, test5_pct):\n",
    "    \"\"\"Calculate balance score based on how well abnormal rates fall within optimal range for 5-test\"\"\"\n",
    "    optimal_min, optimal_max = 10, 60  # Wider range for 5-test combinations\n",
    "    \n",
    "    scores = []\n",
    "    for pct in [test1_pct, test2_pct, test3_pct, test4_pct, test5_pct]:\n",
    "        if optimal_min <= pct <= optimal_max:\n",
    "            score = 100\n",
    "        elif pct < optimal_min:\n",
    "            score = (pct / optimal_min) * 100\n",
    "        else:\n",
    "            score = max(0, 100 - ((pct - optimal_max) * 1.5))\n",
    "        scores.append(score)\n",
    "    \n",
    "    return sum(scores) / 5\n",
    "\n",
    "classification_5_test_candidates['Balance_Score'] = classification_5_test_candidates.apply(\n",
    "    lambda row: calculate_balance_score_5test(\n",
    "        row['Test_1_Abnormal_Numeric'], \n",
    "        row['Test_2_Abnormal_Numeric'], \n",
    "        row['Test_3_Abnormal_Numeric'],\n",
    "        row['Test_4_Abnormal_Numeric'],\n",
    "        row['Test_5_Abnormal_Numeric']\n",
    "    ), axis=1\n",
    ")\n",
    "\n",
    "# 3. Predictive Score: Optimal 3+ abnormal rate for discrimination (adjusted for 5-test)\n",
    "def calculate_predictive_score_5test(three_plus_abnormal_pct):\n",
    "    \"\"\"Calculate predictive score based on 3+ abnormal rate for 5-test combinations\"\"\"\n",
    "    optimal_min, optimal_max = 5, 25  # Much lower range for 5-test combinations\n",
    "    \n",
    "    if optimal_min <= three_plus_abnormal_pct <= optimal_max:\n",
    "        return 100\n",
    "    elif three_plus_abnormal_pct < optimal_min:\n",
    "        return (three_plus_abnormal_pct / optimal_min) * 100\n",
    "    else:\n",
    "        return max(0, 100 - ((three_plus_abnormal_pct - optimal_max) * 2))\n",
    "\n",
    "classification_5_test_candidates['Predictive_Score'] = classification_5_test_candidates['Three_Plus_Abnormal_Numeric'].apply(\n",
    "    calculate_predictive_score_5test\n",
    ")\n",
    "\n",
    "# 4. Clinical Relevance Score: Based on logical test groupings (enhanced for 5-test)\n",
    "def calculate_clinical_score_5test(test1, test2, test3, test4, test5):\n",
    "    \"\"\"Calculate clinical relevance score based on test relationships for 5-test combinations\"\"\"\n",
    "    \n",
    "    # Define clinical test groups\n",
    "    lipid_tests = ['Serum Cholesterol', 'Serum Triglycerides', 'Serum HDL Cholesterol', \n",
    "                   'Serum LDL Cholesterol', 'Total Cholesterol', 'Triglycerides', 'LDL Cholesterol']\n",
    "    \n",
    "    liver_tests = ['Aspartate Aminotransferase (AST)', 'Alanine Aminotransferase (ALT)', \n",
    "                   'Alkaline Phosphatase', 'Total Serum Bilirubin']\n",
    "    \n",
    "    kidney_tests = ['Serum Creatinine', 'Blood Urea Nitrogen']\n",
    "    \n",
    "    diabetes_tests = ['HbA1c', 'Blood Glucose', 'Blood Sugar', 'Glucose']\n",
    "    \n",
    "    thyroid_tests = ['TSH', 'Free T4']\n",
    "    \n",
    "    infection_tests = ['Hepatitis B Surface Antigen', 'Hepatitis C Antibody', 'HIV Antibody']\n",
    "    \n",
    "    iron_tests = ['S.Iron', 'Serum Ferritin']\n",
    "    \n",
    "    cbc_tests = ['White Blood Cell Count', 'Red Blood Cell Count', 'Hemoglobin', 'Platelet Count']\n",
    "    \n",
    "    cardiac_tests = ['Troponin', 'CK-MB', 'LDH']\n",
    "    \n",
    "    tests = [test1, test2, test3, test4, test5]\n",
    "    \n",
    "    # Check for complete panels (highest score)\n",
    "    lipid_count = sum(1 for test in tests if test in lipid_tests)\n",
    "    liver_count = sum(1 for test in tests if test in liver_tests)\n",
    "    infection_count = sum(1 for test in tests if test in infection_tests)\n",
    "    cbc_count = sum(1 for test in tests if test in cbc_tests)\n",
    "    \n",
    "    if lipid_count >= 4:\n",
    "        return 100  # Complete or near-complete lipid panel\n",
    "    elif liver_count >= 3 and lipid_count >= 1:\n",
    "        return 95   # Comprehensive liver + metabolic assessment\n",
    "    elif infection_count >= 3:\n",
    "        return 90   # Complete infection screening panel\n",
    "    elif cbc_count >= 3:\n",
    "        return 90   # Complete blood count panel\n",
    "    elif lipid_count >= 3:\n",
    "        return 85   # Major lipid panel\n",
    "    \n",
    "    # Check for logical multi-system combinations\n",
    "    diabetes_kidney = sum(1 for test in tests if test in diabetes_tests) + sum(1 for test in tests if test in kidney_tests)\n",
    "    thyroid_general = sum(1 for test in tests if test in thyroid_tests)\n",
    "    \n",
    "    if diabetes_kidney >= 2 and thyroid_general >= 1 and lipid_count >= 1:\n",
    "        return 80   # Comprehensive metabolic + endocrine panel\n",
    "    elif diabetes_kidney >= 2 and liver_count >= 2:\n",
    "        return 75   # Metabolic + liver assessment\n",
    "    \n",
    "    # Default score for mixed panels\n",
    "    return 50\n",
    "\n",
    "classification_5_test_candidates['Clinical_Score'] = classification_5_test_candidates.apply(\n",
    "    lambda row: calculate_clinical_score_5test(row['Test 1'], row['Test 2'], row['Test 3'], row['Test 4'], row['Test 5']), axis=1\n",
    ")\n",
    "\n",
    "# Calculate overall score (weighted average with increased weight on patient count)\n",
    "classification_5_test_candidates['Overall_Score'] = (\n",
    "    classification_5_test_candidates['Patient_Count_Score'] * 0.30 +  # Increased from 0.25\n",
    "    classification_5_test_candidates['Balance_Score'] * 0.20 +        # Decreased from 0.25\n",
    "    classification_5_test_candidates['Predictive_Score'] * 0.25 +\n",
    "    classification_5_test_candidates['Clinical_Score'] * 0.25\n",
    ")\n",
    "\n",
    "# Sort by overall score\n",
    "classification_5_test_candidates = classification_5_test_candidates.sort_values('Overall_Score', ascending=False)\n",
    "\n",
    "# Select candidates with overall score > 50 (lowered threshold for 5-test)\n",
    "classification_5_test_candidates = classification_5_test_candidates[\n",
    "    classification_5_test_candidates['Overall_Score'] >= 50  # Lowered threshold for 5-test combinations\n",
    "].reset_index(drop=True)\n",
    "\n",
    "print(f\"\\nğŸ† TOP 5-TEST CLASSIFICATION MODEL CANDIDATES\")\n",
    "print(\"=\"*100)\n",
    "print(f\"Selected {len(classification_5_test_candidates)} combinations with Overall Score â‰¥ 50\")\n",
    "print(\"âš ï¸ NOTE: Threshold lowered due to constraints of 5-test combinations\")\n",
    "\n",
    "# Display detailed results\n",
    "for i, (_, row) in enumerate(classification_5_test_candidates.iterrows(), 1):\n",
    "    print(f\"\\n{i}. {row['Test 1']} + {row['Test 2']} + {row['Test 3']} + {row['Test 4']} + {row['Test 5']}\")\n",
    "    print(f\"   ğŸ“Š Overall Score: {row['Overall_Score']:.1f}/100\")\n",
    "    print(f\"   ğŸ‘¥ Patients: {row['Total Patients']:,} (Score: {row['Patient_Count_Score']:.1f})\")\n",
    "    print(f\"   âš–ï¸  Balance: {row['Balance_Score']:.1f} (Abnormal rates: {row['Test 1 Abnormal %']} | {row['Test 2 Abnormal %']} | {row['Test 3 Abnormal %']} | {row['Test 4 Abnormal %']} | {row['Test 5 Abnormal %']})\")\n",
    "    print(f\"   ğŸ¯ Predictive: {row['Predictive_Score']:.1f} (3+ Abnormal: {row['Three_Plus_Abnormal_Numeric']:.1f}%)\")\n",
    "    print(f\"   ğŸ¥ Clinical: {row['Clinical_Score']:.1f}\")\n",
    "    \n",
    "    # Add sample size warning\n",
    "    three_plus_count = int(row['Three_Plus_Abnormal_Numeric'] * row['Total Patients'] / 100)\n",
    "    if three_plus_count < 50:\n",
    "        print(f\"   ğŸš¨ WARNING: Only ~{three_plus_count} patients with 3+ abnormal tests - very limited sample!\")\n",
    "    elif three_plus_count < 100:\n",
    "        print(f\"   âš ï¸  CAUTION: Only ~{three_plus_count} patients with 3+ abnormal tests - limited sample\")\n",
    "\n",
    "# Show summary statistics\n",
    "print(f\"\\nğŸ“ˆ CANDIDATE SUMMARY:\")\n",
    "print(f\"Total Candidates: {len(classification_5_test_candidates)}\")\n",
    "if len(classification_5_test_candidates) > 0:\n",
    "    print(f\"Average Overall Score: {classification_5_test_candidates['Overall_Score'].mean():.1f}\")\n",
    "    print(f\"Average Patient Count: {classification_5_test_candidates['Total Patients'].mean():.0f}\")\n",
    "    print(f\"Score Range: {classification_5_test_candidates['Overall_Score'].min():.1f} - {classification_5_test_candidates['Overall_Score'].max():.1f}\")\n",
    "    \n",
    "    # Statistical adequacy assessment\n",
    "    adequate_count = 0\n",
    "    for _, row in classification_5_test_candidates.iterrows():\n",
    "        three_plus_count = int(row['Three_Plus_Abnormal_Numeric'] * row['Total Patients'] / 100)\n",
    "        if three_plus_count >= 100:\n",
    "            adequate_count += 1\n",
    "    \n",
    "    print(f\"Combinations with adequate sample size (â‰¥100 in 3+ abnormal group): {adequate_count}/{len(classification_5_test_candidates)}\")\n",
    "\n",
    "# Display the final candidate dataframe structure\n",
    "print(f\"\\nğŸ“‹ CLASSIFICATION_5_TEST_CANDIDATES DATAFRAME:\")\n",
    "print(f\"Shape: {classification_5_test_candidates.shape}\")\n",
    "\n",
    "# Save the results\n",
    "classification_5_test_candidates.to_csv('../model_data_insight/classification_5_test_candidates.csv', index=False)\n",
    "print(f\"\\nğŸ’¾ Results saved to '../model_data_insight/classification_5_test_candidates.csv'\")\n",
    "\n",
    "# Show recommended candidates with warnings\n",
    "if len(classification_5_test_candidates) > 0:\n",
    "    print(f\"\\nğŸ¯ RECOMMENDED 5-TEST COMBINATIONS FOR CLASSIFICATION MODEL:\")\n",
    "    print(\"=\"*85)\n",
    "    print(\"âš ï¸ PROCEED WITH CAUTION: All 5-test combinations have reduced statistical power!\")\n",
    "    print(\"=\"*85)\n",
    "    for i, (_, row) in enumerate(classification_5_test_candidates.iterrows(), 1):\n",
    "        three_plus_count = int(row['Three_Plus_Abnormal_Numeric'] * row['Total Patients'] / 100)\n",
    "        adequacy = \"ğŸš¨ VERY LIMITED\" if three_plus_count < 50 else \"âš ï¸  LIMITED\" if three_plus_count < 100 else \"âœ… ADEQUATE\"\n",
    "        \n",
    "        print(f\"{i}. {row['Test 1']} + {row['Test 2']} + {row['Test 3']} + {row['Test 4']} + {row['Test 5']}\")\n",
    "        print(f\"   Score: {row['Overall_Score']:.1f} | Patients: {row['Total Patients']:,} | 3+ Abnormal: {row['Three_Plus_Abnormal_Numeric']:.1f}% (~{three_plus_count} patients)\")\n",
    "        print(f\"   Statistical Adequacy: {adequacy}\")\n",
    "else:\n",
    "    print(f\"\\nâš ï¸  No combinations met the minimum score threshold of 50\")\n",
    "\n",
    "print(f\"\\nğŸ¯ FINAL RECOMMENDATIONS FOR 5-TEST CLASSIFICATION:\")\n",
    "print(\"=\"*65)\n",
    "print(\"1. âœ… USE these combinations only if you have specific clinical need for 5-test assessment\")\n",
    "print(\"2. âš ï¸  CONSIDER reducing to 3-4 test combinations for better statistical power\")\n",
    "print(\"3. ğŸ”„ COMBINE multiple datasets if available to increase sample sizes\")\n",
    "print(\"4. ğŸ“Š USE simpler models (fewer parameters) to avoid overfitting\")\n",
    "print(\"5. ğŸ”¬ VALIDATE extensively with cross-validation techniques\")\n",
    "print(\"6. ğŸ“ˆ FOCUS on 2-3 test abnormalities rather than 4-5 test abnormalities\")\n",
    "\n",
    "classification_5_test_candidates"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "a20b736a",
   "metadata": {},
   "outputs": [],
   "source": [
    "classification_5_test_candidates.to_csv('classification_5_test_candidates.csv', index=False)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
